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 1 
Summary 
 
The transmission of influenza A viruses from avian to other species involves numerous 
adaptive processes to overcome the species barrier. One major determinant of host-
range restriction is the viral hemagglutinin (HA). HA plays a crucial role in virus entry 
into the host cell by mediating receptor-binding and membrane fusion. Virus adaptation 
to mammals results in alteration of receptor-binding specificity. There is growing 
evidence that the HA-mediated membrane fusion activity contributes to host range 
restriction as well. This study aimed to identify host specific differences in membrane 
fusion properties and to characterise potential alterations during interspecies 
transmission. 
 
In the first part of the thesis Eurasian avian-like swine viruses that emerged by 
transmission of an avian H1N1 virus in pigs in the late 1970s in Europe were shown to 
have a higher pH optimum of HA-mediated fusion (pH 5.1-5.4) and a decreased HA 
stability when compared to avian precursors (pH 4.9-5.2). These results indicate that 
this avian-to-swine transmission was accompanied by changes in HA stability. 
Sequence comparison revealed eight amino acid substitutions that separate the HA of 
early avian-like swine viruses from their putative avian precursor. Furthermore, 
mutations in one of these positions contribute to the low stability phenotype. In 
agreement with natural avian-to-swine transmission, experimental adaptation of a 
potential avian precursor of the avian-like swine lineage to pigs resulted in a decreased 
HA stability. This states the first formal proof that viral membrane fusion and stability 
properties change during interspecies transmission.  
 
The second part of the thesis investigated differences in membrane fusion activity 
among different avian virus species. Comparison of H7 viruses from wild birds and 
domestic poultry suggests that Eurasian H7 poultry viruses have a higher pH optimum 
of membrane fusion (pH 6.2) and thus possess a lower stability than H7 viruses from 
wild birds (pH 5.2). Moreover, all tested Eurasian H7 viruses express a lower HA 
stability than HAs from other subtypes (H2, H3, H4, H5, H13, H14 und H16). Previous 
studies indicate that H5 viruses with low HA stability replicate but do not transmit via 
respiratory droplets in the ferret model (Imai et al., 2012; Herfst et al., 2012). Thus, it 
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is feasible, that H7 viruses originated from poultry are restricted in ferrets and humans 
to similar extend.  
 
In the last part, fusion properties of human pandemic and zoonotic viruses were studied. 
HAs of pandemic viruses from the last century initiated fusion in a narrow pH range 
between pH 5.0 and 5.2. In contrast, the swine-origin 2009 pandemic virus HA starts 
to fuse at a pH 0.2 units higher, which might be due to the swine origin of this HA. This 
further suggests that fusion characteristics continue to adapt in the course of subsequent 
circulation. The pH optimum of fusion of a zoonotic human H7N9 (2013) virus 
represents an intermediate in that it is lower when compared to putative ancestors 
circulating in wild birds, but still higher than that of typical human-adapted viruses. 
This may account for limited human-to-human transmission observed for this virus.     
 
In order to further investigate which changes in HA are needed for the emergence of 
avian viruses in humans, HA substitutions separating the 1968 Hong Kong pandemic 
virus HA from the putative avian precursor were examined. In addition to the well-
known switch in receptor specificity, binding avidity changed prior to or during the 
emergence in humans. In this study, no difference in viral stability was observed 
between the pandemic virus and the putative avian precursor. This indicates that the 
avian ancestor was already sufficiently stable to facilitate replication and transmission 
in humans. 
 
In sum, this study shows that membrane fusion properties vary between host species 
and alter during influenza A virus emergence in new hosts. This suggests HA-mediated 
fusion and HA stability to act as host range restriction factors. Alterations in membrane 
fusion activity and viral stability may not be essential for initial infection of new host 
individuals. However, an optimal stability seems to be necessary to facilitate 
transmission within populations of new host species. 
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Zusammenfassung 
 
Die Anpassung aviärer Influenza A Viren an neue Wirtsspezies umfasst eine Vielzahl 
von adaptiven Prozessen. Das Glykoprotein Hämagglutinin (HA) des Influenza A 
Viruses stellt dabei eine der Hauptdeterminanten der Wirtsrestriktion dar. Dies lässt 
sich auf die essentielle Rolle des HAs während des viralen Zelleintrittes zurückführen, 
wobei es sowohl die Bindung an den zellulären Rezeptor als auch die Fusion der viralen 
mit der endosomalen Membran vermittelt. Die Adaptation an die meisten 
Säugerspezies, inklusive Schwein, Frettchen und Mensch, resultiert in einer 
veränderten Rezeptorspezifität. Jüngste Studien deuten darauf hin, dass die HA-
vermittelte Membranfusion ebenfalls zur Limitierung des Wirtsspektrums beiträgt.  
Das Ziel der vorliegenden Arbeit war es wirtsspezifische Unterschiede in der 
Membranfusionsaktivität von Influenza A Viren zu identifizieren. Dabei sollten 
potentielle Veränderungen der Fusionseigenschaften während einer Übertragung auf 
neue Wirtsspezies charakterisiert werden. Hierbei lag der Fokus auf der Transmission 
sowohl zwischen Vogel und Schwein, als auch von tierischen Influenza A Viren auf 
den Menschen. 
Im ersten Teil der Arbeit wurde die Fusionsaktivität eurasischer aviär-ähnlicher 
Schweineviren untersucht, welche im Europa der späten 1970er Jahre bei der 
Transmission eines aviären H1N1 auf Schweine entstanden. Dabei konnte gezeigt 
werden, das aviär-ähnliche Schweineviren ein höheres pH Optimum der HA-
vermittelten Fusion und eine geringere HA-Stabilität aufweisen als ihre aviären 
Vorläufer. Dies deutet darauf hin, dass die Übertragung vom Vogel auf das Schwein 
mit einer Veränderung der HA-Stabilität einhergeht. Mittels Vergleich der HA 
Aminosäuresequenz früher aviär-ähnlicher Schweineviren mit ihren potentiellen 
aviären Vorläufern konnten acht Aminosäureunterschiede identifiziert werden. Es 
konnte gezeigt werden, dass eine dieser Mutationen zu der verringerten HA-Stabilität 
beiträgt. Übereinstimmend mit diesen Ergebnissen resultierte die experimentelle 
Adaption eines aviären Viruses an das Schwein in einer verringerten HA-Stabilität. 
Dies ist der erste experimentelle Nachweis, dass die virale Membranfusions- und HA-
Stabilitätseigenschaften sich im Zuge einer Interspeziesübertragung verändern. 
Der zweite Teil der Arbeit behandelt Unterschiede in der Membranfusionsaktivität von 
Viren verschiedener aviärer Spezies. Hierfür wurden H7 Viren verglichen die aus wild 
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lebenden Wasservögeln und domestiziertem Geflügel isoliert wurden. Eurasische H7 
Geflügelviren wiesen dabei ein höheres pH-Optimum der Fusion und damit eine 
geringe HA-Stabilität auf als H7 Viren aus wild lebenden Wasservögeln. Verglichen 
zu repräsentativen Viren anderer Subtypen (H2, H3, H4, H5, H13, H14 und H16) 
konnte für alle getesteten eurasischen H7 Viren eine geringere Stabilität beobachtet 
werden. Erste Studien mit H5 Viren zeigen, dass eine geringe HA-Stabilität eine 
Aerosoltransmission im Frettchen-Model limitiert. Da humane Influenza Viren 
vorwiegend über Aerosole übertragen werden, wäre es möglich, dass die geringe 
Stabilität von H7 Geflügelviren eine Übertragung auf den Menschen beschränkt.  
Im letzten Teil wurden die Fusionseigenschaften pandemischer und humaner 
zoonotischer Viren untersucht. Hämagglutinine pandemischer Viren des letzten 
Jahrhunderts induzieren Fusion in einem engen pH-Bereich zwischen pH 5.0 und 5.2. 
Im Gegensatz dazu fusioniert das HA der Schweinegrippe von 2009 bei einem um 0.2 
pH Einheiten höheren pH. Dies könnte auf den porzinen Ursprung dieses HAs 
zurückzuführen sein, was darauf hindeutet, dass die viralen fusogenen Eigenschaften 
einer fortgesetzten Adaption während einer andauernden Zirkulation in Schweinen 
unterliegen. Das pH-Optimum der Fusion eines zoonotischen H7N9 (2013) Virus weißt 
einen intermediären Phänotyp auf. Es zeigt einen geringeren pH der Fusion als putative 
Vorläufer in wild lebenden Wasservögeln, fusioniert jedoch bei einem höheren pH-
Wert als typische human-adaptierte Viren. Dies könnte zu der beobachteten geringen 
Mensch-zu-Mensch Übertragung dieses Virus beigetragen haben.  
Um zu untersuchen welche Adaptionen im HA essentiell für die Anpassung aviärer 
Viren an den Menschen sind, wurden die Aminosäuresubstitutionen, welche das HA 
des pandemischen 1968 Virus von seinen möglichen aviären Vorläufern unterscheidet, 
näher analysiert. Zusätzlich zu dem bereits beschriebenen Wechsel der 
Rezeptorspezifität konnte eine Veränderung der Rezeptorbindungsstärke beobachtet 
werden, welche während oder vor Übertragung auf den Menschen erworben wurde. 
Während dieser Untersuchung konnten keine Unterschiede in der viralen Stabilität 
zwischen dem pandemischen und dem putativen aviären Vorläufer detektiert werden. 
Dies deutet darauf hin, dass der aviäre Vorläufer bereits eine ausreichende Stabilität 
besaß um Replikation und Transmission im Menschen zu gewährleisten. 
Zusammenfassend zeigt diese Studie, dass sich die viralen 
Membranfusionseigenschaften von Influenza A Viren bei der Übertragung auf eine 
neue Wirtsspezies anpassen. Das deutet darauf hin, dass die HA-vermittelte Fusion und 
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die HA-Stabilität als Wirtsrestriktionsfaktoren fungieren. Veränderung der viralen 
fusogenen Eigenschaften könnten essentiell für eine initiale Infektion neuer 
Wirtsspezies sein. Damit scheint eine optimale virale Stabilität benötigt zu werden um 
Transmission zwischen Individuen einer neuen Wirtspopulation zu gewährleisten. 
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1 Introduction 
1.1 Historical overview of influenza   
 
Influenza viruses have posed a threat to humans for ages (reviewed in Lina, 2008; 
Morens and Taubenberger, 2010; Morens et al., 2010). Unspecific clinical signs 
complicated the identification of the causing disease. Even though records of past 
pandemics describe diseases with clinical manifestation typical for influenza infection, 
the source of the diseases remains obscure.  
One of the first recorded cases of contagious infection of the upper respiratory tract 
including influenza-like symptoms can be found in Hippocrates’ ‘Sixth Book of the 
Epidemics’. However, the hypothesis that an influenza virus may be the causing agent 
remains highly speculative. Several European reports suggest a pandemic affecting 
France, Italy and England between 1173 and 1174. However, the universal use of 
‘plaque’ for epidemics with significant mortality in this time hampers the retrospective 
reasoning.  
The term ‘influenza’ or ‘influenza di freddo’ (cold influence) was first recorded in 
1357, when an epidemic wave hit Florence in Italy. Later, in 1414, a large epidemic in 
France was described to rise like a “smelly and cold wind” affecting everyone from the 
poorest to the rich. The earliest documented outbreak generally accepted as a real 
influenza pandemic emerged in February 1427 in Southern Europe.  
Between 1500 and 1900, records about epidemic diseases became more detailed. The 
first well-described outbreak was documented in 1580. In the summer of that year, a 
contagious disease spread from Asia via Africa to Europe, resulting in a significant 
number of deaths in Spanish, French and Italian cities. Since then, the term ‘influenza’ 
has been used to describe such massive epidemics. In the 18th century, a global 
pandemic originating in China spread to Russia and subsequently westwards across 
Europe, reaching North America in the spring of 1781. This event was followed by 
further epidemics in the course of the 19th century (1790, 1803, 1817, 1830 and 1837).  
In 1889 an epidemic emerged in Russia with a high prevalence, infecting 40% of the 
population. Isolation of a so far unknown bacterium from patient sputum resulted in the 
discovery of Haemophilus influenza by Pfeiffer. For many years this bacterium was 
believed to represent the causative agent of influenza.  
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The first influenza A virus was cultivated in vitro more than ten years after the ‘Spanish 
flu’ of 1918. In 1931 the first influenza virus was isolated from pigs, followed by 
amplification of the first human influenza virus in 1934 (A/Puerto 
Rico/8/1934(H1N1)). Both viruses are descendants of the 1918 pandemic virus.      
Further global pandemics occurred within the last 100 years (1957, 1968 and 2009) and 
caused millions of deaths. The identification of the influenza A virus led to intense and 
continuing research (reviewed in Cox et al., 2004; Lina, 2008). 
 
1.2 Influenza A virus taxonomy 
 
Influenza A viruses form one out of five genera of the family Orthomyxoviridae. These 
five genera, influenza virus A, influenza virus B, influenza virus C, Thogotovirus and 
Isavirus (Wadell Harrach et al., 2011), display a similar genome structure of segmented, 
linear single-stranded RNA with negative polarity. Among the individual genera, the 
number of segments, the structure and number of glycoproteins as well as the host range 
differ.  
Both influenza A and B viruses have eight genome segments and possess two 
membrane associated glycoproteins, hemagglutinin (HA) and neuraminidase (NA). 
Whereas influenza A viruses can infect a variety of avian and mammalian species, 
including humans, influenza B viruses are restricted to humans. Influenza C viruses 
contain only seven segments and express no NA, but instead a protein with combined 
function of receptor-binding and sialidase activity, the hemagglutinin-esterase-fusion 
(HEF) protein (reviewed in: Krug and Fodor, 2013). Members of the Thogotovirus 
genus, Thogoto and Dhori viruses, harbour six and seven gene segments, respectively. 
Both viruses possess a non-influenza virus related protein (GP) which shares 
similarities with Baculovirus gp64 protein (Morse et al., 1992). 
Influenza A viruses are further sub-classified based on HA and NA antigenicity. Until 
today, 17 HA (H1-H17) and ten NA subtypes (N1-N10) have been identified. The 
WHO Memorandum (“A revision of the system of nomenclature for influenza viruses: 
a WHO memorandum.,” 1980) defined the full nomenclature for each new influenza 
isolate to include, in that order, virus type (A, B or C), the host of origin (except 
humans), the country of isolation, an individual strain number, and the year of isolation. 
For example, A/duck/Alberta/35/1976 (H1N1) defines an influenza A virus isolated 
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from a duck in Alberta in 1976.This virus belongs to the H1N1 subtype, 35 is the 
sequential number of the strain. 
 
1.3 Influenza A virus morphology and genome structure 
 
Influenza A virions have a spheroidal or filamentous shape with a diameter of 80 to 120 
nm (figure 1.1). The subviral components can be subcategorized into three major 
structures: viral envelope, matrix, and the ribonucleoprotein (RNP) core (reviewed in 
Nayak et al., 2013).  
The envelope is formed by a lipid bilayer, derived from the host cell plasma membrane 
during virus budding. The viral envelope incorporates three viral transmembrane 
proteins. The viral HA forms homotrimeric structures and represents the most abundant 
envelope protein (80%). The viral NA is embedded as a homotetramer into the envelope 
and with about 17% states the second highest membrane protein proportion. Each 
protein extends 10 to 12 nm from the membrane. A third transmembrane protein, M2, 
is incorporated into the viral membrane in minor quantities, forming a proton channel.  
The matrix protein M1 covers the inner side of the lipid bilayer. M1 interacts with the 
cytoplasmic tails of the membrane-associated proteins HA, NA, and M2, and at the 
same time binds to each of the eight RNPs within the virion core.  
Eight RNPs represent the large part of the virion core. Each RNP is formed by one of 
the eight different single-stranded RNA segments covered by several copies of the 
nucleoprotein (NP). A heterotrimeric polymerase complex consisting of PB1 
(polymerase basic protein 1), PB2 (polymerase basic protein 2) and PA (polymerase 
acid protein) binds to a partially double-stranded panhandle structure formed by 
conserved 5’ and 3’ RNA termini of each segment. This results in a twisted rod-like 
structure that is folded back and coiled on itself. Recently, minor proportions of non-
structural viral proteins were found to be present in the virion; these are NS1 and the 
nuclear export protein NEP/NS2 (reviewed in Nayak et al., 2013). 
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Figure 1.1: Influenza A virion. a Schematic illustration; modified from Clancy, 2008. b 
Electron microscopic picture of filamentous and spherical virions (Calder et al., 2010).  
The influenza A genome consists of eight single-stranded RNA segments with a 
negative polarity (vRNA). Each segment codes for up to three viral proteins (table 1). 
The three largest segments encode the polymerase complex proteins PB2 (segment 1), 
PB1 (segment 2) and PA (segment 3). Some influenza virus strains encode the 
proapoptotic PB1-F2 on segment 2, which is synthesized using the +1 reading frame. 
Segments four to seven code for the structural proteins HA (segment 4), NP (segment 
5), NA (segment 6), M1 (segment 7) and M2, a splice product of segment seven. The 
eighth segment encodes the nonstructural protein NS1 and the splice variant NEP/NS2.  
Coding regions of each segment are flanked by 3’ and 5’ non-coding regions. Each 
region can be separated into a highly conserved part at the ends of each segment, and 
variable segment-specific regions directly up- and downstream of the coding sequence.  
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Table 1: Overview of viral RNA segments and encoded proteins. The table was modified from 
Cox et al., 2004; Vasin et al., 2014. 
Genome 
Segment 
Length, 
nta Protein 
Length, 
aa Function 
1 2341 PB2 759 Component of the viral RNA transcriptase 
complex; recognition of the 5'-capped host pre-
mRNAs; affect host range and virulence 
2 2341 PB1 757 Catalytic subunit of viral RNA transcriptase 
complex; RNA-dependent RNA polymerase; 
required for both replication and transcription 
  PB1-F2  87 Influenza A virulence factor; induction of 
mitochondria-associated apoptosis; affects PB1 
polymerase activity 
  PB1 N40 718 N-terminal truncated form of PB1; maintenance 
of balance between PB1 and PB1-F2 expression 
3 2233 PA 716 Component of viral transcriptase complex; 
Promoter binding; RNA endonuclease activity 
  PA-X 252 Modulation of innate host response and viral 
virulence 
  PA-N155 562 Function unknown; not essential 
  PA-N182 535 Function unknown; not essential 
4 1778 HA 566 Surface glycoprotein; receptor-binding; 
membrane fusion; major antigen 
5 1565 NP 498 Major component of viral RNP complex; 
regulates nuclear cytoplasmic RNA transport 
6 1413 NA 454 Surface glycoprotein; sialidase activity; 
facilitates virion release from cell surface by 
removal of sialic acids from infected cells 
7 1027 M1 252 Forms matrix layer beneath viral envelope; 
multiple roles in infection and assembly; 
Involved in RNP nuclear export 
  M2 97 Ion-channel activity; involved in RNP release; 
splice product of segment 7 
  M42 99 Alternative splice product of segment 7; ion-
channel activity; not-essential 
8 890 NS1 230 Multifunctional non-structural protein; 
interferon antagonist; inhibits mRNA nucleus 
export; regulation of host and viral gene 
expression 
  
NS2 (NEP) 121 NS1 splice variant; structural component of 
viral particle; viral nuclear export protein 
    
NS3 174 NS1 splice variant; associated with mouse 
adaptation; function unknown 
a Influenza A virus A/PR/8/1934 (H1N1) 
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1.4 Influenza A virus replication cycle 
 
Viral replication is a complex process involving numerous viral and host cell factors 
(reviewed in: Krug and Fodor, 2013). HA-mediated virus adsorption to terminal sialic 
acid receptors attached to glycoproteins or lipids on the host cell surface initiates cell 
infection (figure 1.2). The viral sialidase NA helps to overcome the mucus barrier by 
cleavage of non-functional decoy receptors. Additionally, NA supports viral entry, 
facilitating elution from the cell surface in the course of a dynamic attachment-elution 
cycle during the entry process. Receptor-binding induces receptor-mediated 
endocytosis of the virion into clathrin-coated endocytotic vesicles. There is evidence 
that a minor fraction of virions is endocytosed using an alternative, clathrin-
independent pathway (de Vries et al., 2011; Rossman et al., 2012).  
The virus-containing endosomes mature to lysosomes and are acidulated by membrane 
associated H+-ATPases. The viral M2 proton channel allows protonation of the virion 
core. This mediates dissociation of M1 from RNP-associated NP proteins, preparing 
the release of RNPs into the cytoplasm. By the time the endosomal pH drops below a 
threshold, ranging from pH 5.5 to 5.0, a conformational transition of the HA is 
triggered. As a result, the HA fusion peptide integrates into the endosomal membrane 
and facilitates fusion of the viral and endosomal membranes (described in detail in 
1.5.2). Consequently, vRNPs are released into the cytoplasm.  
Unusual for negative-sense RNA viruses, transcription and replication of influenza A 
viruses take place in the nucleus. Two nuclear localization sequences (NLS) were 
identified in the NP protein. These motifs recruit alpha importins to RNPs and allow 
nuclear import using the classical import pathway (reviewed in Hutchinson and Fodor, 
2013). 
After nuclear import, primary transcription is initiated. A so far unknown mechanism 
of selective transcription restricts synthesis to primary transcript mRNA; namely, the 
polymerase genes, NP and NS1. At first, full length complementary RNA (cRNA) is 
synthesized along viral RNAs (vRNA). vRNAs contain 5’ triphosphates, where the 
viral polymerase complex can initiate cRNA synthesis de novo. The cRNA is used as a 
template for further vRNA amplification and subsequent mRNA production. Various 
models were proposed for cRNA and vRNA synthesis involving several viral (NP, viral 
polymerase proteins, NS1, NEP, small viral RNAs) and host proteins (e.g. MCM, 
UAP65, tat-SF1, capped RNA primers and ribonucleoside triphosphates; reviewed in 
INTRODUCTION 
 
 12 
Nagata et al., 2008; Resa-Infante et al., 2011). Nevertheless, the specific mechanism of 
vRNA and cRNA synthesis remains unknown. cRNA synthesis peaks early in infection, 
followed by vRNA synthesis starting two hours after infection. Together with vRNA 
synthesis, mRNA production increases within the first hours. 
As the viral polymerase is not able to initiate de novo mRNA transcription, primers are 
excised from cellular pre-mRNAs. The process, called ‘cap snatching’, transfers 
cellular 5’-cap structures from mRNA to vRNAs. This process is initiated by vRNA 
binding to PB1. The binding prompts the association of 5’-cap structures of cellular 
mRNAs with PB2. After annealing to the 3’ ends of the vRNA, the cellular primer is 
cut 10 to 13 nucleotides downstream of the 5’-cap by the endonuclease PA. The free 3’ 
end is then used to prime further transcription performed by the viral RNA-dependent 
RNA-polymerase PB1. The transcription elongates until a uridine repetition of four to 
seven units is reached 16 to 20 nucleotides from the 5’ end. Along the uridines a poly 
A tale is synthesized by polymerase stuttering. M2 and NS2 mRNAs are spliced by the 
cellular spliceosome. As splicing is incomplete, only 10 to 15% of the mRNAs are 
converted to M2 and NEP/NS2 mRNA, respectively (reviewed in: Krug and Fodor, 
2013).  
In a next step, the poly-adenylated mature mRNA is exported from the nucleus for 
subsequent translation. To facilitate export, viral polymerase complexes interact with 
the host polymerase II to recruit the transcription export (TREX) complex and 
NXF1/TAP (reviewed in: Krug and Fodor, 2013). 
Localization sequences in viral mRNAs coding for membrane-associated proteins HA, 
NA and M2 direct them to ribosomes at the rough endoplasmic reticulum (rER). During 
translation, the growing polypeptide chains are translocated into the rER lumen and 
transmembrane domains are inserted into the rER membrane. During maturation the 
proteins travel along the Golgi- and trans-Golgi network and are modified post-
translationally by glycosylation and palmitoylation (HA and M2). Additionally, HA 
precursor proteins (HA0) are cleaved into the two subunits HA1 and HA2 by intra- or 
extracellular host-proteases. Finally, the membrane-associated HA, NA and M2 
proteins are transported to the cell membrane via the trans-Golgi-network (reviewed in: 
Krug and Fodor, 2013).  
The viral mRNAs of the remaining proteins (M1, NP, PB1, PB2, PA, NS1 and 
NEP/NS2) are translated at free cytoplasmic ribosomes. After synthesis, these proteins 
are relocated to the nucleus. Within the nucleus, PB1, PB2, and PA condense to new 
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polymerase complexes. With increasing concentration of polymerase complexes, viral 
mRNA transcription is inhibited, whereas vRNA synthesis continues. During 
transcription, the nascent vRNA is encapsidated by NP proteins, which interact with 
viral polymerase complexes resulting in RNP formation (reviewed in: Krug and Fodor, 
2013).  
In late infection stages, newly assembled RNPs are exported from the nucleus. The 
matrix protein M1 directly binds RNPs and interacts with NEP/NS2. The nuclear export 
factor Crm1 is then recruited by nuclear export sequences (NES) in NEP/NS2 causing 
nuclear depletion of RNPs. In the host cell cytoplasm, RNPs interact with recycling 
endosomes through Rab11; a protein of the vesicular transport system. Endosome-
associated RNPs are transported to the apical plasma membrane, making use of the 
microtubule network. A small proportion of RNPs are observed to migrate 
independently of Rab11 by diffusion or short range movements along actin filaments 
(reviewed in Hutchinson and Fodor, 2013).  
 
 
Figure 1.2: Schematic illustration of influenza A replication cycle. The picture was modified 
from Neumann et al., 2009. 
At the cell membrane, assembly and subsequent budding is initiated at cholesterol- and 
sphingolipid-enriched membrane patches, so called lipid raft domains. Whereas HA 
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and NA are lipid raft associated, M2 accumulates at the rim of these domains (Leser 
and Lamb, 2005; Takeda et al., 2003). M1 proteins then bind to HA and NA 
cytoplasmic tails and interact with RNPs via NP binding at the same time. Packaging 
signals in the terminal regions of each segment lead to complex formation of specific 
segments (reviewed in Hutchinson et al., 2010). 
The detailed mechanism of virus budding is still poorly understood. Individually 
expressed HA, NA and M1 proteins are found to alter membrane curvature forming 
virus like particles (VLPs). Thus, the currently proposed model suggests that HA and 
NA initiate the budding process. Binding to HA and NA cytoplasmic regions triggers 
M1 polymerization at the budding site, resulting in prolonged budding. At the budding 
neck, M2 facilitates membrane scission by curving the lipid bilayer (reviewed in 
Rossman and Lamb, 2011). The released virion may remain attached to the host cell 
through HA-bound sialic acids. To free budding virions, NA sialidase activity 
facilitates removal of sialic acids at the cell surface (reviewed in Rossman and Lamb, 
2011).   
 
1.5 Glycoproteins of influenza A virus 
1.5.1 Hemagglutinin 
 
The influenza A virus HA, a type I transmembrane protein, is encoded by the fourth 
gene segment, and the mature protein consists of 566 amino acids. According to 
structural and antigenic properties of the 17 HA subtypes, they cluster into two groups 
(Gamblin and Skehel, 2010): group 1 (H1, H2, H5, H6, H8, H9, H11, H12, H13, H16, 
H17) and group 2 (H3, H4, H7 H10, H14, H15). 
The first HA structure was resolved using X-ray crystallography for bromelain-released 
HA ectodomain of A/Aichi/1968 (H3N2) (Wilson et al., 1981). A highly conserved 
fusion domain close to the viral envelope and a membrane distal globular head domain 
linked by a stalk region can be distinguished. The core of the fusion domain forms a 54 
residue triple stranded coiled coil, which is flanked by spring loaded B loops, α-helices 
and membrane proximal regions (figure 1.3a). 
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Figure 1.3: Influenza Hemagglutinin. a Molecular and schematic model of a H1 HA trimer 
(2WRH, Protein Data Bank) with bound sialic acid receptor. Green, HA1; cyan, HA2; red, 
fusion protein; blue, receptor-binding site. SP, Signal peptide; TM, Transmembrane domain; 
CT, Cytoplasmic tail. b Receptor-binding site formed by 130 loop, 190 loop and 220 loop. 
Amino acids contacting sialic acid (Neu5Ac) are indicated. Hydrogen bonds are depicted as 
dotted lines. 
In HA0, the first 12 amino acids of the HA2 subunit form a prominent loop that is 
protease-accessible. After cleavage, the fusion peptide (amino acid 1 to 20 in HA2) is 
located in the protein close to the viral envelope fixed by hydrogen bonds. The fusion 
domain is kept in a high-energy conformation, partly stabilized by the globular head 
domain. The distal globular head harbours the receptor-binding pocket and a vestigial 
esterase subdomain. The head domain contains most of the major antigenic sites and is 
poorly conserved. 
HA is synthesized as a HA0 precursor at the rER. During transportation through the 
trans-Golgi network it is glycosylated and palmitoylated at several positions. In the 
course of, post-translational processing, HA0 is proteolytically cleaved into two 
subunits (reviewed in Böttcher-Friebertshäuser et al., 2014; Steinhauer, 1999), HA1 
and HA2, which remain connected via a single disulphide bridge (figure 1.3a). HA0 
cleavage is essential for a low-pH triggered conformational change necessary for 
membrane fusion induction. Most avian and mammalian viruses harbour a single 
arginine, or in some cases a single lysine, at the cleavage site (reviewed in Böttcher-
Friebertshäuser et al., 2014; Steinhauer, 1999). This monobasic cleavage site serves as 
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a substrate for trypsin-like proteases such as mini-plasmin (Murakami et al., 2001) or 
ectopic anionic trypsin I (Towatari et al., 2002). Recently, additional proteases in 
human airway epithelium, with similar cleavage motifs, were described to cleave HA0: 
TMPRSS2 (transmembrane protease serine S1 member 2), HAT (human airway 
trypsin-like) protease (Böttcher et al., 2006b) and TMPRSS4 (Chaipan et al., 2009). 
Expression of these proteases is restricted to defined tissues. This restricts Influenza A 
virus replication to the gastrointestinal tract in birds and the respiratory tract in 
mammals. In rare cases low pathogenic avian influenza (LPAI) viruses with a 
monobasic cleavage site acquire multiple repetitions of basic residues in the cleavage 
site by insertion or amino acid substitutions. These motifs (consensus sequence: R-X-
R/K-R) are cleaved by ubiquitous available proteases such as furin or PC5 and PC6, 
resulting in systemic infections with high mortality rates. So far, these highly 
pathogenic avian influenza (HPAI) viruses arose from H5 and H7 subtypes only, with 
limited spread to humans.  
During the viral replication cycle HA has two functions: i) virus adsorption to the cell 
via receptor-binding and ii) fusion of the viral and the endosomal membrane during cell 
entry. 
 
1.5.1.1 Receptor-binding 
 
Receptors for influenza A viruses are terminal sialyloligosaccharides (Sialic acids; 
Gottschalk, 1957) which are part of the cellular glycocalyx, composed of glycolipids, 
glycoproteins, proteoglycans and glycophospholipids (Varki and Sharon, 2009). Sialic 
acids represent the most diverse sugar on the cell surface with all sialic acid species 
sharing a nine-carbon backbone. The most common sialic acid species in mammalian 
cells are N-acetylneuraminic acids (Neu5Ac) and N-glycolylneuraminic acids 
(Neu5Gc) (Varki and Varki, 2007). Whereas Neu5Gc is not expressed in humans and 
birds, pigs present both Neu5Ac and Neu5Gc (Chou et al., 1998; Muchmore et al., 
1998; Schauer et al., 2009; Walther et al., 2013). The horse trachea predominantly 
contains Neu5Gc (Suzuki et al., 2000). 
 
Receptor-binding takes place at a topological depression in the globular head of HA1; 
the receptor-binding pocket (RBP) (figure 1.3b). The amino acids which contact 
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terminal sialic acids on oligosaccharides are conserved among subtypes (Nobusawa et 
al., 1991; Weis et al., 1988, 1990). The RBP bottom is formed by four conserved amino 
acids two tyrosine’s (residue 98 and 195, H3 numbering here and following), one 
tryptophan (residue 153) and one histidine (residue 183). The edges of the depression 
are built by the ‘130-loop’ (residues 133-138), the ‘190-helix’ (residue 190-198) and 
the ‘220-loop’ (residues 221-228) (reviewed in Skehel and Wiley, 2000). For sialic acid 
recognition mainly hydroxyl groups in C8 and C9 within the sialic acid are important 
(Kelm et al., 1992; Matrosovich et al., 1992).  
Differences in the chemical linkage between sialic acids and the following sugar 
correlates with viral host species (Rogers et al., 1983; Rogers and D´Souza, 1989; 
Rogers and Paulson, 1983). Whereas avian and equine influenza viruses preferably bind 
to terminal sialyl-galactosyl residues linked by a α2,3 linkage (Neu5Acα2,3Gal), most 
mammalian viruses, including human and pig viruses, display strong binding to 
terminal α2,6-linked moieties (Neu5Acα2,6Gal; Connor et al., 1994; Gambaryan et al., 
2005; Ito et al., 1998; Matrosovich et al., 2000, 1997; Nobusawa et al., 1991; Rogers 
and D´Souza, 1989) (figure 1.4).  
The diverse viral receptor-binding preferences correlate with the availability of 
sialyloligosaccharides at the infection site. Studies on the receptor distribution in 
epithelial cells of duck intestines, the site of infection in aquatic birds, reveal a strong 
abundance of Neu5Acα2,3Gal but no Neu5Acα2,6Gal (Gambaryan et al., 2002, 2003; 
Pillai and Lee, 2010). Ciliated cells of the human airway epithelium show high levels 
of Neu5Acα2,3Gal surface expression. In contrast, non-ciliated cells possess mainly 
Neu5Acα2,6Gal sialic acid moieties and efficient replication in this cellular subset 
seems to be crucial for human infection. Type II pneumocytes express both 
Neu5Acα2,3Gal and Neu5Acα2,6Gal (Matrosovich et al., 2004). Thus a switch in the 
receptor-binding specificity is needed for the establishment of avian viruses in pigs and 
humans (reviewed in Baigent and Mccauley, 2003; Horimoto and Kawaoka, 2001; 
Matrosovich et al., 2000). In agreement with receptor availability, human and avian 
viruses differ in their cell tropism upon human infection. The respiratory epithelium of 
pigs was believed to contain both receptor types (Ito et al., 1998; Nelli et al., 2010; 
Scholtissek, 1990), leading to the common notion of pigs as ‘mixing vessel’ during 
human adaptation of avian viruses (Kida et al., 1994). However, current knowledge 
suggests that the receptor distribution in pigs is similar to the human respiratory tract 
(Van Poucke et al., 2010) and that pigs are not unique in the role as intermediate host. 
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Some avian species, e.g. chickens and common quail, are found to express both α2,3- 
and α2,6-linked sialic acids on respiratory and intestinal epithelia (Costa et al., 2012; 
Nelli et al., 2010; Trebbien et al., 2011). 
 
Figure 1.4: Structure of human (α2,6) and avian type (α2,3) sialic acid receptors. Gal, 
galactose; R, penultimate oligosaccharide, usually ß1-3/4GlcNAc or ß1-3GalNAc. 
All pandemic viruses preferably bind to Neu5Acα2,6Gal-terminated sugars, although 
weak binding to avian type receptors was detected for some isolates (Rogers and 
D´Souza, 1989). Structural studies revealed that the switch of receptor preference is 
accomplished by amino acid substitutions which “widen” the RBP (Gamblin et al., 
2004). 
In human H2 and H3 viruses the two amino acid substitutions, Q226L and G228S (H3 
numbering), determine a switch in receptor-binding preference from avian (α2,3 
linkage) to human type (α2,6 linkage) receptors (Connor et al., 1994; Naeve et al., 1984; 
Rogers and Paulson, 1983). Additional mutations in close proximity (residues 136, 190 
and 225; H3 numbering) modulate binding specificity and affinity (Martin et al., 1998; 
Matrosovich et al., 2000; Nobusawa et al., 2000). For human H1 viruses introduction 
of asparagine in residues 190 and 225 facilitates a switch in receptor-binding specificity 
(Glaser et al., 2005; Matrosovich et al., 2000). 
Most avian viruses share general binding to terminal Neu5Aca2-3Gal, but differ in 
recognition of modified subterminal saccharides. Duck viruses from various subtypes 
(H1 to H5, H9 and H11) preferably recognize Neu5Acα2,3Gal connected by a ß1-3 
linkage to the penultimate sugar, e.g. Neu5Acα2-3Galß1-3GlcNAc and Neu5Acα2-
3Galß1-3GlcNAc. Additional sulfation of the subterminal GlcNAc residue at the 6-OH 
group does not influence binding. In contrast, fucosylation significantly reduces 
binding (Gambaryan et al., 2006, 2005, 2008). 
Gull viruses of subtypes H4, H6, H13 and H14 show high binding avidity to fucosylated 
α2,3 sialyloligosaccharides (Neu5Acα2-3Galß1-4(Fuca1-3)GlcNAc; Neu5Acα2-
3Galß1-3(Fuca1-3)GlcNAc), unaffected by the type of linkage to the subterminal sugar 
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(Gambaryan et al., 2005; Yamnikova et al., 2003). Terrestrial poultry H5, H7 and H9 
viruses show most abundant binding to fucosylated and sulfated sialyloligosaccharides 
with ß1-4 connections between terminal and penultimate sugar residues; e.g. 
Neu5Acα2-3Galß1-4(6-O-HSO3)GlcNAc, Neu5Acα2-3Galß1-4(Fuca1-3)(6-O-
HSO3)GlcNAc (Gambaryan et al., 2005, 2008, 2004). Accordingly, H5 and H9 viruses 
with ‘duck-virus-like’ and ‘poultry-virus-like’ binding properties were isolated from 
corresponding species (Gambaryan et al., 2005, 2008, 2004). Additionally, avian H5 
and H7 HAs are found to have more glycosylation sites, which are associated with 
reduced binding affinity (Matrosovich et al., 1999).  
Interestingly, some avian viruses show limited binding to human type receptors. For 
example, several quail H9N2 (Matrosovich et al., 2001; Saito et al., 2001) and a few 
Eurasian poultry H7 viruses (Belser et al., 2008; Gambaryan et al., 2008; Yang et al., 
2010) were identified to recognize Neu5Acα2-6Gal. In consistence with binding 
specificities, chickens and quails possess both Neu5Acα2-3Gal- and Neu5Acα2-6Gal-
terminated sialyloligosaccharides at the respiratory and intestinal epithelia (reviewed 
in Nicholls et al., 2008). 
Human H7N9 isolates obtained in Southeast Asia during an outbreak in 2013 display 
binding to both human and avian type receptors (Ramos et al., 2013; van Riel et al., 
2013; Watanabe et al., 2013; Zhou et al., 2013). As a consequence, they effectively 
attach to cells of the human upper respiratory tract as well as type I and type II 
pneumocytes in the lower respiratory tract (van Riel et al., 2013). The enhanced binding 
to α2,6-linked sialic acids is conferred by a leucine at residue 226, a substitution 
facilitates human type binding in H9N2 viruses, too. Potentially, binding was further 
enhanced by the introduction of valine at residue 186, which was reported to influence 
H7 HA receptor-binding (Gambaryan et al., 2012; Yang et al., 2013). Unlike human-
adapted H3 viruses, none of the H7N9 viruses contain 228S.  
 
1.5.1.2 Membrane fusion 
 
The second function of HA during viral cell entry is to mediate fusion of the viral and 
endosomal membranes  (reviewed in Russell, 2014).  
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Figure 1.5: Illustration of HA-mediated membrane fusion. a Schematic illustration of 
influenza A cell entry (http://www.virology.ws). b Structural rearrangement of HA during cell 
entry following acidification. The B loop (cyan) of the meta-stable neutral pH HA (2WRH, 
protein data bank) connecting the A (purple) and B helix (green) folds back into an alpha helix 
upon acidification (1HTM, protein data bank).  
HA-mediated receptor-binding initiates virion internalization into the host cell, by 
clathrin-mediated or clathrin-independent endocytosis (Lakadamyali et al., 2004; 
Matlin et al., 1981). Following internalization, virion-containing vesicles are 
transported through the endosomal pathway (figure 1.5a). The endocytosed material is 
exposed to pH 6.5 to 6.0 within the first 5 minutes. This early endosome is further 
acidulated by H+-ATPases to pH 5.5 to 5.0 in late endosomes and up to pH 4.8 in 
lysosomes (Sun and Whittaker, 2013). 
With decreasing pH, the M2 ion channels allow protonation of the virion core. As a 
result, the M1-RNP interaction is weakened, which assists RNP release later in 
infection (reviewed in Scott and Griffin, 2015).    
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At a threshold pH, the meta-stable HA undergoes a conformational transition, starting 
with distortion of the globular head and relaxation of the B loop (residues 56-75, H3 
numbering) (figure 1.5b). Protons penetrate into the stalk region and induce a 
conformational change of the central helices (Xu and Wilson, 2011). Dissociation of 
the globular head allows the B loop to fold down, extending helix A (residues 76-126) 
through helix C (residues 38-55). This energetically favourable conformation induces 
the insertion of the fusion peptide into the target membrane. HA2 residues 106 to 112 
shift from the coiled coil structure to a reversed turn, allowing the membrane-proximal 
region to zip up into the central coiled coil. This process brings the transmembrane 
domain in close proximity to the fusion peptide and results in hemifusion of the outer 
leaves of the membrane bilayers. The following fusion of the inner lipid layer creates a 
fusion pore, leading to vRNP release into cytoplasm. To create a fusion pore, at least 
six HAs have to act together (Dobay et al., 2011).  
The threshold pH of fusion induction differs among virus strains and HA subtypes 
(Galloway et al., 2013; Scholtissek, 1985). To date, over 70 amino acid residues were 
identified to influence the pH optimum of fusion. They cluster in regions which 
dramatically change in secondary and tertiary structure during the conformational 
transition (reviewed in Russell, 2014). In addition, the enzymatic activity of NA was 
described to influence the pH of HA-mediated membrane fusion (Reed et al., 2010; Su 
et al., 2009) by a so far unknown mechanism. 
Most of the pandemic viruses emerged during the twentieth century fuse at pH 5.2 to 
5.0 (Galloway et al., 2013), leading to the classical point of view that membrane fusion 
occurs at the stage of the late endosome. In contrast, some swine viruses and the 
majority of tested H5N1 isolates induce the HA conformational transition between pH 
4.6 and 6.0 (Galloway et al., 2013; Scholtissek, 1985), suggesting fusion induction at 
earlier stages during endosome maturation. In addition, viral adaptation to different cell 
lines alters pH optimum of membrane fusion (Lin et al., 1997; Murakami et al., 2012).  
 
The energy barrier to induce transition of the meta-stable pre-fusion structure to the 
post-fusion conformation can also be overcome by heat, denaturant urea or low pH 
conditions (Carr et al., 1997; Ruigrok et al., 1986; Scholtissek, 1985). As the 
irreversible rearrangement of the protein abolishes HA receptor-binding capacity 
(Skehel and Wiley, 2000), the absence of a target membrane leads to viral inactivation. 
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likely to lose infectivity in acidic environment during transmission and at the infection 
site prior infection (Reed et al., 2010).  
For example, mutations in the stem region of an H9N2 HA affecting HA stability seem 
to be essential for transmission in ferrets (Sorrell et al., 2011). Recent studies show that 
HA stability also modulates transmission efficiency of in vivo adapted H5N1 viruses 
(Herfst et al., 2012; Imai et al., 2012; Linster et al., 2014). Thus, HA environmental 
stability is associated with the pH at which HA-mediated fusion is initiated, and there 
is accumulating evidence that HA stability influences inter- and intra-species 
transmission (discussed in detail in 1.7). However, to date there is no formal proof that 
viral stability changes in the course of host switch. In addition, there is a gap in current 
knowledge as to whether the pH optimum of fusion and HA stability vary among 
viruses from different species. 
 
1.5.2 Neuraminidase 
 
The influenza A virus NA is a type II transmembrane glycoprotein, which is embedded 
in the viral membrane forming a tetramer complex stabilized by calcium (reviewed in 
Air, 2012). It consists of an amino-terminal signal domain, which is not cleaved and 
forms a highly conserved six amino acid cytoplasmatic tail, important for virion 
incorporation. The NA has a box-shaped head containing the catalytic centre (figure 
1.6a) and major antigenic sites. The NA head is linked to the viral membrane by a stalk 
region of varying lengths, depending on subtype and host species (reviewed in Air, 
2012). Within the host cell single monomers are synthesized at the rough endoplasmic 
reticulum and further processed in distal Golgi vesicles followed by transport to the cell 
membrane.  
The catalytic side forms a deep pocket on the distal surface of the head domain and 
catalyses the cleavage of α-ketosidic linkages between terminal sialic acids and the 
adjacent sugar (Gottschalk, 1957). Within the catalytic centre nine highly conserved 
amino acids (figure 1.6b), of which six are basic (R118, R152, R224, R292, and R371), 
two acidic (E119 and E276) and two hydrophobic (W178 and I222), contact the sialic 
acid (Lentz et al., 1987).  
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Figure 1.6: Influenza A virus neuraminidase. a Structure of an N1 neuraminidase tetramer 
(2HTY, protein data bank) in complex with sialic acid. Catalytic centre is coloured in purple, 
hemadsorption site (HAD) in cyan. b Conserved amino acids forming the catalytic centre 
binding sialic acid. Hydrogen bonds are indicated as dotted lines. 
NA promotes viral entry and virion release from the cell by cleavage of terminal sialic 
acids. During cell entry NA cleaves soluble receptor analogues expressed in human 
mucus, preventing competitive inhibition of HA. After virion assembly and in the 
course of viral budding, NA depletes sialic acids from the cell membrane at the budding 
site. This process facilitates both virion detachment from the cell surface and prevention 
of virion agglutination after release (reviewed in Air, 2012).  
Analogous to HA receptor-binding specificity NA recognizes different sialic acid 
substrates, with a preference depending on the host organism. Avian NA cleaves 
NeuAcα2,3Gal preferred over NeuAcα2,6Gal. In correspondence to receptor-binding a 
switch in the NA substrate preference from NeuAcα2,3Gal to NeuAcα2,6Gal was 
observed for human N2 NA after introduction into the human population (Baum and 
Paulson, 1991). The substrate specificity is mainly determined by glutamic acid in 
position 276 within the catalytic centre (Kobasa et al., 1999).   
For many years, NA activity is believed to play a role in host range restriction (Hinshaw 
et al., 1983b). For example, NA from viruses isolated from land-based birds exhibits a 
stalk deletion which decreases catalytic activity (Banks et al., 2001; Bender et al., 1999; 
Matrosovich et al., 1999). This deletion in many cases is accompanied by changes in 
HA receptor-binding avidity (Baigent and McCauley, 2001; Matrosovich et al., 1999; 
Spackman et al., 2003) and most likely reflects adaptation to differences in sialic acid 
availability. The compensation of altered receptor-binding avidity by modification of 
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NA enzymatic activity illustrates that a balance between HA binding and NA activity 
is needed for efficient virus replication (reviewed in Hughes et al., 2000; Wagner et al., 
2002). Additionally, the sialidase activity of NA supports infection inducing apoptosis 
by TGF-ß activation (Schultz-Cherry and Hinshaw, 1996).  
Since NA activity is crucial for replication in humans (reviewed in Air, 2012), the NA 
represents a target for antiviral treatment. Sialidase inhibitors, such as Oseltamivir 
(TamifluTM), inhibit NA activity in a competitive way by blocking the catalytic centre. 
NA inhibitors are widely used for influenza A virus treatment in humans. At the same 
time, a rapid occurrence of escape mutants harbouring a single point mutation (E199G) 
(Gubareva et al., 1997) can be observed.        
 
1.6 Influenza A virus ecology  
 
The natural reservoir of influenza A viruses are wild aquatic birds of the orders 
Anseriformes (geese, ducks and swans) and Charadriiformes (gulls and shorebirds) 
from which almost all subtype combinations of NA and HA could be isolated (reviewed 
in Fouchier and Guan, 2013). Occasionally, influenza viruses spread to other avian 
species, including domestic poultry such as chickens, turkeys and quail, or mammalian 
species (e.g. pigs, horses, several carnivores including dogs and cats as well as sea 
mammals and humans) (figure 1.7). In rare cases continued circulation leads to virus 
adaptation to the new host resulting in new host-specific lineages. The diversity of 
subtype combinations isolated from non-aquatic avian and mammalian species is 
limited (reviewed in Yoon et al., 2014). Thus, interspecies transmission seems to be 
restricted by several viral and host properties. For example, avian viruses replicate 
poorly in the porcine and human respiratory tract as receptor abundance differs between 
avian and mammalian hosts. However, this restriction is not complete as avian viruses 
are frequently isolated from other species.  
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Figure 1.7: Influenza A virus ecology. The illustration was modified from Webster et al., 1992. 
Currently, three endemic Influenza A virus subtypes are circulating in pigs, forming 
distinct geographically restricted lineages; H1N1, H3N2 and H1N2 (Vincent et al., 
2014). Many of these viruses are descendants of human viruses. Although there are 
several reports of sporadic infections with avian viruses, only one circulating lineage, 
the so-called avian-like swine lineage, originated from an avian source. Over the last 
two decades, swine viruses were frequently isolated from humans (reviewed in Yoon 
et al., 2014) and turkeys (Olsen et al., 2003). Based on the avian and human receptor 
type distribution, pigs have been postulated as an intermediate host during the 
emergence of pandemic human strains as well (Ito et al., 1998; Scholtissek et al., 1983). 
Still, there is phylogenetic evidence indicating a genetic flow from man to pigs rather 
than the other way round (reviewed in Yoon et al., 2014). 
Domestic birds are susceptible to numerous subtypes, normally presenting mild 
symptoms or no disease at all (reviewed in Franca and Brown, 2014). The majority of 
viruses isolated from poultry species belong to the subtypes H5, H6, H7 and H9 
(reviewed in Neumann and Kawaoka, 2015). Viruses from the H5 and H7 lineages may 
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evolve into highly pathogenic viruses upon introduction into poultry by generation of a 
multiple basic amino acid motif in the HA cleavage site. This results in cleavage by 
ubiquitous proteases facilitating systematic spread and mortality rates up to 100% 
(reviewed in Franca and Brown, 2014).  
Among terrestrial poultry quails are unique, as they support replication of a wide 
spectrum of influenza viruses. As the quail respiratory tract possesses both avian and 
human type receptors, quails may act as an intermediate host during human adaptation 
(Perez et al., 2003). However, no quail-to-human transmission has been described yet. 
 
Influenza virus infections are common respiratory diseases in horses. In 1956, H7N7 
viruses were found to circulate in the horse. After the occurrence of an H3N8 virus, 
first isolated in 1963, the H7N7 virus seemed to be eradicated step by step from the 
horse population (Webster et al., 1992). Today, H3N8 viruses circulate globally in 
horses, forming two geographically distinct lineages; American and European H3N8 
viruses (reviewed in Yoon et al., 2014). The coincidence of widespread respiratory 
diseases in horses and man before 1900 suggests horses may have served as 
intermediated hosts in the past (reviewed in Cox et al., 2004). 
Mammalian carnivores, such as cats and dogs, had not been considered as influenza 
virus hosts for a long time. Recent studies, however, describe two influenza subtypes 
circulating in dogs: H3N8 virus of avian origin and avian-like H3N2 viruses. Cats were 
found to be infected with viruses of avian (H7N3) and mammalian origin (human H2N2 
and H3N2; seal H7N7; reviewed in Yoon et al., 2014). 
Sporadically, influenza viruses are isolated from marine mammals as well. Between 
1979 and 1980, outbreaks of H7N7 and H4N6 viruses resulted in a mass mortality 
among North American seals. Later, H4N6 and H3N3 viruses were isolated from tissue 
samples of stranded seals. In whales, viruses of the H13 subtype were detected at 
several occasions (reviewed in Yoon et al., 2014).  
Even though bats harbour a variety of different virus species, so far they have not been 
considered as reservoir for influenza viruses. Recently, the genomes of two new 
influenza subtypes were amplified from bats; H17N10 and H18N11 (Tong et al., 2013).  
 
The variety of influenza A hosts increases the risk of human infection. Within the 
massive increase in food demand and the growing population during the last century, 
the interface between influenza virus hosts is enlarged tremendously. For example, 
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backyard poultry farms and live poultry markets present optimal conditions for 
interspecies transmission and the exchange of viruses between waterfowl and terrestrial 
poultry. Additionally, the housing conditions of domesticated pigs of populations in a 
condensed area may facilitate rapid virus amplification. Therefore, domestic animals 
such as poultry and pigs which are in frequent contact with humans may act as potential 
intermediate hosts in the course of influenza virus transmission to man (Cauldwell et 
al., 2014). 
 
1.6.1 Avian influenza 
 
Wild birds are believed to state the natural reservoir of influenza A viruses (Olsen et 
al., 2006). For most of the viruses isolated from other hosts (humans, cats, seals, whales, 
pigs, horses and several bird species), an avian origin could be proven phylogenetically 
or antigenically (Li et al., 2004; Shortridge, 1992; Webster et al., 1992). This suggests 
avian species as the natural reservoir of influenza A viruses (Kawaoka et al., 1988; 
Webster et al., 1992). 
Infection of avian species is mostly asymptomatic and restricted to the intestinal tract 
(Webster et al., 1978), but H5, H7 and H9 HPAI viruses can cause lethal systemic 
infection in poultry and aquatic birds. 
The efficiency of virus replication after bird-to-bird transmission strongly depends on 
the species, virus strain and environmental factors (Alexander, 2007; Alexander et al., 
1978; Narayan et al., 1969; Westbury et al., 1981). This may explain why out of the 
variety of influenza A virus subtypes mainly H5, H7 and H9 are circulating in domestic 
poultry species. The genetic similarity among aquatic bird and poultry viruses of these 
subtypes suggests continued gene exchange with ongoing cross-infections (Alexander, 
2007)   
In 1997 a H5N1 HPAI virus outbreak was detected on poultry markets in South East 
China. The virus origin was traced back to a progenitor circulating in geese one year 
earlier. In May 1997 the first human case of H5N1 HPAI virus infection was 
documented in Hong Kong. By December 18 cases were confirmed of which six died 
(Shortridge et al., 1998). Most cases were linked to direct poultry contact with limited 
human-to-human spread (Buxton Bridges et al., 2000; Li et al., 2004; Peiris et al., 2004; 
Subbarao et al., 1998). After eradication of this H5N1 virus from domestic poultry by 
INTRODUCTION 
 
 28 
the culling of millions of animals, the virus continued to circulate undetectably in Asian 
poultry. Later, in 2003/04, a descendant of this virus re-emerged in South East Asia 
(reviewed in Alexander, 2007). Since then H5N1 viruses have been endemic in South 
East Asian poultry markets.  
Avian H7 viruses separate into the North American and Eurasian lineage with little 
genetic exchange between both. Introduction of H7 viruses to domestic poultry was 
detected on several occasions in Asia, Europe and the American continent. The huge 
reservoir of H7 viruses in domestic animals (Gilbert et al., 2008; Woo et al., 2006) and 
sporadic human infections in Asia and Europe (Campitelli et al., 2004; Fouchier et al., 
2004) raised public health concerns. In vitro studies demonstrate that several H7 
viruses, currently circulating in Asian poultry, bind human-type receptors (Gambaryan 
et al., 2012), replicate in respiratory tissue cultures (Zhou et al., 2013), but show only 
limited airborne transmission between ferrets (Belser et al., 2008).  
Besides H5 and H7 viruses, H9N2 viruses have caused several outbreaks in poultry in 
Germany, Italy, Ireland, USA, South Africa, Korea, China, Pakistan and the Middle 
East during the last 25 years (reviewed in Alexander, 2007). Interestingly, H9N2 
viruses were detected in Asian swineherds, too. Additionally, binding to human type 
sialic acid receptors could be shown for some H9N2 viruses, raising concerns about 
possible future pandemics (Matrosovich et al., 2001). The potential capacity to infect 
humans was proven in March 1999 when H9N2 viruses were isolated at two 
independent occasions in Hong Kong from non-severe cases. For five additional 
patients an infection with H9N2 viruses was shown later that year in mainland China 
(Peiris et al., 1999). 
 
1.6.2 Swine influenza 
 
Influenza A viruses are the main reason for respiratory diseases in pigs with half of the 
herds in North America showing influenza-specific antibodies. Thus, influenza A 
viruses exhibit a vast reservoir in pig populations worldwide.  
In 1919 a new respiratory disease in pigs was described in Iowa which was associated 
to the spread of the 1918 pandemic (Koen, 1919). The observed symptoms were similar 
to those in humans infected with Spanish flu, and therefore the disease was called 
‘swine influenza’. In the 1930s the causing agent of the disease was identified as an 
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influenza virus (Shope, 1931). After genetic material of the Spanish flu was isolated, 
the swine influenza virus was demonstrated to be genetically related to the 1918 
pandemic virus (Taubenberger et al., 1997). Descendants of this so-called classical 
swine lineage continued to circulate on the American continent and genetically and 
antigenically remain relatively stable.   
In 1976, the North American swine flu spread to Europe (Nardelli et al., 1978; Pensaert 
et al., 1981). In 1979, novel H1N1 viruses were isolated from pigs (Pensaert et al., 
1981), closely related to European H1N1 duck viruses (Krumbholz et al., 2014; 
Pensaert et al., 1981; Scholtissek et al., 1983). Descendant viruses of this avian-to-
swine transmission became endemic in Europe and Asia, forming the so-called 
Eurasian avian-like swine lineage (EAsw) (Kuntz-Simon and Madec, 2009; Vincent 
et al., 2014) and completely replaced the North American lineage. 
In 1995, a North American classical swine virus reassorted with a circulating seasonal 
human H3N2 virus and acquired human HA, NA and PB1 genes. This so-called double 
reassortant later obtained an avian PA and PB2 gene following another reassortment. 
The resulting triple reassortant (Zhou et al., 1999) spread over North America and 
continued to circulate after 1998 in parallel to the H1N1 classical swine viruses. 
Subsequent reassortment between both lineages resulted in two new genotypes; H1N1 
and H1N2 (Karasin et al., 2002, 2000). These new lineages maintained the triple 
reassortant internal genes, involving avian (PB2 and PA), swine (M, NP and NS) and 
human (PB1) genes, while H1 and N1 were replaced (Vincent et al., 2008).   
Today, avian-like swine viruses are endemic in Eurasia but not detectable in the North 
American region. Both the classical swine viruses as well as viruses evolved from the 
triple reassortant do not circulate in Europe or Asia but are widespread in North 
America. Descendants of the human-like H3N2 viruses co-circulate with the other 
lineages in pig populations worldwide.   
Swine viruses are shown to be able to infect other domestic animals, for example 
turkeys (Hinshaw et al., 1983a), as well as humans but with limited capacity to spread 
between humans (Goldfield et al., 1977). Vice versa, pigs are susceptible to some avian 
viruses of different subtypes (Kida et al., 1994). Additionally, human viruses are 
frequently isolated from pigs, and most of the swine virus lineages are descendants of 
human viruses (reviewed in Nelson et al., 2015). This shows that pigs are susceptible 
to swine, avian and human viruses, raising the opportunity for genetic reassortment. 
The exchange of genetic material may result in the emergence of influenza viruses with 
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new antigenic properties. Introduction of such a virus into a human population with 
little or no pre-existing immune response may cause the next pandemic. However, other 
mammals, including humans, and some avian species, such as turkeys, can be infected 
with avian and swine viruses and serve as ‘mixing vessels’ as well (Hinshaw et al., 
1983a; Myers et al., 2007; Smith et al., 2009). Nevertheless, close contact of domestic 
pigs and humans may constitute an interface for avian viruses to facilitate adaptation to 
humans.   
 
1.6.3 Influenza in humans 
 
Influenza viruses have circulated in humans at least since the 16th century causing both 
seasonal outbreaks and global pandemics. Pandemics typically originate from influenza 
viruses expressing an HA with antigenic properties which humans have no pre-existing 
immunity to.     
The first well-documented pandemic in 1918, the so-called H1N1 ‘Spanish flu’ 
claimed 20 to 50 million deaths worldwide. Not before the late 1990s, the genome 
sequence was determined from archival formalin-fixed tissue samples (Taubenberger 
et al., 1997) and later from Arctic permafrost samples. Subsequently the pandemic virus 
was reconstituted using reverse genetics (Tumpey et al., 2005). Genome sequencing 
data indicates that this H1N1 virus is closely related to classical swine viruses and 
suggests an avian origin for HA. So far the genetic basis for the high virulence and 
mortality is not fully understood but it seems that the HA (Kobasa et al., 2004; Pappas 
et al., 2008), the replication complex (Pappas et al., 2008; Tumpey et al., 2005), the 
NS1 (Geiss et al., 2002) and the PB1-F2 protein (McAuley et al., 2007) contributed to 
this phenotype. Surprisingly, none of the typical amino acid motifs related to high 
pathogenicity, such as a multi-basic cleavage site or lysine at position 627 in PB2, are 
present in the pandemic virus.  
After the pandemic expired in 1919, the virus continued to circulate in humans. In 1957, 
the H1N1 virus acquired HA, NA and PB1 gene segments from an avian H2N2 virus 
by gene exchange, the so called reassortment (Kawaoka et al., 1989; Scholtissek et al., 
1978). The resulting novel H2N2 virus caused the second pandemic of that century, the 
H2N2 ‘Asian flu’, killing around one million people worldwide.  
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The H2N2 virus continued to circulate in the human population before it reassorted 
with an avian H3 virus in 1968. There, the human virus obtained new HA and PB1 gene 
segments of avian origin (Kawaoka et al., 1989; Scholtissek et al., 1978), resulting in 
the emergence of the H3N2 ‘Hong Kong flu’. It is speculated that the relatively mild 
course of this pandemic is a consequence of pre-existing N2 antibodies in humans 
retained from the previous pandemic (Schulman and Kilbourne, 1969; Viboud et al., 
2005). 
In February 2009, a novel H1N1 virus was isolated from influenza-infected patients in 
Mexico. Genome analysis suggests that this virus was originated from pigs after 
reassortment of a triple reassortant swine virus circulating in North America with a 
Eurasian avian-like swine virus which provided a new N1 NA and M gene segment 
(Garten et al., 2009). This swine-like H1N1 virus spread rapidly all over the world with 
mild clinical outcome. Subsequently, the pandemic H1N1 virus was reintroduced into 
the North American pig population. Continued reassortment with swine viruses resulted 
in multiple virus variants containing one or more gene segments of the pandemic virus, 
which may have the potential to infect humans. As an example, a swine-originated 
H3N2 virus acquired the pandemic M gene segment and was transmitted to humans in 
North America. Between 2011 and 2012, 201 confirmed cases were reported, out of 
which one was fatal. Additionally, only half of the cases are related to direct contact to 
pigs, suggesting the potential for human-to-human transmission (Epperson et al., 2013).   
 
Human infections with avian viruses were reported for three additional subtypes (H5, 
H7 and H9). In most cases, these zoonotic infections are self-limiting with no sustained 
transmission among humans.  
In 1997 a HPAI H5N1 virus infected 18 people in Hong Kong out of which six died. 
This was the first reported incidence where a purely avian influenza virus caused severe 
illness in humans. After re-emerging of descendants of this virus in 2003 a total of 607 
human cases were reported until end 2012; more than half of them lethal (reviewed in 
(de Wit and Fouchier, 2008).  
Avian H7N7 viruses are associated with sporadic human infection. One of the biggest 
outbreaks started in 2003 in the Netherlands spreading to neighbouring countries. In 
the process, an entirely avian virus was transmitted to humans. The majority of the 
recorded 89 cases only developed conjunctivitis (Fouchier et al., 2004). The worldwide 
circulation in wild and domestic avian species and the principal capacity of H7 viruses 
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to infect humans raised global health concerns. A recent outbreak in South East China 
where a newly evolved H7N9 virus infected 125 people between March and May of 
2013 confirmed these concerns (Gao et al., 2013; Guan et al., 2013). 75% of the cases 
were linked to poultry contact and only little human-to-human transmission was 
reported in some family clusters (Gao et al., 2013). 
H9N2 viruses have circulated in poultry since the mid 1980s and are frequently isolated 
from pigs. Between 1998 and 2003, Southeast Asia reported seven human cases in total 
with mild symptoms. Viruses isolated from patients showed mammalian-like 
characteristics; e.g. recognition of human-type receptors. This suggests that H9N2 
viruses can infect humans and this raises concerns H9N2 viruses may cause the next 
pandemic (reviewed in Herfst and Fouchier, 2014). 
 
1.7 Determinants of host range 
 
The potential of influenza A viruses to infect new species relies on multiple viral and 
host genetic factors. Since viruses interact with a variety of host-cell factors at every 
stage of the replication cycle, incompatibilities may abolish viral replication and 
transmission. Crossing the species barrier and emerging in new recipient species 
involves several phases: First, the habitats of donor and recipient species need to 
overlap, at least temporary, to allow interspecies contact. Second, pathogen-host 
interactions in single individuals of the recipient species which allow replication and 
pathogen shedding need to be established. Third, intraspecies contact between hosts is 
needed and pathogen spread needs to be facilitated to persist in the new species 
(reviewed in Kuiken et al., 2011). Host restriction factors which limit influenza virus 
spread to new species may explain the sporadic occurrence of human infections. 
Typically, they result in dead-end infections with no sustained transmission.  
One of the best-studied host restriction factors on cellular level is the availability of 
suitable receptors on cell surfaces at the infection site. Epithelial cells of the duck 
intestines predominantly express α2,3-linked sialic acids (Siaα2,3; Ito and Kawaoka, 
2000). Cells of the human tracheal epithelium primary contain α2,6-linked sialic acids 
(Siaα2,6). Sialic acids with an α2,3 linkage are found on some alveolar cells in the 
human lower respiratory tract (Matrosovich et al., 2004; Nicholls et al., 2007; van Riel 
et al., 2006). Consequently, avian viruses favour Siaα2,3, while human adapted viruses 
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were found to predominantly bind Siaα2,6 (Matrosovich et al., 2000). As a result, 
human-to-human transmission is restricted for avian viruses and a switch in the 
receptor-binding specificity is essential to facilitate productive infection and 
transmission in mammals. HA of the H1 subtype was observed to alter binding 
specificity to Siaα2,6 recognition after replacement of glutamic acid in residue 190 by 
aspartic acid in humans and pigs (Gamblin et al., 2004; Glaser et al., 2005; Matrosovich 
et al., 2000; Rogers and D´Souza, 1989).  
For HAs of the H2 and H3 subtypes the substitution of glutamine by leucine in residue 
226 and glycine by serine in residue 228 accomplished transition of receptor-binding 
specificity from α2,3 (avian type) to α2,6-linked (human type) sialic acids (Connor et 
al., 1994). The same amino acids may facilitate a change in sialic acid recognition of 
H7 viruses. The HA of the human H7N9 virus from 2013 possesses the human type 
leucine in position 226 but the avian type glycine in 228; resulting in binding to both 
receptor types (Watanabe et al., 2013). This virus is able to spread via respiratory 
droplets between ferrets, whereas viruses with the avian signature do not transmit 
(Belser et al., 2008). However, transmission is less efficient than for human adapted 
viruses (Belser et al., 2013; Watanabe et al., 2013; Zhou et al., 2013). This is supported 
by only two reported family clusters during the 2013 outbreak (Gao et al., 2013). 
Additionally, some North American H7 viruses display increased binding to human 
type receptors (Gambaryan et al., 2012) and transmit via direct contact but not via 
droplet transmission between ferrets (Belser et al., 2013, 2008). This suggests that an 
alteration of receptor-binding specificity alone is not sufficient to establish sustained 
airborne transmission in ferrets (Maines et al., 2011).  
Indeed, differences in the mode of transmission restrict influenza viruses from crossing 
the species barrier. Whereas for avian viruses waterborne transmission is typical, all 
known human adapted viruses spread via respiratory droplets. Airborne transmission 
seems to be essential for circulation in humans and viral spread by direct contact 
appears to play a minor role. Two studies investigated adaptive mutations in H5N1 
viruses needed for the establishment of airborne transmission in ferrets, a model 
organism for human-to-human transmission (Herfst et al., 2012; Imai et al., 2012). 
Thus, previous studies showed that a switch in receptor-binding specificity is needed 
for airborne transmission of avian viruses (reviewed in Neumann and Kawaoka, 2015), 
mutations conferring human type binding were artificially introduced into both HAs 
prior adaptation (Q222L/G224S and N224K/Q226L, respectively). Both groups 
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continuously passaged avian H5N1 viruses in ferrets and identified a limited number 
of mutations conferring airborne transmissibility. Mutations in HA affected two 
functional properties apart from receptor-binding specificity: i) receptor-binding 
avidity and ii) HA stability. Both airborne transmissible H5N1 viruses lost the same N-
glycosylation site (pos. 158-160) in the globular head during adaptation by different 
amino acid substitutions (N158D and T160A, respectively). HA glycosylation is known 
to affect antigenicity, receptor-binding specificity, and avidity (reviewed in Wright et 
al., 2013). In both studies the removal of the glycosylation results in increased binding 
to human type receptors (Imai et al., 2012; Linster et al., 2014). 
Furthermore, both viruses acquired an additional mutation in the HA stalk region 
(T318I and H110Y, respectively), which is found to increase HA stability. The higher 
stability was essential to facilitate droplet transmission but sole introduction of these 
mutations into the original avian virus was not sufficient to confer transmissibility (Imai 
et al., 2012; Linster et al., 2014). In fact, more than 70 mutations in the HA of several 
subtypes (H1-H3, H5 and H7) were identified to affect HA stability and pH of fusion 
induction (reviewed in Russell, 2014), and some could be linked to transmission (Reed 
et al., 2009). DuBios and colleagues demonstrated that a higher pH optimum of HA-
mediated fusion correlates with increased virulence in certain avian species (DuBois et 
al., 2011). In contrast, mutations increasing the pH of the HA conformational change 
attenuates H5N1 viruses in ducks (Reed et al., 2010), but enhances replication in mice 
(Zaraket et al., 2013a) and the upper respiratory tract of ferrets  (Zaraket et al., 2013b). 
Thus, HA stability and the pH optimum of membrane fusion may be critical to facilitate 
virus replication and transmission and changes are needed for establishment of new 
lineages. Until today, differences in membrane fusion activity and HA stability between 
species and alterations during interspecies transmission are poorly investigated.  
 
Viral NA may also contribute to efficient replication and transmission. The abundance 
of viral receptors on target tissues differs among species. As a consequence, HA 
receptor-binding avidity may change during host switch. Alteration of receptor-binding 
properties after reassortment or transmission to new hosts may result in an imbalance 
of binding avidity and NA sialidase activity. Since an optimal balance between HA and 
NA features is essential for efficient viral replication and transmission (Lakdawala et 
al., 2011; Yen et al., 2011), an equilibrium has to be re-established upon transmission 
to novel host species. Changes in HA binding avidity can compensate for altered NA 
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activity and vice versa (Baigent and McCauley, 2001; Mitnaul et al., 2000; Wagner et 
al., 2002). For example, bird-to-chicken transmission frequently results in an NA stalk 
deletion (Banks et al., 2001; Hossain et al., 2008). The deletion enhances viral 
replication and pathogenicity in domestic poultry (Munier et al., 2010; Sorrell et al., 
2010), and reduces virus release from the cell surface (Castrucci and Kawaoka, 1993; 
Matrosovich et al., 1999). In ferrets, an NA stalk deletion abolishes respiratory droplet 
transmission (Blumenkrantz et al., 2013).  
Avian polymerases show a low replication efficiency in mammals, making an increase 
in polymerase activity necessary for host adaptation (Naffakh et al., 2008). PB2 
represents the main determinant for host range and virulence among the three proteins 
of the polymerase complex PA, PB1 and PB2. The most prominent adaptive mutation 
in PB2 is E627K (Subbarao et al., 1993). Glutamic acid (E) is found in all avian isolates 
and restricts replication in mammals at 33°C; the temperature of the mammalian upper 
respiratory tract (Hatta et al., 2007). Lysine (K) is associated with mammalian 
adaptation and confers increased pathogenicity in mice as well as transmission in pigs 
and ferrets (Chen et al., 2007; Gao et al., 2013; Hatta et al., 2001; Shinya et al., 2004; 
Steel et al., 2009). The mammalian signature (K) is present in some human pandemic 
isolates (1957 and 1968) (Scholtissek et al., 1978), and is frequently selected during 
replication of avian viruses in humans and terrestrial poultry (reviewed in Wright et al., 
2013). Moreover, 627K was detected in most of the human isolates of the human H7N9 
virus in 2013 (Gao et al., 2013). It was shown that the mutation E627K partially 
compensates for decreased replication efficiency at lower temperatures within the 
human respiratory tract (33°C) compared to avian intestines (41°C) (Hatta et al., 2007; 
Scull et al., 2009). Hypothetically, this is facilitated by stabilizing the interaction of 
polymerase complex proteins PB1, PB2 and PA  (Weber et al., 2015). A lack of 627K 
can be compensated by a basic residue in position 591 (Mehle and Doudna, 2009). 
Other adaptive mutations in PB2 were described to favour replication in mammals. For 
example, the exchange of aspartic acid by asparagine in position 701 increases the 
virulence of avian viruses in mammals (Gabriel et al., 2005). In mammalian cells an 
increased replication efficiency was conferred by a T271A substitution (Bussey et al., 
2010). The influence of the polymerase adaptation on transmission was shown for the 
1918 pandemic. Whereas the HA and NA derived from the 1918 pandemic are not able 
to facilitate respiratory droplet transmission on their own, the addition of the pandemic 
PB2 resulted in airborne transmission between ferrets (Van Hoeven et al., 2009). 
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Other host-specific genetic signatures involved in host switch were identified within all 
polymerase subunits as well as the NP. Indeed, NP is described to interact with importin 
α (Gabriel et al., 2011; O’Neill et al., 1995) and is involved in the suppression of 
interferon (IFN) induction (Mänz et al., 2013). 
The efficiency to prevent and control the cellular IFN response is one important factor 
determining host range. Virus driven IFN type I and II induction results in the 
expression of hundreds of antiviral genes capable to interfere with viral replication. The 
main IFN antagonist produced by influenza A viruses is the non-structural protein NS1. 
NS1 is able to block IFN induction by abolishing activation of retinoic acid-inducible 
gene 1 (RIG-I) as well as inhibiting the expression of other antiviral genes (Hale et al., 
2008; Marazzi et al., 2012).  
As the present study is focused on the role of HA membrane fusion activity as host 
restriction factor during interspecies transmission, other host range determinants are not 
investigated.   
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Aim of the study 
 
In the course of interspecies transmission, influenza viruses undergo rapid evolution in 
response to novel selective pressures within the new host. Typically, interspecies 
transmission is restricted to individuals with no or limited spread. In rare cases these 
viruses acquire the ability to transmit and establish stable lineages in new species. The 
underlying host range restriction mechanisms and adaptive changes required for viral 
emergences in new host species are not fully understood.  
 
The influenza HA possesses the major host specificity by determining receptor-binding 
specificity. Differences in the availability of avian (α2,3) and human type (α2,6) 
receptors at the infection site define host range and restrict interspecies transmission. 
Recently, the HA-mediated membrane fusion activity was suggested to contribute to 
interspecies transmission (Herfst et al., 2012; Imai et al., 2012). Nevertheless, 
knowledge about differences of pH stability and fusion in birds and mammalian species 
is limited. To address this question, this work is focused on the role of viral membrane 
fusion activity and HA stability during interspecies transmission using several 
experimental models. 
 
First, adaptation of an avian influenza virus to pigs in Europe in the 1970s during the 
emergence of the avian-like swine lineage was studied. Second, an avian H1N1 virus 
experimentally adapted to pigs was characterised regarding receptor-binding 
specificity, fusion activity, and replication in human airway epithelial cells. Third, 
differences in fusion and HA stability between different bird species were investigated, 
comparing closely related duck and poultry viruses of the same HA subtype (H7). 
Fourth, the influence of stability and fusion on the emergence of pandemic viruses was 
studied with particular focus on the pandemic of 1968. Additionally, fusion activity of 
the novel H7N9 virus isolated from humans was examined.
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2 Materials 
2.1 Chemicals 
 
Agarose Seakem® Cambrex Bio Science, Rockland 
Ampicilin (sodium salt) Sigma-Aldrich, Steinheim; Germany 
Avicel FMC Biopolymer 
Bacto-Agar BD Biosciences, Heidelberg; Germany 
Boric acid Riedel-de Haen, Seelze; Germany 
Bromphenol blue (sodium salt) Roth, Karlsruhe; Germany 
Calcium chloride (CaCl2) Merck, Darmstadt; Germany 
Dimethyl sulfoxide (DMSO) Sigma-Aldrich, Steinheim; Germany 
Ethanol (EtOH) Roth, Karlsruhe; Germany 
Ethidium bromide (EtBr) Roth, Karlsruhe; Germany 
Ethylenediaminetetraacetic acid (EDTA) Roth, Karlsruhe; Germany 
Glycerol Roth, Karlsruhe; Germany 
Horse serum Sigma-Aldrich, Steinheim; Germany 
Hydrochloric acid (HCl) Merck, Darmstadt; Germany 
Hydrogen peroxide (H2O2)  Sigma-Aldrich, Steinheim; Germany 
Magnesium chloride (MgCl2) Merck, Darmstadt; Germany 
Monopotassium phosphate (KH2PO4) Merck, Darmstadt; Germany  
Monosodium phosphate (NaH2PO4) Merck, Darmstadt; Germany  
Paraformaldehyde (PFA)  Roth, Karlsruhe; Germany  
Peptone  Merck, Darmstadt; Germany  
Polyethylene glycol (PEG 4000) Sigma-Aldrich, Steinheim; Germany  
Sodium acetate (NaAc) Merck, Darmstadt; Germany  
Sodium chloride (NaCl) Roth, Karlsruhe; Germany 
Sodium hydroxide (NaOH) Sigma-Aldrich, Steinheim; Germany 
Tris(hydroxymethyl)aminomethane (Tris) Acros Organics, Geel, Belgium 
Triton X-100 Serva, Heidelberg; Germany 
True BlueTM peroxidase substrate KPL; USA 
Tween 80 Sigma-Aldrich, Steinheim; Germany 
Yeast extract Merck, Darmstadt; Germany 
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2.2 Consumables 
 
Cell culture flasks (25, 75 and 175 cm2) Greiner, Frickenhausen; Germany 
Cell culture plates (6, 12, 24 and 96 well) Greiner, Frickenhausen; Germany 
Cell scraper,  Greiner, Frickenhausen; Germany 
Combi-Tips Ritips Ritter, Schwabmünchen; Germany 
Cryo-tubes (2 ml) Corning; Netherlands 
Eppendorf reaction tubes (1.5 and2 ml) Eppendorf, Hamburg; Germany 
Micro-tubes, screw capped (0.5, 1.5 and 2 ml) Sarstedt, Nürnbrecht; Germany 
Nunc-Immuno 96-well microtiter plates Thermo Scientific, Langenselbold;  
Germany 
Parafilm Pechiney Plastic, Neenah 
PCR reaction tubes (0.2 ml) Biozyme, Hess. Oldendorf; Germany 
Plastic pipettes (2, 5 and 10 ml) Greiner, Frickenhausen; Germany 
Polypropylene reaction tubes (15 and 50 ml) Greiner, Frickenhausen; Germany 
PP-Test tubes (5 ml) Greiner, Frickenhausen; Germany 
Scalpel PfM AG, Colone; Germany 
Single-use pipette tips B Braun, Melsungen, Germany 
TipOne pipette tips Starlab, Ahrensburg; Germany 
 
2.3 Commercial kits  
 
Dual Luciferase® Reporter Assay System Promega, Mannheim; Germany 
HiSpeed Plasmid Maxi Kit Qiagen, Hilden; Germany 
One-Step RT-PCR Kit Qiagen, Hilden; Germany 
peqGold Plasmid Miniprep Kit I PeqLab, Erlangen; Germany 
QIAamp® viral RNA Mini Kit Qiagen, Hilden; Germany 
QIAquick® Gel Extraction Kit Qiagen, Hilden; Germany 
QIAquick® PCR Purification Kit Qiagen, Hilden; Germany 
QuikChange™ Site-Directed Mutagenesis Kit Stratagene, Basel; Switzerland 
RNeasy® Mini Kit Qiagen, Hilden; Germany 
MATERIAL 
 
 40 
2.4 Laboratory equipment 
 
Eppendorf table centrifuge 5424 Eppendorf, Hamburg; Germany 
Eppendorf research pipette                                     
(1-10 µl; 10-100 µl; 100-1,000 µl) Eppendorf, Hamburg; Germany 
GelDoc 2000 Biorad, Richmond; USA 
Hera Cell 150 Incubator Heraeus Instruments, Hanau; Germany 
Hera Safe Biosafety cabinet Heraeus Instruments, Hanau; Germany 
Light microscope Optech Mod. 1B Exacta + Optech GmbH, München; Germany 
Luminometer Centro LB 960 Berthold Technologies, Bad Wildbach; Germany 
Magnetic stirrer MR 2000 Heidolph, Schwabach; Germany 
Microwave Bosch 
Multifuge 3S-R Heraeus Instruments, Hanau; Germany 
NanoDrop 1000 PeqLab, Erlangen; Germany 
Optima™ L-100K Ultracentrifuge Beckman Coulter, Krefeld; Germany 
Precision scale Sartorius, Göttingen; Germany 
Shaker Kreutz, Reiskirchen; Germany 
Spectrafuge™ Mini-Centrifuge Labnet International, Woodbridge; USA 
Thermal Cycler 2720  Applied Biosystems, Darmstadt; Germany 
Thermo block Dri Block DB-A2 Techne, Staffordshire; UK 
Water bath 1004 GFL, Burgwedel; Germany 
 
2.5 Buffer and solutions 
   
Ammonium chloride solution (NH4Cl; 1 M) NH4Cl 2.67 g 
 dH2O 50 ml 
   
Ampicillin stock solution Ampicillin 100 mg 
 dH2O ad 1 l 
   
ELISA buffer Horse serum 10% 
 Tween 80 1% 
 in PBSdef  
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Erythrocyte suspension (1%) chicken blood 1 ml 
 PBSdef ad 100 ml 
   
DNA sample buffer (5x) Glycerol 3 ml 
 Bromphenol blue 0.025 g 
 Xylencyanole 0.025 g 
 dH2O ad 10 ml 
   
PBS++ (Phosphate buffered saline)  NaCl 8.00 g 
 KCl 0.20 g 
 Na2HPO4 1.15 g 
 KH2PO4 0.20 g 
 MgCl2 0.10 g 
 CaCl2 0.13 g 
 dH2O ad 1 l 
   
PBSdef (Phosphate buffered saline) see PBS++, without 
MgCl2 and CaCl2  
   
Permeabilization buffer  Triton X-100 0.3 % 
 Glycine 20 mM 
 In PBSdef  
   
Reaction buffer Tween 80 0.02 % 
 BSA-NA 0.1 % 
 
Neuraminidase 
inhibitior 
1 µM 
 in PBSdef  
   
Sodium acetate buffer pH 5.5 (3 M) C2H3NaO2 24.61 g 
 dH2O Ad 100 ml 
 pH adjusted:  Acetic acid 
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TBE buffer (10x) Tris 108 g 
 Boric acid 55 g 
 0.5 M EDTA, pH 8.0 4 ml 
 dH2O ad 1l 
   
TSS buffer PEG 10 g 
(transformation and storage solution) DMSO 5 ml 
 1 M MgCl2 pH 6.5 5 ml 
 LB-Medium 85 ml 
   
Washing buffer Tween 80 1 ml 
 PBSdef ad 1 l 
 
2.6 Nucleotides 
 
Cloning Primers 5' à 3' 
  
BM-HA-F TATTCGTCTCAGGGAGCAAAAGCAGGGG 
BM-HA-R ATATCGTCTCGTATTAGTAGAAACAAGGGTGTTTT 
BM-NA-for TATTCGTCTCAGGGAGCAAAAGCAGGAGT 
BM-NA-rev ATATCGTCTCGTATTAGTAGAAACAAGGAGTTTTTT 
 
Sequencing Primers 5' à 3' 
  
H1dk900fwd GTGACACAAAGTGCCAAACC 
H1dk960-rev TTGGGCATTCTCCAATAGTG 
pCAGGS-46-F ACGTGCTGGTTATTGTGC 
pCAGGS-46-R ATAATTTTTGGCAGAGGG 
H3-F668 AGCATCAGGGAGAGTCAG 
H3-R739 GGTCTGGACCCGATATTC 
N1-824-R AGGAGCATTCAACTCGACTG 
N1-610-F GGGCAGTGGCTGTATTGAAA 
MATERIAL 
 
 43 
 
Mutagenesis Primers 
  
QC-N-N416D-F GGCAAGGAATTCAACGACCTAGAAAGAAGAATTGAG 
QC-N-N416D-R CTCAATTCTTCTTTCTAGGTCGTTGAATTCCTTGCC 
QC-N-R419K-F ATTCAACAATCTAGAAAAAAGAATTGAGAATTTGAATA 
QC-N-R419K-R TATTCAAATTCTCAATTCTTTTTTCTAGATTGTTGAAT 
QC-N-T393S-R GAGTTCACCTTGTTACTGATTCCGTCGATTGCA 
QC-N-T393S-F TGCAATCGACGGAATCAGTAACAAGGTGAACTC 
QC-N-S457F-F CTAGATTTCCATGACTTCAATGTGAGAAATTTG 
QC-N-S457F-R CAAATTTCTCACATTGAAGTCATGGAAATCTAG 
 
2.7 Enzymes  
 
Restriction Enzymes 
 
DpnI 5'…GAm6|TC…3' Fermentas, St. Leon-Rot; Germany 
Esp3I (BsmBI) 5'…CGTCTC(N)1|…3' Thermo Scientific, St. Leon-Rot; Germany 
 
Other Enzymes 
 
Dnase I Thermo Scientific, St. Leon-Rot; Gemany 
Pfu DNA-Polymerase Thermo Scientific, St. Leon-Rot; Gemany 
Phusion® High Fidelity DNA-Polymerase NEB, Frankfurt a. M.; Gemany 
RevertAiD H Minus M-Mulv Reverse 
Transcriptase 
Thermo Scientific, St. Leon-Rot; Gemany 
RiboLock™ RNase Inhibitor Thermo Scientific, St. Leon-Rot; Gemany 
Shrimp Alkaline Phosphatase Fermentas, St. Leon-Rot; Gemany 
T4 DNA-Ligase Fermentas, St. Leon-Rot; Gemany 
Vibrio cholerae sialidase Sigma-Aldrich, Steinheim; Germany 
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2.8 Antibodies 
 
α-Influenza A NP (mouse) Centers for Disease Control and Prevention, Atlanta; 
USA 
α-mouse IgG (rabbit), HRP conjugated DAKO; Denmark 
α-H1 IgG (rabbit) Provided by Markus Eickmann, Marburg; Germany  
Goat α-rabbit, Alexa Fluor® 488 dye 
conjugated 
Thermo Scientific, Darmstadt; Germany 
 
2.9 Cell culture 
 
Prokaryotic cells 
 
Escherichia coli, XL1-blue strain Stratagene, La Jolla; USA 
Genotype:   
recA1 gyrA96 thi-1 hsdR17 supE44 relA1   
lac [F' proAB laclqZΔM15 Tn10 (Tetr)]  
 
Media for prokaryotic cells 
 
LB-Medium Yeast extract 5 g 
 Peptone  10 g  
 NaCl 5 g 
 dH2O 1l 
   
LB-Agar 1.5 % Bacto-Agar in LB-Medium 
   
Addition of 50 µg/ml Ampicillin after autoclaving  
(Temperature below 50°C)   
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Eukaryotic cells 
 
Name Organism Type 
BHK-T7 Mesocricetus auratus, hamster, 
Syrian golden 
baby hamster kidney fibroblasts; 
transient expression of T7-
Polymerase 
HEK293 Homo sapiens, human kidney, embryonic 
HeLa Homo sapiens, human cervical cancer 
MDCK Canis familiaris, cocker spaniel kidney 
 
 
 
Media for eukaryotic cells 
 
Growth medium 1x DMEM 500 ml 
 FCS 50 ml 
 L-Glutamine [200 mM] 5.5 ml 
 Penicillin/Streptomycin  
 [5000 U/ml/5000 µg/ml] 5.5 ml 
   
Infection medium 1x DMEM 500 ml 
 BSA (30%) 0.1 % 
 L-Glutamine [200 mM] 5 ml 
 Penicillin/Streptomycin  
 [5000 U/ml/5000 µg/ml] 5 ml 
   
2x MEM infection medium 2x MEM 250 ml 
 BSA (30%) 0.2% 
 
Penicillin/Streptomycin  
[5000 U/ml/5000 µg/ml] 
5 ml 
   
Overlay Medium 2x MEM infection medium 
mixed with Avicel solution 
1:1 
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Supplements for eukaryotic cells 
 
Autoclaved Avicel solution (2.5% (w/v) in dH2O) Institute of Virology, Marburg; 
Germany 
Bovine serum albumin (BSA; 30%) PAA, Linz; Austria 
Dulbecco’s modified Eagle’s medium (DMEM) Gibco BRL, Eggenstein; Germany 
Fetal calf serum (FCS) Gibco BRL, Eggenstein; Germany 
L-Glutamine [200 mM], 100x Gibco BRL, Eggenstein; Germany 
Lipofectamine™ 2000 Invitrogen, Karlsruhe; Germany 
Minimum essential medium (2xMEM) Gibco BRL, Eggenstein; Germany 
OptiMEM Gibco BRL, Eggenstein; Germany 
Penicillin/Streptomycin [5000 U/ml, 5000 µg/ml] Gibco BRL, Eggenstein; Germany 
Sodium bicarbonate solution, 7.5 % 
Sigma-Aldrich, Steinheim; 
Germany 
Trypsin EDTA solution, 0.05% Gibco BRL, Eggenstein; Germany 
Trypsin, tosyl phenylalanyl chloromethyl ketone 
(TPCK)-treated 
Worthington, Lakewood; USA 
 
2.10 Plasmids  
 
Plasmid Insert Origin 
pHW2000 Bi-directional expression plasmid Provided by Erich 
Hoffmann and Robert 
Webster, 
 Contains human RNA-Polymerase I 
promoter and RNA-Polymerase 
dependent cytomegalovirus (CMV) 
promoter 
St.Jude Children’s 
Research Hospital, 
Memphis, TN, USA 
 This plasmid was used for generation 
of recombinant viruses (Hoffman et 
al., 2000; Hoffmann et al., 2001) and 
site directed mutagenesis 
 
pHW2000-HAwt HA of A/duck/Bavaria/1/1977a Dr Jürgen Stech; FLI 
Riems, Germany 
pHW2000-HA49 HA of A/duck/Bavaria/1/1977; 
T492S 
Jan Baumann 
pHW2000-HA72 HA of A/duck/Bavaria/1/1977; 
N722D 
Jan Baumann 
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Plasmid Insert Origin 
pHW2000-HA113 HA of A/duck/Bavaria/1/1977; 
S1132F 
Jan Baumann 
pHW2000-HA-
2009 
HA of A/Hamburg/05/2009b Jan Baumann 
pHW2000-HA-
Marseille 
HA of A/swine/Marseille/2260/1980c Jan Baumann 
pCAGGS Eucaryotic expression vector for 
mammalian cells; contains CMV-
Promotor 
Dr Mikhail Matrosovich 
pCAGGS-HAwt HA of A/duck/Bavaria/1/1977 Jan Baumann 
pCAGGS-HA49 HA of A/duck/Bavaria/1/1977; 
T492S 
Jan Baumann 
pCAGGS-HA72 HA of A/duck/Bavaria/1/1977; 
N722D 
Jan Baumann 
pCAGGS-HA75 HA of A/duck/Bavaria/1/1977; 
R752K 
Jan Baumann 
pCAGGS-HA113 HA of A/duck/Bavaria/1/1977; 
S1132F 
Jan Baumann 
pCAGGS-HA-
1918 
HA of A/Brevig Mission/1/1918d Dr Mikhail Matrosovich 
pCAGGS-HA-
1957 
HA of A/Singapore/1/1957e Jan Baumann 
pCAGGS-HA-
1968 
HA of A/HK/1/1968f Dr Tatyana Matrosovich 
       pCAGGS-HA-
H7N9 
HA of A/Shanghai/1/2013g Genescript™ 
       pCAGGS-HA-
H7N9 T712N 
HA of A/Shanghai/1/2013 T712N Jan Baumann 
       pCAGGS-HA-
H7N9 N1162D 
HA of A/Shanghai/1/2013 N1162D Jan Baumann 
       pCAGGS-HA-
H7N9 T712N, 
N1162D 
HA of A/Shanghai/1/2013 T712N 
N1162D    
Jan Baumann 
       pCAGGS-HA-
Marseille 
HA of A/swine/Marseille/2260/1980 Jan Baumann 
       pGL4.73 
[hRluc/SV40] 
encodes for Renilla luciferase 
reporter gene controlled by an SV40 
promoter 
Provided by Prof. Dr 
Friedemann Weber 
       pTM-Luc Firefly luciferase gene Promega, Mannheim; 
Germany 
HA accession numbers: a, KT715448; b, EPI350266; c, KT715456; d, AF117241; e, CY125894; f, 
EPI8443; g, NC_026425.  
MATERIAL 
 
 48 
2.11 Viruses 
 
H1N1 Viruses 
 
Virus Subtype HA Accession No.  
Avian   
A/duck/Alberta/35/19761 H1N1 KT715447a 
A/duck/Bavaria/1/19772 H1N1 KT715448a 
A/duck/Bavaria/2/19772 H1N1 KT715449a 
A/duck/Schleswig/21/19792 H1N1 KT715450a 
A/coot/Schleswig/4/19792 H1N1 KT715446a 
A/coot/Schleswig/2/19802 H1N1 KT715445a 
Avian-like swine   
A/swine/Arnsberg/6554/19792 H1N1 KT715451a 
A/swine/OLI/1/19802 H1N1 KT715452a 
A/swine/Marseille/2260/19802 H1N1 KT715456a 
A/swine/Italy/v147/19812 H1N1 KT715455a 
A/swine/Germany/2/19812 H1N1 KT715453a 
A/swine/Germany/S27/19812 H1N1 KT715454a 
A/swine/Italy/215990-3/20053 H1N1 GQ175964b 
A/swine/England/453/20064 H1N1 CY116206b 
A/swine/Italy/50175/20073 H1N1 FJ770258b 
Swine viruses with human-like HA   
A/swine/Italy/30019-2/20073 H1N2 FJ770266b 
A/swine/Italy/50127/20073 H3N2 EPI162378b 
Classical swine   
A/Thailand/271/20055 H1N1 EF101749b 
A/Illinois/09/20076 H1N1 EPI482788b 
A/Iowa/02/20096 H1N1 EPI482799b 
A/South Dakota/03/20086 H1N1 JF758482b 
Human   
A/HK/1/19687 H3N2 EPI8443b 
A/Hamburg/05/20091 H1N1 EPI350266b 
a, viruses sequenced in this work. 
b, sequence obtained from GISAID EpiFlu™ Database (www.platform.gisad.org). 
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1, repository of the Institute of Virology, Philipps University, Marburg, Germany. 
2, Christoph Scholtissek at the Institute of Medical Virology, Justus Liebig University, Giessen, Germany. 
3, repository of the Istituto Zooprofilattico Sperimentale della Lombardia e dell’ Emilia Romagna, 
Parma, Italy. 
4, Sharon Brookes and Ian Brown, Animal and Plant Health Agency, Addlestone, Surrey, United 
Kingdom. 
5, Ian Barr, WHO Collaborating Centre for Influenza, Melbourne, Victoria, Australia. 
6, Alexander Klimov and Amanda Balish, Centers for Disease Control and Prevention, Atlanta, GA.  
7, H3N2, Earl Brown, University of Ottawa, Ottawa, Canada.  
 
H7Nx Viruses 
 
Virus Subtype HA Accession No.a 
H7 European wild bird   
A/duck/HK/293/19781 H7N2 AAC54379 
A/mallard/Netherlands/12/20002 H7N3 ABI84599 
A/mallard/Italy/33/20012 H7N3 AAT37406 
A/mallard/Sweden/56/20022 H7N7 AAY46207 
A/mallard/Sweden/102/20022 H7N7 AAY46216 
A/mallard/Sweden/105/20022 H7N7 AAY46219 
A/mallard/Sweden/106/20022 H7N7 AAY46220 
A/mallard/Sweden/64/20032 H7N7 AEL99955 
A/mallard/Netherlands/9/20052 H7N7 ADQ20635 
H7 North American wild bird   
A/mallard/Alberta/279/19771 H7N3 ABB87784 
A/green winged teal/Alberta/228/19851 H7N3 ABB87800 
A/ruddy turnstone/DE/2378/19881  H7N7 ABB87822 
A/laughing gull/DE/22/20021 H7N3 AEO94612 
H7 European poultry   
A/turkey/Italy/977/19993 H7N1 ABS89321 
A/turkey/Italy/2732/19993 H7N1 ABV01277 
A/turkey/Italy/3560/19993 H7N1 AAK58937 
A/turkey/Italy/8912/20023 H7N3 ABO44178 
A/turkey/Italy/251/20033 H7N3 ABO44156 
H7 North American poultry   
A/turkey/MN/1200/19801 H7N3 ABI84683 
A/turkey/MN/1/19881 H7N9 ABI84694 
a, sequence obtained from GISAID EpiFlu™ Database (www.platform.gisad.org). 
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1, viruses kindly provided by Robert Webster, St. Jude Children’s Research Hospital Memphis, 
Tennessee, USA. 
2, viruses kindly provided by Ron AM Fouchier, Department of Viroscience, Erasmus MC, Rotterdam, 
Netherlands. 
3, viruses kindly provided by Research and Innovation Department, Istituto Zooprofilattico Sperimentale 
delle Venezie, OIE/FAO and National Reference Laboratory for Newcastle Disease and Avian Influenza, 
OIE collaborating Center for Diseases at the Human-Animal Interface, Padova, Italy.   
 
 
Viruses of other subtypes 
 
Virus Subtype HA Accession No.a  
A/mallard/Alberta/119/19981  H1N1 AGG27509 
A/mallard/Alberta/205/19981 H2N9 AY633196 
A/mallard/Alberta/290/19981 H3N8 AY633252 
A/mallard/Alberta/47/19981 H4N1 CY004925 
A/duck/Minnesota/1525/19811 H5N1 CY014726 
A/gull/Netherlands/04/20072 H13N6 Not available  
A/mallard/Guryev/263/19821  H14N5 Not available 
A/gull/Netherlands/01/20072 H16N3 Not available 
a, sequence obtained from GISAID EpiFlu™ Database (www.platform.gisad.org) 
1, viruses kindly provided by Robert Webster, St. Jude Children’s Research Hospital Memphis, 
Tennessee, USA. 
2, viruses kindly provided by Research and Innovation Department, Istituto Zooprofilattico Sperimentale 
delle Venezie, OIE/FAO and National Reference Laboratory for Newcastle Disease and Avian Influenza, 
OIE collaborating Center for Diseases at the Human-Animal Interface, Padova, Italy.   
 
 
Recombinant H3N2 viruses 
 
Virus Subtype Description  
rHK  H3N2 Recombinant A/Hong Kong/1/1968 
rHK/R5 a H3N2 I60R, N81D, K92N, G144A and 
S193N in rHK68 HA 
rHK/R5+1 a H3N2 D60G mutant in R5 HA 
a, for detailed description see Van Poucke et al., 2015.
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3 Methods 
3.1  Molecular methods 
3.1.1 Preparation and transformation of competent Escherichia coli  
 
TSS buffer is used to create transformation-competent XL1-blue Escherichia coli 
bacteria, which are able to take up circular plasmid DNA after heat shock treatment. 
The selection of successfully transformed bacteria is performed using a plasmid-coded 
antibiotic resistance gene. Only bacteria which have incorporated a transformed 
plasmid, are able to grow on growth medium containing selective antibiotics.  
20 µl of XL1-blue E. coli bacteria were incubated in 5 ml LB medium at 37°C with 
shaking over night. From this overnight culture, 200 µl bacteria were transferred into 
fresh LB medium without antibiotics and incubated for two to four hours at 37°C on a 
shaker until an OD600nm of 0.5 to 0.8 was reached. Then the culture was directly 
transferred onto ice and stored for 30 min, followed by low speed centrifugation (3000 
rpm) for 10 min. The supernatant was discarded, and the pellet was re-suspended in 2 
ml TSS buffer. 200 µl of the bacteria were mixed with 50 to 100 ng plasmid DNA and 
incubated on ice for another 30 min. After heat shock treatment at 42°C for 45 sec the 
complete bacteria solution was plated on agarose plates containing ampicillin. Plates 
were incubated over night at 37°C to allow bacteria growth. Single colonies were used 
for further plasmid expansion.   
 
3.1.2 Plasmid DNA preparation from Escherichia coli 
 
The plasmid isolation from E. coli was done with commercial kits. Depending on the 
isolation scale, either the peqGOLD Plasmid Miniprep Kit I (PeqLab) for small or the 
HiSpeed Plasmid Maxi Kit (Qiagen) for large volumes was used. Both systems are 
based on alkaline cell lysis. Plasmid containing E. coli colonies were grown in 5 ml 
ampicillin-supplemented LB medium over night at 37°C. The overnight culture was 
either used directly for plasmid isolation or for bacteria amplification. For bacteria 
growth 200 ml ampicillin-containing LB medium were inoculated with 500 µ
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suspension and incubated over night at 37°C. After growth, cells were pelleted (4000 
rpm, 15 min), and plasmid DNA was isolated according to manufacturers’ instructions.       
 
3.1.3 Spectral-photometric quantification of DNA 
 
The absorption maximum of DNA is 260 nm and can be used for DNA quantification 
in solution. The quantification is based on the Lambert Beer equation: 
 𝐴 = 𝜀𝑏𝑐 
 
A, absorption 
ε, molar coefficient 
b, path length 
c, concentration 
 
The molar coefficient for double stranded DNA at 260 nm is 0.020 (µg/ml)-1 cm-1 and 
the cuvette path length is 10 mm. Consequently, the concentration of DNA is calculated 
using the formula: 
 𝐷𝑁𝐴	𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛	 µ𝑔𝑚𝑙 = 𝐴456 ∙ 50 µ𝑔𝑚𝑙 
A, absorption  
 
For quantification of the isolated DNA, the concentration of 1 µl eluted DNA was 
determined using a NanoDrop photometer. 
 
3.1.4 Restriction enzyme digestion of double stranded DNA 
 
Using restriction endonucleases, double stranded DNA can be cut at specific nucleotide 
sequence motifs. Depending on the restriction enzyme, specific 5’ and 3’ ends are 
created which can be used for subsequent ligation of DNA fragments. The restriction 
enzymes used in this study are listed in 2.7 including their specific recognition sites. 
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All restriction reactions were performed according to the manufacturers’ instructions 
using recommended buffers, temperatures and incubation times. 
 
3.1.5 DNA dephosphorylation 
 
To avoid religation of endonuclease digested plasmids, DNA 5’ ends were 
dephosphorylated using Shrimp Alkaline Phosphatase (SAP). Directly after 
endonuclease treatment, 3 units of SAP per 1 µg DNA were added to the reaction 
followed by incubation at 37°C for 2 h. The enzyme activity then was heat inactivated 
at 65°C for 15 min.    
 
3.1.6 DNA ligation 
 
Restricted DNA fragments were ligated into dephosphorylated, linearized vector DNA 
used for transient expression in cells. To facilitate covalent binding of free 3’OH groups 
with free 5’ phosphate residues, a T4-DNA ligase was used. The linearized vector DNA 
was mixed with restricted insert DNA at a ratio of 1:3 or 1:6. One unit of T4-DNA 
ligase was added per 10 µl ligation mixture followed by overnight incubation at 16°C.  
 
3.1.7 DNA amplification by polymerase chain reaction (PCR) 
 
The polymerase chain reaction (PCR) allows amplification of specific DNA fragments 
from a complex DNA mixture using sequence-specific oligonucleotide primers. The 
reaction can be divided into three parts which are repeated in a certain number of cycles. 
In the first step, double stranded DNA is denatured into single strands by high 
temperature. The subsequent cooling allows the short oligonucleotide primers to anneal 
at specific nucleotide sequences flanking the DNA sequence of choice. Following this 
hybridization, a DNA-dependent DNA-polymerase synthesizes the complement DNA 
strand starting from the primer’s 5’ ends, this step is called elongation. Multi-cycle 
repetition of these steps leads to an exponential enrichment of specific DNA fragments.  
To increase amplification accuracy, all PCR reactions were done using a Pfu 
polymerase, isolated from the archaea Pyrococcus furiosus. This polymerase is able to 
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proof read synthesized DNA by a 3’-5’ exonuclease activity, which decreases the 
mutation rate to 10-6 nucleotide exchanges per site. The elongation time for each DNA 
fragment was calculated based on the Pfu polymerase synthesis capacity of 2,000 bases 
per minute,. The temperature of primer annealing is estimated according to the primer 
melting points, which were calculated using the Wallace-Ikatura equation:  
 𝑇; °𝐶 = 2(𝐿 + 𝐺 + 𝐶) 
 
L, primer length 
G, number of guanine residues  
C, number of cytosine residues 
 
Reaction mix (50 µl): 
 
dH2O    37 µl 
Pfu-reaction buffer    5 µl 
dNTP-mix [10 mM]    2 µl 
forward primer [20 pmol]   2 µl 
reverse primer [20 pmol]   2 µl 
DNA template [50-100 ng/µl]  1 µl 
Pfu DNA polymerase    1 µl 
 
PCR program:  
 
Initial denaturation 95 °C 5 min  
Denaturation 95 °C 30 sec   
Annealing 50 - 62 °C 30 sec 30 cycles 
Elongation 72 °C 2 min/kb   
Final Elongation 72°C 10 min  
 4 °C ∞  
 
All PCR reactions were performed in a PCR Thermo Cycler 2720.  
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3.1.8 One-step RT-PCR  
 
For direct amplification of DNA from isolated viral RNA a one-step RT-PCR was 
performed using the OneStep RT-PCR Kit (Qiagen). The kit includes all necessary 
enzymes including the reverse transcriptases Omniscript™ and Sensiscript™ as well 
as a HotStar Taq-Polymerase™. The PCR was performed according to manufacturers’ 
instructions.  
 
3.1.9 Site directed mutagenesis  
 
Site directed mutagenesis allows for the introduction of single or multiple nucleotide 
exchanges as well as insertions and deletions into a given plasmid. In this work a PCR 
mutagenesis protocol using two complementary primers covering the target sequence 
was applied. Both primers contain single or double nucleotide exchanges to introduce 
mutations. Using both primers the plasmid was amplified by PCR. As a consequence, 
this in vitro system synthesizes mutated plasmid DNA as linear fragments. In contrast 
to the parental plasmid, the linear DNA is unmethylated. This allows the specific 
degradation of the not mutated parental DNA by DpnI digestion, cutting methylated 
target motifs (5’…Gm6ATC…3’) only. Subsequently, the linear mutated plasmid was 
transformed into E. coli XL1-blue bacteria, which facilitate circularization and 
amplification. PCR based site directed mutagenesis was performed as followed:  
 
Reaction mix (50 µl): 
 
dH2O     37 µl 
Pfu-reaction buffer     5 µl 
dNTP-mix [10 mM]     2 µl 
forward primer [20 pmol]    2 µl 
reverse primer [20 pmol]    2 µl 
DNA template [50 ng/µl]    1 µl 
Pfu DNA polymerase [2.5 U/µl]   1 µl 
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PCR program:  
 
Initial denaturation 95 °C 5 min  
Denaturation 95 °C 30 sec   
Annealing 50 - 65 °C 30 sec 20 cycles 
Elongation 68 °C 2 min/kb   
Final Elongation 68°C 10 min  
 4 °C ∞  
 
DpnI digestion 
 
PCR reaction   50 µl 
Tango™ Buffer (10x)    5 µl 
DpnI enzyme   10 U 
 
The DpnI digestion was performed for one hour at 37°C followed by enzyme 
inactivation at 80°C for 20 min. Subsequently, the mutagenesis reaction was 
transformed into transformation competent E. coli XL1-blue bacteria. Selection for 
successful transformation was carried out via growth on ampicillin-containing LB-agar 
culture plates. Single bacteria colonies from these plates were then used for further 
plasmid amplification and plasmid isolation. 
 
3.1.10 Electrophoretic separation of DNA fragments 
 
Gel electrophoresis allows separation of DNA fragments according their size. This 
method is based on the movement of the negatively charged DNA in an electrical field 
from the negative electrode (cathode) to the positive electrode (anode). The movement 
speed depends on the fragment size, the bigger the slower, and the pore diameter, the 
smaller the slower. The pore diameter is defined by the agarose concentration used for 
agarose gel preparation.  
Samples were mixed with 5x DNA sample buffer and transferred to a 0.8 % agarose 
gel in TBE running buffer. DNA-marker GeneRuler™ 1kb ladder and O´Gene Ruler™ 
100 bp DNA ladder were used as size standard. The electrophoresis was performed at 
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120 V and 50 mA. The gel was stained using ethidium bromide which intercalates into 
double stranded DNA structures. The DNA was visualized using UV-light and the 
agarose gel was analysed using a GelDoc 2000 system. 
 
3.1.11 Purification of PCR products 
 
To purify DNA sample from enzymes, nucleotides, and primers, a QIquick® PCR 
purification Kit (Qiagen) was used. The protocol is based on the ability of DNA to bind 
silica membranes under salty high pH conditions (> pH 7.5). After the binding step, 
contaminations were washed away using ethanol-containing buffers. The purification 
was done according to manufacturers’ instructions and purified DNA was eluted in 50 
µl deionized water. 
 
3.1.12 DNA sequencing 
 
In order to sequence viral gene segments, viral RNA was isolated using the QIAamp® 
viral RNA Mini Kit. The isolation was performed according to manufacturers’ 
instructions. Briefly, 140 µl virus stock was inactivated using a highly denaturing buffer 
(AVL buffer). RNA was precipitated with 560 µl ethanol (96%) and RNA was bound 
to a silica membrane (QIAmp Mini column). After washing the pure RNA was eluted 
in 50 µl RNAse-free water. The extracted viral RNA was transcribed into cDNA and 
further amplified (section 3.1.8) using universal HA specific primers (Hoffmann et al., 
2001). Following gel purification (section 3.1.11), 100 to 200 ng of purified viral cDNA 
was sent for Sanger sequencing (Sanger et al., 1977) to the SeqLab company 
(Göttingen; Germany). Sequence analysis was done using Geneious 5.5.9 (Drummond 
et al., 2011; Available from www.geneious.com). 
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3.2  Cellular methods 
3.2.1 Cell culture 
 
Madin-Darby canine kidney (MDCK), human embryonic kidney (HEK 293T),  and 
Henrietta Lacks cervical cancer (HeLa) cells, as well as baby hamster kidney fibroblasts 
(BHK) were maintained in Dulbecco´s modified Eagle´s medium (DMEM, Gibco) 
supplemented with 10% fetal calf serum (FCS), penicillin/streptomycin (100 IU ml-
1/100 µg ml-1) and 2 mM glutamine (growth medium). Cells were grown in cell culture 
flasks and passaged when the cells reached complete confluency. For cell passaging 
DMEM medium was removed and cells were washed twice with PBS++. To detach cells 
from plastic, trypsin-EDTA was added (0.5 ml for 25 cm2 flask; 2 ml for 75 cm2 flask). 
After detachment cells were re-suspended in the fresh growth medium (4.5 ml for 25 
cm2 flask; 8 ml for 75 cm2). A proportion of the cells was transferred to a new growth 
medium containing flask. Cell lines were maintained at 37°C, 5% CO2 and 95% 
humidity.  
 
3.2.2 Transfection of eukaryotic cells 
 
Transfection is used to introduce plain linear or circular DNA into eukaryotic cells, in 
order to specifically control gene expression or to synthesize foreign genes. For this 
purpose, a cationic liposomal agent is used (Lipofectamine™ 2000; Invitrogen). 
Mixing Lipofectamine with DNA results in the formation of liposome/DNA 
complexes, which are endocytosed by target cells. Lipid-mixing then leads to release 
of the DNA into the cytoplasm. Subsequently, the DNA enters the cell nucleus where 
transcription occurs. 
Plasmid DNA (0.8 – 1 µg) in OptiMEM medium was mixed with OptiMEM containing 
Lipofectamine (amount depends on plasmid concentration; described in manufacturers’ 
instructions) at a ratio of 1:1, followed by incubation at room temperature for 20 min 
to allow DNA uptake into liposomes. HEK393 or HeLa cells grown to 70 – 80 % 
confluence were washed twice with PBS++, the transfection mix was added and cells 
were incubated for 4 h at 37°C, 5% CO2 and 95% humidity. Transfection mixture then 
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was discarded, cells were covered with growth medium and incubated for 24 to 48 h at 
37°C, 5% CO2 and 95% humidity.   
 
3.3 Virological methods 
3.3.1 Virus growth 
 
Avian, human, and porcine viruses were grown either in MDCK cells or in 
embryonated chicken eggs. Viruses used in this study are MDCK-grown if not 
indicated otherwise (section 2.11). After virus growth stocks were prepared for all 
viruses and stored at -80°C. The HA of all viruses was sequenced and virus titres were 
determined using hemagglutination assay and focus-forming assay. An additional 
plaque titration was performed for viruses used in growth kinetics. 
 
3.3.1.1 Virus growth in cell culture 
 
MDCK cells grown to 80 – 90 % confluency were washed twice with PBS++ followed 
by virus infection with an MOI (multiplicity of infection) of either 0.001 or 0.005 
depending on viral replication efficiency. MOI is defined as virus particle per cell and 
is calculated as follows: 
 𝑀𝑂𝐼 = 	𝑐𝑒𝑙𝑙	𝑛𝑢𝑚𝑏𝑒𝑟	𝑣𝑖𝑟𝑢𝑠	𝑡𝑖𝑡𝑟𝑒	[𝑃𝐹𝑈/𝑚𝑙] ∙ 𝑡𝑎𝑟𝑔𝑒𝑡	𝑀𝑂𝐼 
 
MOI, multiplicity of infection  
PFU, plaque forming units 
 
For virus infection, infection medium (DMEM; 0.1% BSA; 1% 
Penicillin/Streptomycin; 1% L-Glutamine) supplemented with 1 µg/ml TPCK-treated 
trypsin was mixed with the desired amount of virus stock. After infection, cells were 
incubated at 37°C, 5% CO2 and 95% humidity for 72 to 96 h depending on virus growth. 
The virus-containing supernatant from infected cultures was harvested, clarified by 
low-speed centrifugation (4000 rpm; 10 min) and used without further purification. 
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Virus stocks were stored at -80°C and titrated using the focus forming assay (section 
3.3.2). 
For studies of receptor-binding properties, after clarification, viruses were concentrated 
by ultracentrifugation (25,000 rpm; 1.5 h). The virus pellet was re-suspended in 300 µl 
glycerol (50% in dH2O) each and stored at -20°C. 
 
3.3.1.2 Virus growth in embryonated eggs 
 
For virus growth 11-day-old eggs were screened for living chicken embryos. Eggs 
containing living embryos were disinfected with iodine, and 100 µl infection medium 
containing 500 – 2,000 focus forming units (FFU) per ml of virus, was injected directly 
into the allantoic fluid (injection needle: 0.55 x 25 mm). The puncture was closed using 
Ponal-Glue (Henkel). Infected eggs were incubated for 48 h at 37°C and 95% humidity. 
After incubation eggs were stored over night at 4°C to allow blood vessel contraction. 
The virus-containing allantoic fluid was removed using a plastic pipette and clarified 
by low speed centrifugation (4000 rpm; 10 min). Aliquoted virus stocks were stored at 
-80°C.   
 
3.3.2 Focus forming assay 
 
Using the focus forming assay (Matrosovich et al., 2007), the amount of infectious 
particles can be determined as focus forming units (FFU). By omitting trypsin, the viral 
HA is not cleaved into the fusion competent form, which prevents further virus spread 
to neighbouring cells. The resulting individual infected cells can be stained 
immunohistochemically (section 3.3.3), thereby every infected cell represents a single 
infectious viral particle or focus forming unit. Infected cells were counted, and the virus 
titre was calculated according to the virus dilution as FFU/0.1 ml. 
For titration, confluent monolayers of MDCK cells grown in 96-well plates were 
inoculated with 0.1 ml of serial 10-fold virus dilutions in infection medium. The 
titration was performed in three replicates per dilution. Cells were incubated at 37°C, 
5% CO2 and 95% humidity. Eight hours post infection cells were fixed with 4% 
METHODS 
 
 61 
paraformaldehyde and stained immunohistochemically for influenza NP expression as 
described below (section 3.3.3).  
 
3.3.3 Plaque assay 
 
In order to detect infectious viral particles, which are able to initiate multi cycle 
replication, viruses are titrated using the avicel plaque test. The viscous avicel overlay 
allows only short distant diffusion of released virions. As a consequence, virus spread 
results in local plaque formation with each detected plaque representing one infectious 
particle. The resulting titer is indicated as plaque forming unit per milliliter (PFU/ml).  
The assay was performed as described before (Böttcher et al., 2006a). Briefly, titration 
was carried out using 90% confluent MDCK cells in 6-well plates. The cells were 
washed twice with PBSdef followed by infection with 10-fold dilutions of the virus 
sample in 1 ml infection medium. After 1h of virus adsorption at 37°C, 5% CO2 and 
95% humidity 2 ml avicel overlay containing TPCK-trypsin (1µg/ml) was added to 
each well and cells were incubated at 37°C, 5% CO2 and 95% humidity. Two days post 
infection the overlay medium was removed and cells were washed twice with PBSdef to 
remove residual medium. The cells were then fixed with 4% paraformaldehyde for 1 h 
at 4°C and stained immunohistochemically for Influenza A virus NP.  
 
3.3.4 Immunohistochemical staining of virus-infected cells 
 
Influenza virus infected cells were stained as described before (Matrosovich et al., 
2007). Paraformaldehyde-fixed cells were permeabilized with 0.3% Triton X-100. To 
detect viral infection, cells were incubated with a monoclonal mouse anti-influenza-NP 
antibody (in 10% horse serum; 0.05% Tween 80 in PBSdef; kindly provided by 
Alexander Klimov, Center for Disease Control; USA) for two hours. Cells were washed 
three times with PBSdef followed by treatment with peroxidase-labelled polyclonal 
rabbit anti-mouse serum (Dako; 10% horse serum, 0.05% Tween 80 in PBSdef). After 
washing with PBSdef 50 µl TrueBlue™ peroxidase substrate (KPL; supplemented with 
0.1% H2O2;) was added to stain infected cells. The reaction was stopped by washing 
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with deionized water. Infected cells were counted for virus dilutions that produced 
between 50 and 200 infected cells and recalculated to focus forming units per 0.1 ml. 
 
3.3.5 Inhibition of infection by the lysosomotropic agent 
ammonium chloride 
 
Inhibition of virus infection by lysosomotropic agents is based on their ability to 
accumulate in acidic cell compartments and prevent their acidification by proton 
absorption. Ammonium chloride (NH4Cl) is known to accumulate in endosomal 
vesicles and interfere with their acidification during lysosome maturation. In the course 
of ATPase-driven protonation of the endosome, NH4Cl inhibits a variety of lysosomal 
hydrolases (de Duve et al., 1974; Ohkuma and Poole, 1978).  
NH4Cl elevates the endosomal pH and prevents the HA conformational transition and 
subsequent membrane fusion in a dose-dependent manner. Interpretation of the results 
can be made as follows: The less NH4Cl needed for infection inhibition, the lower the 
pH necessary for fusion induction (Matlin et al., 1981). 
In order to quantify the inhibitory effect of NH4Cl, monolayers of confluent MDCK 
cells were infected with 200 FFU influenza virus in 0.1 ml infection medium in the 
presence of different concentrations of ammonium chloride (from 0 mM to 2.5 mM) in 
a 96-well plate format (Baumann et al., 2015; Krenn et al., 2011). The infection was 
performed without trypsin to limit replication to one cycle. The cells were incubated 
for 16 hours followed by immunohistochemical staining for viral NP (section 3.3.3). 
 
Figure 3.1: Example of inhibition of viral infection by NH4Cl. Results of three replicate 
experiments performed on the same day are shown for A/duck/Schleswig/21/1979 (solid lines) 
and A/swine/Marseille/2260/1980 (dashed lines). Concentrations of NH4Cl that caused 50% 
infection inhibition were determined for each replicate by interpolation.  
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The number of infected cells was quantified and infection efficiency was calculated as 
percentage in respect to infection without NH4Cl. Dose-response curves were plotted 
(figure 3.1) and 50% infection inhibition (IC50) by NH4Cl was determined by linear 
interpolation for each replicate. All experiments were performed in triplicates and 
repeated independently at least twice. Results of all individual replicates were averaged.    
 
3.3.6 Virus inactivation at low pH  
 
The energy barrier to induce the HA conformational transition can also be overcome 
by low pH and denaturing urea in vitro. The structural rearrangement into the fusion 
competent HA abolishes receptor-binding capacity and results in virus inactivation. The 
lower the urea concentration or the higher the pH needed to induce this transition, the 
less stable the virus. In this work virus inactivation at acidic pH was used to determine 
viral stability (Baumann et al., 2015). 
To determine the pH of virus inactivation, viruses were adjusted to 10,000 - 20,000 
FFU followed by exposure to buffers with pH ranging from pH 7.0 to 5.0 in MES-
buffer (100 mM MES, 150 mM NaCl, 0.9 mM CaCl2, 0.5 mM MgCl in dH2O; pH 
adjusted with NaOH) for 15 min. The mixtures were diluted 100-fold with infection 
medium for neutralization. Confluent monolayers of MDCK cells grown in 96 well-
plates were infected with 0.1 ml neutralized virus solution per well. Eight hours post 
infection cells were immunohistochemically stained for influenza NP expression 
(section 3.3.3). Infected cells were counted and plotted in inhibition curves (figure 3.2). 
Using linear interpolation, the pH of 50% infection inhibition (pHinact) was determined. 
Experiments were done in triplicates. Presented values of pHinact represent mean values 
from at least two independent experiments. 
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Figure 3.2: Example of virus inactivation at low pH. Results of three replicate experiments 
performed on the same day are shown for A/duck/Schleswig/21/1979 (solid lines) and 
A/swine/Marseille/2260/1980 (dashed lines). pH values that caused 50% infection inhibition 
were determined for each replicate by interpolation.  
 
3.3.7 Growth kinetics in HTBE cultures 
 
To mimic virus replication in the human respiratory tract 6-week-old differentiated 
human tracheobronchial epithelial (HTBE) cultures (kindly provided by Tatyana 
Matrosovich) were infected with 104 plaque forming units (PFU) of virus. In order to 
do that, cells were washed five times with PBSdef followed by infection with 200 µl 
DMEM containing 104 PFU of virus. After incubation for 1 h at 33°C the inoculum was 
removed and cells were washed once with 300 µl DMEM. For virus replication cells 
were incubated over the course of six days at 33°C, 5% CO2 and 95% humidity.  
Virus sampling was done regularly at a 24 h basis. Released viruses were harvested by 
washing the apical side of the cells with 0.4 ml DMEM for 30 min at 33°C. The 
collected material was titrated (section 3.3.2). The experiment was performed in four 
to five replicates.  
 
3.3.8 Hemagglutination assay 
 
The influenza A surface protein HA binds sialo-glycans on the surface of human or 
chicken erythrocytes. This results in the formation of a cross-connected erythrocyte-
virus network that prevents red blood cells from sedimentation. If the virus 
concentration is reduced, a threshold will be reached where remaining virus particles 
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are not sufficient to cross connect red blood cells to prevent sedimentation. The dilution 
at which this threshold is reached allows a semi-quantitative prediction about the virus 
concentration. As the virus solution may contain HA-exhibiting incomplete virions, no 
differentiation between infectious and non-infectious particles can be made. In order to 
determine the HA titre, virus solutions were diluted in 2-fold steps in a 96-well 
microtiter plate. For each dilution, 50 µl of the previous dilution (with the first dilution 
being the original virus solution) was mixed with 50 µl PBSdef. 50 µl of a chicken red 
blood cell solution (1%) was added to each well followed by incubation for 1 to 3 h at 
4°C. Afterwards, the dilution at which red blood cells sedimented was determined, and 
the hemagglutination titre (HA units; HAU) was calculated according to the formula, 
 𝐻𝐴𝑈 =	 1𝑉𝑖𝑟𝑢𝑠	𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛	𝑜𝑓	𝑠𝑒𝑑𝑖𝑚𝑒𝑛𝑡𝑎𝑡𝑖𝑜𝑛 
. 
3.3.9 Quantification of viral hemolytic activity  
 
Based on the HA-mediated agglutination of erythrocytes, this assay allows 
measurement of the pH of HA-mediated hemolysis. Viruses are agglutinated to human 
red blood cells followed by a stepwise decrease of the pH. At a threshold pH HA 
conformational transition into its fusion competent structure is initiated. This results in 
HA-mediated fusion induction leading to erythrocyte lysis which can be measured by 
detection of peroxidase activity of released hemaproteins (Montaño and Morrison, 
1999). As hemolysis induction exclusively depends on HA fusion activity, this assay 
allows the exclusive investigation of HA pH dependency and influences of other pH 
dependent viral proteins.  
HA-mediated hemolytic activity was measured as described by Baumann et al., 2015. 
64 HAU of virus were incubated with a 0.03 % solution of human erythrocytes (hRBC, 
human red blood cells) for 1 h on ice. After agglutination mixtures were dispensed a 50 
µl in a 96-well plate. The mixtures were incubated in different pH conditions ranging 
from pH 7.0 to 5.0 in sodium acetate buffer (0.1 M sodium acetate buffer adjusted to 
pH 5.0 – 7.0 with NaOH) for 30 min at 37°C followed by neutralization with Tris/HCl, 
pH 7.3. For comparison complete hemolysis was initiated using triton X-100 (0.01%). 
Non-lysed erythrocytes and cell debris were removed by centrifugation (10 min, 2000 
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rpm) and 50 µl of the supernatant was used for detection of hemolytic activity using 
3,3′,5,5′-Tetramethylbenzidine (TMB; 0.05 M sodium acetate buffer, pH 5.2; 1:100 
TMB-stock; 0.03% H2O2; Martin et al. 1984). Peroxidases released from lysed red 
blood cells oxidise TMB (figure 3.3) and the resulting product can be detected 
photometrically.  
 
 
Figure 3.3: Conversion of TMB into partially and fully protonated forms by peroxidase 
activity of hemaproteins in the presence of H2O2 and H2SO4. 
 
After incubation for 30 min at room temperature the reaction was stopped with 25 µl 
5% sulphuric acid and absorption at 450 nm was measured using a microplate reader. 
 
 
Figure 3.4: Example of pH dependency of virus-mediated hemolysis. Results of three 
replicate experiments performed on different days are shown for A/duck/Schleswig/21/1979 
(solid lines) and A/swine/Marseille/2260/1980 (dashed lines). pH values that induced 50% 
hemolytic activity were determined for each replicate by interpolation.  
 
The pH of 50% hemolytic activity (pHhem) was determined for each virus by 
interpolation of hemolysis/pH curves (figure 3.4). 
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3.3.10 Flow cytometric analysis 
 
Using flow cytometry cells can be sorted according their cell shape and structure. In 
combination with fluorescence-labeled antibodies the cell proportion expressing 
specific proteins can be determined. In this study, this method is used to determine HA 
surface expression.  
80% confluent HeLa cells grown in 4 cm2 multiwell plates were transfected with 1 µg 
of HA-encoding or empty pCAGGS plasmids (section 3.2.2). The cells were incubated 
at 37°C, 5% CO2 and 95% humidity. After 24 h cells were scratched from the plates. 
In order to cleave HA 1 µg/µl TPCK-trypsin was added followed by 30 min incubation 
at 37°C. Cells were pelleted (1200 rpm; 10 min) and re-suspended in 200 µl ELISA 
buffer containing anti-H1 HA serum (1:200). After 1 h shaking at room temperature 
cells were washed twice with washing buffer (0.05% Tween in PBSdef) and re-
suspended in 200 µl ELISA buffer containing FITC (Fluorescein isothiocanate)-
labelled anti-rabbit antibodies (1:100). Cells were incubated for 30 min at room 
temperature, washed twice with washing buffer and re-suspended in 500 µl PBSdef. 
10,000 cells were counted using a cell sorter (BD Biosciences-US). Cells were excited 
at 495 nm and fluorescence signals were detected at 520 nm. FITC fluorescence of cells 
transfected with empty vector was subtracted from sample fluorescence and percentage 
of FITC positive cells was calculated.  
 
3.3.11 Quantification of syncytia formation by light microscopy 
 
Plasmid driven HA expression in permanent cell lines such as HeLa and HEK293 cells 
leads to HA presentation at the cell surface. This can be used to study the pH of HA-
mediated cell-to-cell fusion after incubation under different pH conditions. Fused cells 
which include multiple nuclei are known as syncytia and their formation can be 
observed microscopically.  
The quantification of HA membrane fusion activity was performed as described 
previously (Reed et al., 2009).  HeLa cell monolayers of 70 – 80% confluency grown 
in 6-well plates were transiently transfected with 1 µg HA-encoding pCAGGS-HA 
using Lipofectamine 2000 transfection reagent (section 3.2.2). After incubation for 4 h 
at 37°C the transfection medium was replaced by infection medium. Sixteen hours post 
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transfection HA was cleaved by addition of 1 µg/ml TPCK-treated trypsin and 
incubation for 15 min at 37°C. Transfected cells were exposed to different low pH 
sodium acetate buffers ranging from pH 7 to pH 5.1 (145 mM NaCl; 20 mM sodium 
acetate) for 10 min. The supernatant was replaced by infection medium. After 
incubation for three hours at 37°C to allow fusion and syncytia formation, cells were 
fixed with methanol for 10 min and stained with Giemsa dye (Merck; 1:10 in dH2O). 
Cells were washed with deionized water and dried. For quantitative analysis, pictures 
of five microscopic fields, chosen at random, were taken with a 300-fold magnification 
using a light microscope. For each image the percentage of nuclei within syncytia to 
total nuclei number was calculated.  
 
3.3.12 Quantification of syncytia formation using luciferase reporter 
assay 
 
Another approach to detect and quantify HA driven cell-to-cell fusion and syncytia 
formation uses measurements of activity of co-transfected Firefly luciferase. In this 
assay, a Firefly reporter gene regulated by a bacteriophage-derived T7-Polymerase-
dependent promoter is used. On that account, Firefly luciferase is not synthesized in 
eukaryotic cells lacking a T7-Polymerase. The cells, transfected with HA and Firefly 
luciferase plasmids, were mixed with BHK cells constitutively expressing T7-
polymerase. The subsequent low pH treatment leads to cell-to-cell fusion. The resulting 
syncytia formation is accompanied by the mixing of cytoplasmic components of the 
participating cells. As a consequence, the resulting syncytia contain both the T7-
polymerase coding plasmid and an active T7-polymerase. The synthesized Firefly 
luciferase can then be used to quantify HA-mediated fusion activity.    
In this work the luciferase-based quantification of syncytia formation was performed 
as described before by Su et al., 2008. HEK293 cell monolayers of 70 – 80% confluency 
grown in 6-well plates were transfected with 800 ng of pCAGGS-HA, 50 ng of a 
plasmid expressing Renilla luciferase and 400 ng of pTM1 plasmid coding for Firefly 
luciferase under the control of the T7 bacteriophage promoter (section 3.2.2). Sixteen 
hours post transfection cells were scraped and mixed with equal amounts of BHK-T7 
cells constitutively expressing T7-polymerase. After incubation at 37°C for 2 h HA 
expressed on the cell surface was cleaved adding 1 µg/ml TPCK-treated trypsin for 
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10 min at 37 °C. Cells were pelleted (1000 rpm; 5 min) and treated with sodium acetate 
buffers with pH from 5.0 to 7.0 for 3 min at 37°C. The supernatant was replaced by 
DMEM (supplemented with 0.1% BSA), and cells were incubated for 5 h (37°C, 5% 
CO2 and 95% humidity) to allow cell-to-cell fusion and Firefly luciferase synthesis. 
Luciferase activity was measured using the Dual-Luciferase-Assay-Kit (Promega) 
according to the manufacturers’ instructions. For quantitative analysis Firefly luciferase 
activity was normalized against the total amount of transfected cells showing Renilla 
luciferase activity. The pH of fusion induction was defined as pH at which Firefly 
luciferase activity was higher than the activity of mock transfected cells.  
 
3.3.13 Quantitative analysis of viral receptor-binding 
 
Quantitative and qualitative differences in viral receptor-binding properties were 
investigated using two assays, which are both based on HA binding to soluble receptor 
analogues. Viral binding was investigated either by direct binding to horse radish 
peroxidase (HRP)-labelled fetuin (Fet) or binding inhibition using synthetic sialyl 
glycopolymers (SGPs). 
Virus receptor-binding specificity and avidity to α2,3- and α2,6-linked sialic acid 
receptors was determined using a solid phase assay described previously (Matrosovich 
and Gambaryan, 2012). The assay is based on binding of immobilized virus to soluble 
monospecific fetuin. To discriminate between human (α2,6) and avian (α2,3) type 
receptor-binding, HRP-linked asialo-fetuin was re-sialyated using α2,6- and α2,3-
sialyltransferases, respectively. The resulting α2,6-Fet and α2,3-Fet only differ in the 
type of glycosidic linkage between the terminal sialic acid (Neu5Ac) residue and the 
penultimate galactose residue. To quantify receptor-binding to both fetuins peroxidase 
activity was determined.  
Flat-bottomed 96-well plates were coated in batches of 25 plates. 510 ml of a 10 mg/ml 
fetuin working solution were prepared in PBSdef. 0.2 ml of the solution was added to 
each well, followed by overnight incubation at 4°C. Afterwards, the well contents were 
removed, the plates were washed three times with deionized water and air-dried at room 
temperature. 
For each virus, 16 wells of a fetuin-coated plate were incubated with 0.05 ml virus 
solution per well for 1 h at 4°C. The supernatant was discarded, and non-specific 
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binding sites were blocked by adding 0.1 ml of 0.1% Vibrio cholerae sialidase-treated 
BSA (BSA-NA) in PBSdef per well for 1 h at 4°C. BSA-NA was prepared previously 
as follows. 50 ml of a 5 % BSA solution in PBSdef was prepared. One ml of 
Penicillin/Streptomycin (5000 U ml-1/5000 µg ml-1) was added and the pH was adjusted 
to 7.5. Then, one unit Vibrio cholerae sialidase was added and the solution was 
incubated for 24 h at 37°C. The sialidase was inactivated by incubation at 60°C for 24 
h. The BSA-NA solution was aliquoted and stored at -20°C.  
The following procedures were performed on ice. After removal of the blocking 
solution the plate was washed twice with 0.2 ml ice-cold washing buffer. An 
appropriate range of two-fold dilutions of α2,3-Fet and  α2,6-Fet were prepared in 
reaction buffer. Two wells per virus were filled with 0.05 ml fetuin solution per dilution 
and fetuin type. After incubation for 1 h at 4°C the fetuin solution was discarded and 
the plate was washed five times on ice with washing buffer. To detect fetuin bound by 
viruses 0.1 ml/well substrate solution (0.01% TMB, 0.03% H2O2 in 0.05 M sodium 
acetate, pH 5.5) was added, followed by a 30 min incubation at room temperature. The 
reaction was stopped by adding 0.05 ml 5% H2SO4 per well, and absorbency was 
measured at 450 nm (A450nm) using a microplate reader (Epoc, Biotek). Unspecific 
absorbency from wells containing no virus was subtracted from all sample values. The 
resulting data were converted to Scatchard plots (A450nm/c as a function of A450nm). 
Trend lines were drawn for α2,3-Fet and α2,6-Fet. Association constants (Kass) were 
calculated using the formula:  
 𝐾VWW = 	 𝑦6𝐴;VY 𝐾VWW, 𝑎𝑠𝑠𝑜𝑐𝑖𝑎𝑡𝑖𝑜𝑛	𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡  𝑦6, 𝑖𝑛𝑡𝑒𝑟𝑐𝑒𝑝𝑡	𝑜𝑓	𝑡𝑟𝑒𝑛𝑑𝑙𝑖𝑛𝑒	𝑤𝑖𝑡ℎ	𝑦	𝑎𝑥𝑖𝑠	𝐴;VY, 𝑖𝑛𝑡𝑒𝑟𝑐𝑒𝑝𝑡	𝑜𝑓	𝑡𝑟𝑒𝑛𝑑𝑙𝑖𝑛𝑒	𝑤𝑖𝑡ℎ	𝑥	𝑎𝑥𝑖𝑠   
 
Kass are expressed as micromolar amounts with higher values reflecting stronger 
binding. 
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3.4 Phylogenetic analysis 
 
In order to determine the phylogenetic relationship of either H1 or H7 HAs, HA 
nucleotide sequences were obtained from the National Centre for Biotechnology 
Information (NCBI) Influenza Virus Resources Database (Bao et al., 2008; 
http://www.ncbi.nlm.nih.gov) and GISAID EpiFlu™ Database 
(www.platform.gisaid.org/). HAs without published sequences were sequenced as 
described previously (section 3.1.12) and submitted to the NCBI database (for 
accession numbers see 2.11). All not redundant full-length sequences were aligned 
using the Muscle algorithm included in Geneious 5.5.9 (Drummond et al., 2011; 
Available from www.geneious.com). The conduction of the phylogenetic tree was done 
via the MEGA6 software (Tamura et al., 2013) using the minimal evolution method. 
The statistical likelihood of the H7 HA tree was determined using bootstrap analysis 
with 100 repetitions. H1 HA ancestral avian and swine amino acid sequences were 
predicted with the maximum-likelihood method using a Dayhoff matrix-based model 
included in MEGA6. 
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4 Results 
4.1 Differences in the pH-dependent HA-mediated membrane fusion 
activity of avian and swine H1N1 viruses 
 
In the late 1970s a European H1N1 duck virus transmitted to the European pig 
population and became endemic in Europe and Asia, forming the so-called Eurasian 
avian-like swine (EAsw) lineage (see section 1.6.2). In order to study potential changes 
in the viral membrane fusion activity that emerged during avian-to-swine transmission, 
EAsw viruses isolated early after transmission to pigs (1979-1981) were compared with 
contemporary circulating H1N1 viruses from wild aquatic birds (figure 4.1a). The 
phylogenetic relationship between viruses used in this study is shown in figure 4.1b. 
In addition, a limited number of other swine and human viruses, including H1N2 and 
H3N2 swine viruses with human-virus-like HAs, viruses with “classical” swine HA 
isolated from humans after zoonotic infections, recent EAsw virus isolates, and two 
pandemic human viruses, were included in this study for comparison.  
Only limited information about the passage history is available for the EAsw viruses 
and their closest avian ancestors. For this reason, the number of egg and cell culture 
passages is not known for some viruses used in this study. It cannot be excluded that 
viral growth in different cell culture systems alters the glycosylation status of viral 
glycoproteins or results in a changed composition of the cell derived viral envelope. In 
order to eliminate these potential influences on viral phenotypes, all viruses were re-
grown in MDCK cells.  
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Figure 4.1: Phylogenetic relationship of H1 influenza virus HAs. a The phylogenetic tree was 
built using 455 sequences of avian viruses from North America (black), Eurasia, Oceania and 
Africa (brown) and EAsw viruses (blue). Viruses used in this study are marked with red dots. 
The locations of the hypothetical first swine virus and its putative avian precursor are indicated 
by arrows (blue and brown, respectively). b Phylogenetic relationship of H1 viruses tested in 
this study. Colour code of genetic lineages: black, brown and blue, see panel (a); green, H1N2 
swine viruses with human-like HA; purple, human isolates with classical swine HA; red, 
H1N1/2009 pandemic virus. Black dots indicate HA sequences determined in this study. HA 
sequences for A/Illinois/09/2007 and A/Iowa/02/2009 (Shu et al., 2012) were obtained from 
GISAID EpiFlu™ Database (www.platform.gisaid.org/). In both panels the scale bars 
represent units of nucleotide substitutions per site.  
The acidification of endosomes triggers the HA-mediated fusion of the viral and 
endosomal membrane and is essential for viral cell entry. In order to investigate 
variations of the pH of fusion between avian and EAsw viruses, infection of MDCK 
cells in the presence of the lysosomotropic agent ammonium chloride (NH4Cl) was 
performed. NH4Cl accumulates in acidic cellular compartments, such as endosomal 
vesicles, and interferes with their acidification in a dose dependent manner (Matlin et 
al., 1981). Thus, the NH4Cl concentration correlates with the endosomal pH. NH4Cl 
concentrations that inhibit infection by 50% (IC50) were determined from dose-
response curves. Data for individual viruses are summarized in table 2, mean values 
for avian, swine and human viruses are illustrated in figure 4.2a.  
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Table 2: Membrane fusion activity and stability of influenza virusesa.  
 
Virusb 
Infection inhibition 
by NH4Cl,  
IC50 (mM) 
Hemolytic activity, 
pH50-hem 
Inactivation at acidic 
pH, 
pH50-inact 
 Mean  + CI P Mean + CI P Mean + CI P 
     Avian viruses 
A/duck/Alberta/35/1976 0.26 0.011 *** 4.97 0.05  5.27 0.03  
A/duck/Bavaria/1/1977  0.50 0.007  5.20 0.06 *** 5.31 0.11  
A/duck/Bavaria/2/1977  0.31 0.014 * 5.03 0.05  5.43 0.03 ** 
A/duck/Schleswig/21/1979  0.43 0.07  4.96 0.04  5.19 0.07  
A/coot/Schleswig/4/1979 0.55 0.07 * 5.05 0.03 **    
A/coot/Schleswig/2/1980  0.50 0.07  5.10 0.021 ***    
          
     Eurasian avian-like swine 
viruses 
         
A/swine/Arnsberg/6554/1979  0.99 0.16 *** 5.07 0.07 * 5.75 0.017 *** 
A/swine/France/OLI/1980  1.04 0.21 *** 5.29 0.10 *** 5.64 0.03 *** 
A/swine/Marseille/2260/1980  1.13 0.13 *** 5.36 0.05 *** 5.91 0.11 *** 
A/swine/Italy/v147/1981  1.1 0.6 * 5.07 0.07 *    
A/swine/Germany/2/1981  0.95 0.16 *** 5.21 0.09 ** 5.75 0.20 *** 
A/swine/Germany/S27/1981  1.14 0.15 *** 5.13 0.07 ** 5.47 0.03 ** 
A/swine/Italy/215990-3/2005  1.43 0.05 *** 5.39 0.024 ***    
A/swine/England/453/2006  0.83 0.15 **       
A/swine/Italy/50175/2007  1.80 0.10 *** 5.19 0.09 **    
          
     Swine viruses with classical swine HA isolated from humans 
A/Thailand/271/2005  0.67 0.14 * 5.17 0.15 *    
A/Illinois/09/2007  0.75 0.20 *       
A/South Dakota/03/2008  0.65 0.10 *       
A/Iowa/02/2009  2.55 0.10 ***       
          
     Swine viruses with human-like HA 
A/swine/Italy/30019-2/2007 
(H1N2)  
2.13 0.05 ***       
A/swine/Italy/50127/2007  
(H3N2)  
1.45 0.10 ***       
          
     Human pandemic viruses 
A/Hong Kong/1/1968 (H3N2)  0.61 0.05 * 5.08 0.07 *    
A/Hamburg/05/2009  0.67 0.14 * 5.06 0.07 *    
 
a, Viral phenotypes were studied using three assays described in method paragraphs 3.3.5, 3.3.6 and 
3.3.9. The data show mean values of at least two independent experiments and their 95% confidence 
intervals (CI). P values for the difference with respect to a representative avian virus 
(A/duck/Schleswig/21/1979) were calculated using unpaired two-tailed Student´s t-test; *, P < 0.05; **, 
P < 0.005; ***, P < 0.0005. 
b, All viruses are H1N1, if not indicated otherwise.  
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A strong sensitivity to NH4Cl during cell entry can be observed for avian H1N1 virus 
infection ranging from 0.26 to 0.55 mM NH4Cl (figure 4.2a, table 2). In contrast, swine 
viruses display a lower and broader range of NH4Cl susceptibility varying between 0.6 
and 2.5 mM. The two human viruses tested show a slightly higher susceptibility (0.77 
mM) when compared to avian viruses but do not differ significantly. The ability of 
swine viruses to infect cells in the presence of higher NH4Cl concentrations suggests 
that swine viruses enter the cell at a higher pH than both avian and human viruses.    
 
Figure 4.2: Membrane fusion activity and stability of H1N1 viruses. Data depict species 
related mean values of IC50 of NH4C (a), hemolytic activity (pH50-hem) (b) and pH stability      
(pH50-inact) (c) calculated from single experimental points in table 2. P values for the differences 
between viruses of birds, pigs and humans were calculated from single experimental points 
using two-sided unpaired Student´s t-test; *, P < 0.05; **, P < 0.005.  
In addition to pH-dependent fusion activity of the HA, properties of other viral proteins 
(M2, M1 and NP) may affect the pH optimum of virus entry into cells. M2 supports 
viral release regulating the intra-virion pH from that of the endosomal pH (reviewed in 
Scott and Griffin, 2015). The interaction between M1 and NP determines the 
dependence of RNP dissociation on acidification.  Furthermore, interactions between 
M1 and HA/NA may affect fusion efficiency (reviewed in Edinger et al., 2014). In order 
to characterise the HA-specific pH dependency, HA hemolytic activity was determined. 
Virus induced lysis of human red blood cells (hRBCs) was quantified for different pH 
values. The pH of 50% hemolytic activity (pH50-hem) was used for comparison (table 
2). Mean values for viruses from different hosts are depicted in figure 4.2b. The pH of 
hemolytic activity for avian viruses lies within a narrow range between 4.9 and 5.2 pH 
units. (mean: pH 5.0) The HA of swine viruses confer erythrocyte hemolysis ranging 
from pH 5.1 to 5.4 (mean: pH 5.25). The tested human viruses display a pH optimum 
of hemolytic activity at pH 5.1 and thus are comparable to avian viruses. The viral 
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stability depends on the pH optimum of the HA conformational transition (see section 
1.5.2). In the absence of a target membrane the structural rearrangement resulting in the 
fusion competent conformation leads to viral inactivation due to abolished receptor-
binding. To study the pH-dependent viral stability, avian and EAsw viruses were 
incubated in buffers with decreasing pH followed by MDCK cell infection. The pH at 
which viruses were inactivated by 50% (pH50-inact) are listed in table 2, and mean values 
for avian and swine viruses were calculated accordingly (figure 4.2c). The pH that 
inactivates infection of avian viruses ranged from 5.2 to 5.5 (mean: pH 5.3). Porcine 
viruses are inactivated at a mean pH of 5.7 and pH values for single viruses ranged 
from 5.5 to 5.9. Consequently, the higher pH of infection inhibition of EAsw viruses 
suggests a decreased stability when compared to their avian precursors.  
In agreement with the lower susceptibility to NH4Cl during cell entry and the higher 
pH of hemolytic activity, this indicates that for swine HAs the conformational transition 
is initiated at a higher pH than for avian and human viruses. This likely allows swine 
viruses to infect target cells following a less strong acidification. 
 
4.1.1 Analysis of HA sequences of avian and avian-like swine H1N1 
influenza viruses  
 
In order to identify amino acid substitutions in the HA that emerged during the 
establishment of the EAsw lineage and potentially affect membrane fusion activity and 
HA stability, HAs of all tested viruses were sequenced. The amino acid sequence at the 
nodes of the phylogenetic tree which separate EAsw from avian viruses (figure 4.1a) 
was reconstructed by comparing HAs of EAsw viruses isolated from 1979 to 1981 with 
all avian H1 HAs available to date. This comparison revealed eight amino acid 
differences between the putative first EAsw virus and the avian precursor (table 3, 
figure 4.2). HA sequence alignment of closely related avian and EAsw viruses used in 
this study is depicted in figure 4.3. Amino acids are numbered according to H1 HA 
numbering in figure 4.3 and are expressed in accord to the H3 numbering system of 
Noubsawa et al. 1991, hereinafter (see table 3).   
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Figure 4.3: Comparison of amino acid sequences of closely related avian and EAsw viruses. The HA0 
cleavage site is indicated by an arrow. The fusion peptide and HA2 are coloured in red and blue, 
respectively. HA1 is numbered according H1 numbering. Numbering is restarted for HA2. Dots indicate 
sequence accordance with the consensus sequence. Amino acid motif that differ between all avian and 
swine virus HAs are depicted in green.  
Four substitutions are located in the globular head domain of the HA1 subunit (figure 4.4a; 
positions: 126a, 155, 188 and 190; H3 numbering). The two amino acid changes T155I and 
E190D are in close proximity to the receptor-binding pocket (figure 4.4b) and directly interact 
with sialic acid moieties of the receptors. The mutation E190D is known to facilitate adaptation 
of H1 viruses to α2,6-linked sialic acids in humans and pigs (Glaser et al., 2005; Matrosovich 
et al., 2000). Furthermore, glutamic acid at position 190 is conserved among all 16 HA subtypes 
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of aquatic bird viruses. The amino acid 188 is situated at the rim of the receptor-binding pocket 
whereas the conservative mutation S126aN is highly exposed to the solvent and is located in a 
20 Å distance from the receptor-binding site. A potential influence of both residues on receptor-
binding properties is unlikely but cannot be excluded.  Remarkably, none of the four HA1 
mutations are located in regions known to influence HA conformational change or stability.   
  
 
Figure 4.4: Amino acid differences between avian and early avian-like swine H1 HAs. a The globular 
head domain of HA1 (green) contains four amino acid differences (yellow): S126N, T155I, A188T and 
E190D. Four additional substitutions (yellow) are located in the HA2 subunit (cyan): T492S, N722D, 
R752K and S1132F. The fusion peptide is coloured in red. Amino acid positions are numbered according 
to H3 numbering. Mutations are illustrated in X-Ray resolved crystal structure of 
A/mallard/Alberta/35/1976 (2WRH, protein data bank). b Receptor-binding pocket with sialic acid 
receptor as ball-and-stick model. c Interface between two HA monomers in the region of the C helix to 
B loop transition (cyan). 
Another set of substitutions (T492S, N722D, R752K and S1132F) is localized along the HA2 
subunit (figure 4.4). The conservative substitution threonine to serine at amino acid residue 
492 is located in the midsection of the small HA2 helix A and does not contact other parts of 
the HA molecule. Therefore, this substitution is unlikely to affect HA fusion properties. 
Positions 722 and 752 are part of the B loop structure connecting the large central helix C with 
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the antiparallel helix A. Both residues are in close contact with other HA monomers of the 
trimeric complex (figure 4.4c). Substitutions in this region are known to alter HA fusion 
properties (Mair et al., 2014; Russell, 2014; Skehel and Wiley, 2000). Amino acid 1132 is 
located within the long central helix A of HA2 with side chains facing towards the internal 
hydrophobic pocket, which harbours the fusion peptide. The side chains contact phenylalanine 
of residue 32 within the fusion peptide and interact with leucine in position 22 of the 
neighbouring HA2 monomer. Amino acid exchanges influencing the fusion peptide pocket are 
described to alter HA fusion and stability properties (Mair et al., 2014; Russell, 2014; Skehel 
and Wiley, 2000). All of the analysed avian HA sequences harbour serine (S) at position 1132, 
with one exception (Genbank accession number KC209515) that expresses phenylalanine (F) 
at this residue, similar to the EAsw HAs. Remarkably, this mutation emerged after several 
passages of an avian virus (A/mallard/Netherlands/10-Nmkt/1999 (H1N1)) in new born pig 
tracheal cells (Bourret et al., 2013). Hence, this mutation may represent adaptation to cells of 
the porcine respiratory tract. 
Collectively, our analysis of the HA mutations separating avian and swine viruses suggests that 
one to three substitutions in the HA2 subunit may have contributed to the observed alteration 
in the pH requirements for viral cell entry and HA stability. 
 
4.1.2 Influence of mutations acquired during avian-to-swine transmission 
on H1 HA fusion properties  
 
In order to investigate the potential fusion-modulating effect of the four mutations identified 
in the HA2 subunit, fusion activity of single point mutants was studied using cell-expressed 
HA in two cell-based fusion assays. To ensure a high level of expression HAs were cloned in 
pCAGGS plasmids. Single amino acid exchanges were introduced in the HA of 
A/duck/Bavaria/1/1977. The HA of a typical EAsw virus (A/swine/Marseille/2260/1980) was 
included in this study for comparison. 
First, the expression of the wild type and mutant HA plasmids in HeLa cells was tested using 
flow-cytometric analysis. HeLa cells were transfected with each plasmid and HA expression 
was detected using a polyclonal anti-H1 antibody (method section 3.3.10). Figure 4.5 shows 
FITC fluorescent histograms for mock-transfected (grey) in relation to plasmid-transfected 
cells (red). Percentage of cells showing higher fluorescence signals than mock-transfected cells 
was calculated and used as a measure of protein expression levels. The avian HA and the 
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mutants (492S, 722D, 752K and 1132F) show similar HA expression levels, ranging from 70.5% 
to 79.2%. These results indicated that mutations did not significantly affect the levels of protein 
expression. 
 
 
Figure 4.5: Flow-cytometric analysis of HA surface expression in HeLa cells. HeLa cells were 
transfected with plasmids encoding wild type and mutant HAs. Surface expression was detected using 
rabbit anti-H1 and FITC-conjugated anti-rabbit antibodies. 10,000 events were counted and 
percentage of FITC-fluorescent cells was quantified (red line) compared to empty-plasmid transfected 
cells (grey).     
In a next step, the expression plasmids were used in two different cell-based fusion assays. 
Both assays are based on detection of syncytia formation either by quantification of microscope 
images or by measuring luciferase reporter gene expression. 
In order to quantify syncytia formation by light microscopy, HA expressing HeLa cells were 
exposed to low pH conditions followed by Giemsa staining. The ratio of cell nuclei within 
syncytia and the total nuclei amount was calculated to define the pH of fusion induction 
(method section 3.3.11). To determine syncytia formation using luciferase reporter gene 
expression HA expressing HEK293 cells were co-transfected with a Renilla luciferase coding 
plasmid (pGL4.73), and a plasmid coding T7-promotor driven Firefly luciferase (pTM-Luc). 
The cells were mixed with BHK-T7 cells constitutively expressing T7 polymerase. After low 
pH treatment Renilla and Firefly luciferase activity was measured. Firefly luciferase activity 
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was normalized to transfection efficiency represented by Renilla luciferase activity (method 
section 3.3.12).    
Using both assays (figure 4.6 and 4.7), the wild type HA of A/duck/Bavaria/1/1977 was 
observed to induce fusion starting at pH 5.4. The introduction of the avian-like swine amino 
acids in HA at position 722, 752 and 492 did not alter the pH of fusion induction when compared 
to the avian precursor. In contrast, 1132F displayed a 0.2 pH units higher pH of fusion induction 
when compared to the avian HA. Microscopic images for the representative EAsw virus HA 
(A/swine/Marseille/2260/1980) show intense syncytia formation starting at pH 6. In contrast, 
Firefly luciferase activity shown by the porcine HA is not detectable down to pH 5.0 (figure 
4.7). This may be a consequence of increased cell lysis during intense cell-to-cell fusion; 
resulting in reduced Firefly luciferase synthesis. 
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Figure 4.6: Syncytia formation at low pH in HeLa cells expressing wild type and mutant HAs. HeLa 
cells were transfected with avian (black) or swine (blue) wild type or mutant HA (red). Syncytia 
formation was monitored over a range of pH 5.1 – 7.0 a Representative images of fields at pH values 
where syncytia formation was observed first and images from the next higher used pH value are 
depicted. Images were taken at 300x magnification. b Efficiency of syncytia formation within the single 
fields was determined as percentage of cell nuclei in syncytia to total numbers of cell nuclei in the same 
microscopic field. Experiments were repeated twice independently on different days. P values were 
calculated using two-sided unpaired Student´s t-test; ***, P < 0.0005. 
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Figure 4.7: Luciferase activity of HEK293-BHK-T7 hybrid cells after HA cell-to-cell fusion. HeLa 
cells were transfected wild type or mutant plasmid DNA, pGL4.73 and pTM-Luc. Syncytia formation 
efficiency was quantified by determining luciferase activity in relation to transfection efficiency (Renilla 
luciferase activity) at different pH values (5.0 – 7.0). Fluorescence values are plotted as relative 
induction compared to mock-transfection. Relative luciferase activity of avian wild type (a and dashed 
lines  b - f), mutants (b – e; solid lines) and the representative swine HA (A/swine/Marseille/2260/1980, 
f; solid line) are depicted. Graphs show representative results from three independent experiments.  
In conclusion, the mutation S1132F identified during sequence comparison facilitates an 
increase in HA-mediated fusion, whereas effects of other three mutations introduced 
individually were below the detection limits of these assays.    
 
4.1.3 Phenotypic characterisation of the HA of A/duck/Bavaria/1/1977 
virus after serial passages in pigs.  
 
The aim of this project was to identify adaptive mutations associated with avian-to-swine 
transmission. Subsequently, the nature of the mutations was to be studied. On this account, 
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receptor-binding and stability properties as well as replication efficiency in primary human 
tracheo-bronchial epithelial (HTBE) cells was investigated.  
In cooperation with the Friedrich-Löffler Institute (FLI; Insel Riems, Germany) and the 
National Veterinary Research Institute (NVRI; Pulawy, Poland), the avian 
A/duck/Bavaria/1/1977 (H1N1), a putative precursor of EAsw viruses, was serially passaged 
in pigs. For this purpose, pigs were infected intranasally and lung tissue samples were collected 
four days post infection. Sentinel pigs were infected with tissue homogenates prepared from 
collected pooled samples. Four days post infection the procedure was repeated. After passage 
0, 5, 10 and 15 sentinel contact pigs were introduced 2 days post infection in order to monitor 
transmission efficiency (Van Reeth, 2014). Colleagues at the FLI and NVRI isolated viruses 
after passage 15 and 19, respectively. Whereas the original duck virus did not transmit by direct 
contact in pigs, both passaged isolates displayed limited swine-to-swine transmission.  
The HAs of both pig-passaged viruses were sequenced. The sequence analysis revealed five 
coding mutations within the HA glycoprotein of A/duck/Bavaria/1/1977 isolated at the FLI 
(dk/Bav p15): L49M, T155I, K166A, V178I and Q226L (H3 numbering). The virus obtained 
at the NVRI (dk/Bav p19) displayed four amino acid substitutions: K166E, E190D and G225E 
in HA1 subunit and G672S in the HA2 subunit (figure 4.8a). 
The substitutions E190D, Q226L and G225E (figure 4.8b,c) are part of the receptor-binding 
site and are well known to facilitate a switch in the receptor-binding specificity from avian to 
human type preference (Matrosovich et al., 2000, 1997). The side chain of the amino acid at 
position 155 participates in the formation of the pocket that accommodates the acyl substituent 
at 5-N of Neu5Ac. Mutations in this position occurred independently both in the classical swine 
and avian-like swine viruses and it was assumed that these mutations serve to increase the 
affinity of the virus for 5N-glycolyl analog of the sialic acid that is abundant in pigs but absent 
in birds and humans (Matrosovich et al., 2000). Glutamic acid at position 190, glycine at 
position 225 and glutamine at position 226 are conserved among avian viruses of 16 HA 
subtypes (Matrosovich et al., 2008). 
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Figure 4.8: Location of mutations in the HA acquired during passaging of A/duck/Bavaria/1/1977 
in pigs. a One HA monomer is shown in green (HA1) and cyan (HA2). The fusion peptide is coloured 
in red. Mutations identified in the HA of two pig-passaged viruses dk/Bav p15 and dk/Bav p19 are 
illustrated using X-ray data of H1 HA (2WRH, protein data bank). Amino acid positions are named 
according to H3 numbering. b, c Mutations (yellow) identified near the receptor-binding pocket. Sialic 
acid receptor is shown as ball-and-stick model.  
Substitution E190D is known to be essential for adaptation of H1 HA to α2,6-linked sialic acid 
receptors in humans and pigs and occurred several times in nature during pig adaptation. 
(Glaser et al., 2005; Matrosovich et al., 2000). Interestingly, both adaptation experiments 
resulted in amino acid substitutions at position 166 which is located within the globular head 
domain distal to the receptor-binding site. Whereas for dk/Bav p19 (NVRI) lysine (K) was 
substituted by glutamic acid (E), dk/Bav p15 (FLI) displayed a substitution by alanine (A). The 
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resulting decrease in positive charge of the globular head may influence receptor-binding 
avidity.  
Each virus acquired one mutation within the HA stalk; L49M (dk/Bav p15) and G672S (dk/Bav 
p19) respectively. The mutations are located in the HA stalk and are likely involved in the HA 
conformational transition during fusion following acidification and potentially influences HA-
stability.  
 
4.1.3.1 Alteration in receptor-binding specificity during pig passaging 
 
One early step during adaptation to pigs is a switch in receptor-binding specificity (section 
1.5.1.1) from avian (α2,3) to human type (α2,6). The receptor preference, therefore, can be 
used to estimate the degree of adaptation. In order to monitor ongoing adaptation receptor-
binding specificity of the pig-passaged viruses should be investigated. Both viruses acquired 
at least two mutations within the HA that are associated with alterations of receptor-binding 
specificity (dk/Bav p15: Q226L and T155I; dk/Bav p19: G225E and E190D). To characterise 
potential changes in the receptor-binding properties, binding to HRP-conjugated fetuin, 
exhibiting either α2,3- or α2,6-linked sialic acid moieties, was studied. Virus-bound HRP-
fetuin was quantified using TMB and the absorption was measured at 450 nm. Association 
constants (Kass) of virus-fetuin complexes were calculated as described in 3.3.13. 
 
Figure 4.9: Receptor-binding of the original avian virus and its pig-passaged variants. Association 
constants (Kass) for HRP-conjugated fetuin possessing either α2,3- (black) or α2,6-linked (red) sialic 
acid moieties were calculated for avian wild type dk/Bav p0, the two pig-passaged viruses dk/Bav p15 
and dk/Bav p19 and a representative swine virus (sw/Italy/07). Experiments were performed twice 
independently in duplicates each. P values were calculated using two-sided unpaired Student´s t-test; 
*, P < 0.05. 
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The avian wild type virus displayed exclusive binding to sialic acids linked to the penultimate 
sugar by a α2,3 linkage (figure 4.9). Upon several passages in pigs the binding preference of 
dk/Bav p15 and dk/Bav p19 changed to predominant recognition of α2,6-linked sialic moieties, 
although weak binding to avian type receptors remains. A fully adapted representative swine 
virus (sw/Italy/07) possess binding to α2,6-linked sialic acids exclusively. The data indicate 
that the pig-passaged avian A/duck/Bavaria/1/1977 viruses acquired human type receptor-
binding affinity.  
 
4.1.3.2 Changes in HA stability during adaptation of A/dk/Bavaria/1/1977 
in pigs 
 
In section 4.1 it could be demonstrated that HA stability changes during natural avian-to-swine 
transmission. On that account it was to be investigated whether dk/Bav p15 and dk/Bav p19 
differ in HA stability from their avian precursor after experimental adaptation. Both pig-
passaged viruses acquired HA mutations that potentially influence pH induced fusion and HA 
stability (L49M in dk/Bav p15 and G672S in dk/Bav p19). In order to investigate viral stability 
under low pH conditions the viruses were exposed to low pH environments, followed by 
MDCK cell infection (see 4.1).  
 
Figure 4.10: Acid stability of two pig-passaged viruses (dk/Bav p15 and dk/Bav p19, red) and their 
avian precursor A/duck/Bavaria/1/1977 (black). Remaining infectivity after low pH treatment was 
determined using focus forming assay in MDCK cells and expressed as percentage of infectivity under 
neutral conditions. Experiments were done in triplicates and values were obtained from two 
independent experiments. P values were calculated using unpaired two-sided Student´s t-test; ***, P < 
0.0005. 
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The infectivity of the avian precursor A/duck/Bavaria/1/77 showed no reduction (figure 4.10) 
down to pH 5.1 (90% infection). In contrast, pig-passaged viruses dk/Bav p15 and dk/Bav p19 
revealed a significantly reduced ability to infect cells after incubation at pH 5.2 (30% and 60%, 
respectively) and 5.1 (0% and 10%, respectively). Therefore, both passaging experiments 
resulted in viruses exhibiting a decreased stability under low pH conditions. The result agrees 
with the analysis of natural avian and swine isolates and suggests a reduction in HA stability 
during virus adaptation to pigs. 
 
4.1.3.3 Replication efficiency of pig-passaged A/duck/Bavaria/1/1977 in 
human tracheo-bronchial epithelial cells 
 
Pigs are believed to be intermediate hosts that pre-adapt avian viruses for efficient replication 
in humans. Consistently, swine viruses are able to efficiently infect cells of the human airway 
epithelium. To test whether passaging in pigs increased the ability of the avian virus to replicate 
in humans, growth of the pig-passaged viruses in human tracheo-bronchial epithelial (HTBE) 
cultures was studied. HTBE cultures differentiate into ciliated and non-ciliated cells following 
growth on air liquid interface and serve as a model for human airway epithelium (Ilyushina et 
al., 2012; Matrosovich et al., 2007, 2004). Differentiated HTBE were infected with the avian 
wild type (dk/Bav 0) and the pig-passaged viruses dk/Bav p15 and dk/Bav p19. A swine virus 
(A/swine/Italy/50175/2007) and a human 2009 pandemic isolate (A/Hamburg/05/2009) were 
included for comparison. The viral growth was monitored for 144 h, and titres were determined 
as focus forming units (method section 3.3.2).    
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Figure 4.11: Growth curves of pig-passaged viruses (dk/Bav p15 and dk/Bav p19) and their avian 
precursor A/duck/Bavaria/1/1977 in HTBE culture. Air liquid cultures of differentiated HTBE cells 
were infected with 104 FFU/ml of the pig-passaged viruses (dk/Bav p15 and dk/Bav p19, red), the avian 
precursor (dk/BAV p0, black), a swine virus (A/swine/Italy/50175/2007, blue) and a pandemic human 
isolate (A/Hamburg/05/2009, green). Viruses were isolated from the apical cell sides at indicated times, 
and titrated using focus forming assay. Mean values and standard deviations were calculated for 5 
replicates cultures per virus. P values were determined using two-sided, unpaired Student´s t-test; **, 
P < 0.005; ***, P < 0.0005.  
The human pandemic virus A/Hamburg/05/2009 displayed fast growth kinetics reaching peak 
titres of 107 FFU after 48 h (Figure 4.11). The titre for the swine virus peaked at 107 FFU after 
72 h, and consequently displayed a delayed replication efficiency when compared to the human 
virus. The wild type avian virus and the two pig-passaged viruses did not differ in their 
replication and reached titres of 106 FFU within 72 h.  
On this account, the fully adapted swine virus replicates better than avian virus, but less 
effective than the pandemic virus. However, both pig-passaged viruses do not show 
significantly increased fitness in human airway epithelium.  
In sum, the pig-passaged viruses acquired human type receptor-binding as observed for swine 
viruses. In agreement with natural avian-to-swine transmission, experimental adaptation to 
pigs resulted in a decreased stability. These changes do not seem to be sufficient to mediate 
efficient replication in the human respiratory tract.   
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4.2 Fusiogenic activity and stability of H7 viruses from different avian 
species  
 
Recent studies indicate that HA stability and pH of fusion changes during transmission between 
avian and mammal species. This work proved this for an avian-to-swine transmission event 
(section 4.1). However, little is known about differences in stability and fusion in different bird 
species. Gianneccini and colleagues suggest that HA stability and membrane fusion properties 
alter during transmission between bird species, too (Giannecchini et al., 2006). Nevertheless, 
this study comprised only a limited number of viruses and a systematic study of membrane 
fusion and stability properties are missing.  
To fill this gap in knowledge fusion properties of H7 viruses isolated from several wild bird 
species and from terrestrial poultry were to be compared. Our lab had previously compared 
receptor-binding properties of a large set of H7 viruses including representatives of all major 
H7 lineages (Gambaryan et al., 2012). This panel provides the opportunity to test fusion 
properties of wild bird and poultry viruses. In total, 13 wild bird viruses and seven poultry 
viruses were selected (Figure 4.12) from two distinct H7 lineages; the Eurasian (EA) and the 
North American (NAm) lineage. The characterisation of viral fusion properties was performed 
in part by Nancy Mounogou Kouassi in the course of her master thesis (Mounogou Kouassi, 
2014). 
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Figure 4.12: Phylogenetic relationship of avian H7 viruses. The evolutionary tree for HA amino acid 
sequences was generated using the neighbour-joining method included in MEGA6 (Tamura et al., 
2013). Statistical analysis was performed by bootstrapping (100 cycles). The tree based on sequences 
of 65 H7 subtype viruses (for accession numbers see 2.11) available in our lab (Gambaryan et al., 
2012). The scale bar represents 0.05 amino acid substitutions per site. Viruses used in this study are 
coloured in red (wild bird viruses) and blue (poultry viruses). 
RESULTS 
 
 93 
To investigate HA-mediated fusion and viral stability of wild bird (nine EA and four NAm) 
and poultry H7 (five EA and two NAm) viruses, susceptibility to ammonium chloride, pH of 
hemolytic activity and acid stability was determined as described above (see section 3.3.5, 
3.3.6, 3.3.9 and 4.1). To compare H7 viruses with viruses from other subtypes, representative 
viruses from eight additional subtypes (H1, H2, H3, H4, H5, H13, H14, H16; section 2.11) 
were included in this study. The individual experimental results are summarized in table 4 and 
illustrated in figure 4.13.  
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Table 3: Fusion and stability properties of wild bird and poultry H7 viruses. 
Virusa 
Infection inhibition 
by NH4Cl, IC50 
[mM] 
Hemolytic 
activity, pH50-hem 
Inactivation at 
acidic pH, pH50-
inact 
 Mean ± CI Mean ± CI Mean ± CI 
     North American wild aquatic bird viruses       
A/mallard/Alberta/279/1977 (H7N3) 0.38 0.03 5.13 0.16 5.08 0.05 
A/green winged teal/Alberta/228/1985 (H7N3) 0.66 0.08 5.07 0.03 5.17 0.03 
A/ruddy turnstone/DE/1378/1988 (H7N7) 0.41 0.13 5.08 0.05   
A/laughing gull/DE/22/2002 (H7N3) 0.46 0.04 5.33 0.05   
       
     Eurasian wild aquatic bird viruses       
A/duck/HK/293/1978 (H7N2) 0.383 0.021 5.03 0.05 5.03 0.05 
A/mallard/Netherlands/12/2000 (H7N3) 0.98 0.17 5.03 0.05 5.28 0.03 
A/mallard/Italy/33/2001 (H7N3) 0.60 0.14 5.00 0.06 5.16 0.016 
A/mallard/Sweden/56/2002 (H7N7) 1.09 0.09 5.15 0.06 5.14 0.016 
A/mallard/Sweden/102/2002 (H7N7) 1.22 0.07 5.08 0.05 5.43 0.03 
A/mallard/Sweden/105/2002 (H7N7) 1.55 0.29 5.35 0.07 5.44 0.04 
A/mallard/Sweden/106/2002 (H7N7) 0.300 0.019 5.03 0.05 5.15 0.000 
A/mallard/Sweden/64/2003 (H7N7) 0.97 0.09 5.08 0.05 5.18 0.022 
A/mallard/Netherlands/9/2005 (H7Nx) 0.78 0.07 5.12 0.03 5.45 0.05 
       
     North American H7 poultry viruses       
A/turkey/MN/1200/1980 (H7N3) 0.80 0.07 5.23 0.25 5.23 0.05 
A/turkey/MN/1/1988 (H7N9) 0.66 0.05 5.20 0.20 5.08 0.05 
       
     Eurasian H7 poultry viruses       
A/turkey/Italy/977/1999 (H7N1) 1.17 0.24 6.2 0.7 5.53 0.07 
A/turkey/Italy/2732/1999 (H7N1) 1.208 0.016 5.22 0.12 5.22 0.06 
A/turkey/Italy/3560/1999 (H7N1) 1.97 0.12 6.7 0.6 6.09 0.18 
A/turkey /Italy/8912/2002 (H7N3) 1.41 0.13 6.7 0.4 5.49 0.016 
A/turkey/Italy/251/2003 (H7N3) 1.19 0.16 6.1 1.3 5.53 0.07 
       
     Viruses from other subtypes       
A/mallard/Alberta/119/1998 (H1N1) 0.42 0.07 5.15 0.10   
A/mallard/Alberta/205/1998 (H2N9) 0.48 0.12 5.35 0.098   
A/mallard/Alberta/290/1998 (H3N8) 0.252 0.003 5.08 0.049   
A/mallard/Alberta/47/1998 (H4N1) 0.58 0.13 5.23 0.182   
A/duck/Minnesota/1525/1981 (H5N1) 0.42 0.07 5.12 0.033 5.40 0.06 
A/gull/Netherlands/04/2007 (H13N6) 0.32 0.03 5.13 0.049 5.42 0.03 
A/mallard/Guryev/263/1982 (H14N5) 0.46 0.03 5.22 0.163   
A/gull/Netherland/01/2007 (H16N3) 0.43 0.09 5.33 0.049 5.47 0.03 
         a, Viral phenotypes were studied using three assays described in method paragraphs 3.3.4, 3.3.5 and 3.3.8. The 
data show mean values of at least 2 independent experiments and their 95% confidence intervals (CI).  
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Figure 4.13: Membrane fusion activity and stability of EA and NAm H7 viruses. Data depict species 
related mean values of IC50 of NH4Cl (a), hemolytic activity (pH50-hem) (b) and pH stability (pH50-inact) 
(c) from the table 4. EA, Eurasian; NAm, North American; ST, subtypes. P values for the differences 
between viruses of birds, pigs and humans were calculated from single experimental points using two-
sided unpaired Student´s t-test; *, P < 0.05, **, P < 0.005 ***, P < 0.0005  
During infection inhibition EA wild bird viruses show higher susceptibility to NH4Cl (mean 
IC50: 0.8 mM NH4Cl) when compared to EA poultry viruses (mean IC50: 1.4 mM NH4Cl; 
figure 4.13a). In contrast, NAm wild bird viruses are not significantly stronger inhibited 
(mean: 0.5 mM NH4Cl) than NAm poultry viruses (mean: 0.7 mM NH4Cl). Additionally, EA 
H7 viruses from both species were less susceptible to NH4Cl when compared to NAm H7 
viruses and viruses from other subtypes. 
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In a next step, HA hemolytic activity of these viruses was investigated. The quantification of 
50% lysis of red blood cells (pH50-hem) was performed as described in the methods section 
(section 3.3.9) and in the previous chapter (4.1). No difference was observed between NAm 
duck and NAm poultry viruses, both display pH50-hem of 5.1. (figure 4.13b). EA poultry viruses 
show an about 1 pH unit higher mean pH50-hem (mean pH50-hem: pH 6.2) when compared to EA 
duck viruses (mean pH50-hem: pH 5.2). Compared to NAm H7 and viruses from other subtypes 
(mean pH50-hem: pH 5.1), EA poultry viruses display a significantly higher pH50-hem.  
Finally, acid stability of viruses was compared as described in 3.3.6 and 4.1. As expected, EA 
poultry viruses display a 0.4 pH units higher pH of inactivation (mean pHinact: 5.6) when 
compared to EA duck viruses (figure 4.13c). North American viruses display no significant 
difference between poultry (mean pHinact: pH 5.2) and wild bird (mean pHinact: pH 5.2) viruses. 
Viruses of other subtypes displayed a lower acid stability (mean pHinact: pH 5.4) than viruses 
from EA poultry viruses. 
Our results suggest that EA poultry H7 viruses are less dependent on acidification during cell 
entry, show a higher pH of hemolytic activity, and are less stable in acidic environment than 
EA duck H7 viruses. Furthermore, EA poultry H7 viruses show a higher pH of fusion and a 
decreased stability when compared to viruses of other subtypes. In contrast, a few NAm virus 
strains tested do not differ significantly from aquatic bird viruses of other subtypes. 
 
4.3 Characterisation of human adapted influenza A viruses  
 
Human infection with avian or swine viruses are typically restricted to individuals (reviewed 
in Freidl et al., 2014; Short et al., 2015). Recent reports suggest that membrane fusion 
properties contribute to limited transmission upon zoonotic infections. Unlike swine viruses 
(section 4.1) human adapted seasonal and pandemic viruses possess a low pH of fusion 
induction accompanied by high stability (DuBois et al., 2011; Galloway et al., 2013; Reed et 
al., 2010; Scholtissek, 1985). Avian viruses differ in membrane fusion activity depending on 
subtype and strain. In order to identify changes in fusion during human infection, fusion 
properties of pandemic and zoonotic human HAs was to be investigated. 
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4.3.1 HA-mediated fusion of pandemic viruses 
 
In order to study the pH of HA-mediated fusion of human adapted viruses, fusion induction of 
representatives from the four known pandemic viruses was characterised. The HAs of A/Brevig 
Mission/1/1918 (‘Spanish flu’), A/Singapore/1/1957 (‘Asian flu’), A/Hong Kong/1/1968 
(‘Hong Kong flu’) and A/Hamburg/05/2009 (‘Swine flu’) were cloned into expression vectors 
(method section 3.1.4 - 3.1.6) and the start of membrane fusion was investigated using a 
syncytia formation assay (method section 3.3.11). In order to compare fusion properties of 
pandemic viruses with avian and swine viruses, HAs from A/duck/Bavaria/1/1977 and 
A/swine/Marseille/2260/1980 were included in the study.  
Following incubation at low pH, the three pandemic HAs from A/Brevig Mission/1/1918, 
A/Singapore/1/57 and A/Hong Kong/1/1968 display fusion induction at pH below pH 5.2 
(figure 4.14). The HA of the recent pandemic virus, A/Hamburg/05/2009, induces fusion at 
pH 5.4 and with this at the same pH as the avian HA of A/duck/Bavaria/1/1977 (figure 4.14). 
The representative porcine HA (A/swine/Marseille/2260/1980) promotes syncytia formation 
starting from pH 6 (figure 4.14).  
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Figure 4.14: Syncytia formation in HA-expressing HeLa cells upon acidification. HeLa cells were 
transfected with pandemic, avian or swine virus HA. Syncytia formation was monitored over a range 
of 5.1 – 7.0 a Representative images of visual fields at pH values where syncytia formation was observed 
first and images from the next higher measured pH value are depicted. Images were taken at 300x 
magnification b Efficiency of syncytia formation within the single fields was determined as percentage 
of cell nuclei in syncytia to total numbers of cell nuclei in the same field. Values represent the mean of 
two independent experiments. P values were calculated using two-sided unpaired Student´s t-test; ***, 
P < 0.0005. 
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In summary, the HAs of three human pandemic viruses isolated in 1918, 1957 and 1968 show 
a lower pH optimum of HA-mediated fusion than the tested avian and swine HAs. The 2009 
pandemic HA initiate fusion starting from a 0.2 units higher pH when compared to the other 
pandemic HAs. This difference may be a consequence of the porcine origin of this virus and 
suggest this isolate, obtained early during the pandemic course, is not fully adapted to humans, 
yet.   
 
4.3.2 Role of HA substitutions emerged in 1968 pandemic influenza virus 
 
Adaptation of H5N1 viruses to ferrets suggest that at least four substitutions in avian HA may 
be required to establish transmission in mammals. These mutations alter receptor specificity, 
receptor-binding avidity, HA glycosylation and HA stability (Herfst et al., 2012; Imai et al., 
2012; Linster et al., 2014). This part aims to investigate whether this notion applies to human 
pandemic viruses from the past.  
The mature HA of A/Hong Kong/1/1968, an early isolate obtained during the pandemic in 
1968, differs by seven amino acids from the putative avian H3 precursor (Bean et al., 1992; 
Van Poucke et al., 2015; figure 4.15). Two mutations, Q226L and G228S, located in the 
receptor-binding site, interact directly with sialic acid receptors and are well known to facilitate 
a switch in receptor-binding specificity from avian (α2,3) to human (α2,6) type receptors 
(Matrosovich et al., 2000). The remaining five mutations reside in the HA1 subunit. Out of 
these five substitutions, two (A144G and N193S) reside in the globular head domain at the rim 
of the RBP. Three substitutions (D62I, D81N and N92K) are located within the vestigial 
esterase domain which interacts with the HA2 subunit and is involved in the conformational 
transmission during membrane fusion (Skehel and Wiley, 2000; Xu and Wilson, 2011). 
Additionally, substitution D81N generates a glycosylation site. Thus, based on their location 
the five substitutions may influence both receptor-binding and membrane fusion. 
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Figure 4.15: HA substitutions separating A/Hong Kong/1/1968 from avian consensus sequence. a 
H3 HA monomer (2VIU, protein data bank) is coloured in blue (HA1) and green (HA2). HA mutations 
acquired during human adaptation are marked in yellow. One mutation (residue 60) acquired during 
pig-passaging of the avianized mutant rHK/R5 (see the text) is marked in light purple. Amino acid 
positions are numbered according to H3 numbering. b Inset shows amino acid substitution (yellow) in 
the receptor-binding pocket. Sialic acid receptor is depicted as ball-stick model. 
To investigate the role of the five substitutions during viral replication, our lab generated a 
recombinant “avianized” virus (rHK/R5) that contained avian-like amino acids in 
corresponding 5 positions (Hoffmann et al., 2000). rHK/R5 was then compared with wild type 
A/Hong Kong/1/1968 (rHK) for their replication and transmission in pigs. Pigs can be 
efficiently infected by human viruses and show similar pathogenesis to humans (Van Reeth, 
2007; Vincent et al., 2014). This makes swine a useful experimental model to study human 
influenza infection (Meurens et al., 2012; Van Reeth et al., 1998). Our collaborators from 
Ghent University, Sjouke Van Poucke and Kristien Van Reeth, used the pig model to compared 
replication efficiency and transmission of rHK and rHK/R5 (figure 4.16, Van Poucke et al., 
2015). Six- to eight-week-old pigs, serologically negative for influenza, were inoculated 
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intranasally with 106 PFU of either rHK or rHK/R5. After two days six contact pig were 
introduced. Both, direct contact and airborne transmission was possible under the given 
housing conditions. Nasal swaps were collected on a daily basis for 9 days postinoculation and 
postcontact to monitor virus shedding. 50% tissue culture infective doses (TCID50) were 
determined for all swaps by endpoint titration on MDCK cells (described in detail in Van 
Poucke et al., 2015).  
 
Figure 4.16: rHK and rHK/R5 replication and transmission in pigs. Six pigs each were infected with 
either rHK (top panel) or rHK/R5 (bottom panel) and cohoused with six contact animals starting from 
day two post inoculation. Swap samples were taken from inoculated (left bars) and contact animals 
(right bars) daily, followed by TCID50 titration. The detection limit (10 TCID50/ml) is indicated as 
horizontal dotted line. Contact pigs with mutated HA are indicated in blue (T206I), red (D60G) and 
red with black stripes (D60G/D). #, virus-positive sample which was not sequenced. 
No difference in virus shedding was observed between pigs inoculated with rHK and rHK/R5 
(figure 4.16). The wild type rHK virus shows sustained transmission in pigs, whereas no 
transmission could be observed for rHK/R5. Viruses from virus-positive contact animals in the 
rHK/R5 group were sequenced. Viruses isolated from four of five contact pigs contained an 
additional mutation, D60G or T206I. Residue 206 is located in the trimeric interface between 
single HA monomers and was not further investigated in this study. The D60G mutation 
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occurred in the vestigial esterase domain in close proximity of the I62R mutations which 
separates rHK/R5 from rHK (figure 4.15). The virus exhibits the D60G (rHK/R5+1) together 
with the pandemic wild type rHK and the avianized rHK/R5 were characterised regarding 
receptor-binding and HA-mediated membrane fusion activity. 
The receptor-binding to resialylated fetuin containing avian (α2,3) or human (α2,6) type sialic 
moieties was investigated as described in 3.3.13. The pandemic rHK wild type virus and the 
two mutants rHK/R5 and rHK/R5+1 show predominant binding to α2,6 fetuin but still bind 
fetuin harbouring α2,3 sialic acids (figure 4.17a). Thus, introduction of the five avian amino 
acids in HA of rHK does not alter receptor-binding specificity but slightly increases binding 
avidity to both α2,3 and α2,6. The additional mutation detected during pig transmission does 
not further change receptor-binding avidity of rHK/R5+1. 
 
 
Figure 4.17: Receptor-binding and susceptibility against NH4Cl of recombinant A/Hong 
Kong/1/1968 derived viruses. a Association constants of rHK, avian-like rHK/R5 or pig-passaged 
rHK/R5+1 for fetuin presenting either α2-3 (black bars; 3fet) or α2-6 (grey bars; 6fet) sialic acids are 
shown. Error bars represent standard deviation of the data from two independent experiments. *, P < 
0.05. b Inhibition of virus infection by 0.25 mM NH4Cl. Viruses were mixed with 0.25, 0.5 and 1.0 mM 
NH4Cl followed by MDCK cells infection. Remaining infectivity is displayed as percentage of infection 
without NH4Cl. Values resulted from two independent experiments, each performed using three 
replicates. **, P < 0.005; ***, P < 0.0005. 
Three of the five mutations (D61I, D81N and N92K) as well as the pig derived D60G mutation 
are located in the HA vestigial esterase domain between globular head and stalk region. Thus, 
an effect on HA receptor-binding is unlikely. To investigate the role of these mutations on HA-
mediated fusion activity, susceptibility to inhibition by NH4Cl during viral cell entry was 
determined (see chapter 3.3.5 and 4.1). No difference in sensitivity to NH4Cl was observed 
between the human wild type rHK and rHK/R5 (figure 4.17b). The infectivity of both viruses 
is inhibited to a comparable degree using three different NH4Cl concentrations (0.25 mM, 0.5 
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mM and 1.0 mM). In contrast, the pig-passaged virus HK/R5+1 displayed a significant more 
sensitive phenotype at all concentrations.  
These findings suggest that the five avian substitutions do not alter the dependency on 
endosomal acidification. The additional mutation 60G in HK/R5+1 results in a stronger 
reliance on endosomal acidification during viral entry. This suggest that non-optimal 
membrane fusion activity may have contribute to the inefficient transmission of rHK/R5 in 
pigs.  
 
4.3.3 HA-mediated membrane fusion activity of zoonotic 
A/Shanghai/2/2013 (H7N9) isolated from humans 
 
Since May 2013, a H7N9 virus has infected more than 100 people in several provinces in south-
eastern China. This virus had been circulating in poultry before crossing barrier species. 
Typical for zoonotic viruses, more than 75% of the infections were related to poultry contact 
and only little human-to-human transmission was observed (Gao et al., 2013). This virus shows 
dual receptor specificity binding both human and avian type receptors (Watanabe et al., 2013). 
As previous sections of this work demonstrate that membrane fusion properties change during 
interspecies transmission (section 4.1 and 4.2), it was tempting to examine fusion activity of 
the human H7N9 isolate A/Shanghai/2/2013. 
HA and NA of the zoonotic H7N9 virus show high sequence homology to two South East 
Asian avian viruses A/duck/Zhejiang/12/2011 (H7N3) and A/wild bird/Korea/A14/2011 
(H7N9), respectively. The internal genes are likely derived from a closely related H9N2 
A/brambling/Beijing/16/2012-like virus, following reassortment (Gao et al., 2013). In order to 
predict potential mutations occurred prior to and during emergence of the zoonotic H7N9 virus,  
HA sequences of A/Shanghai/2/2013 and A/duck/Zhejang/12/2011 were compared. Seven 
amino acid differences (figure 4.18) separate both HAs. Five of them (D174S, T179V, G186V, 
I202V and Q226L; H3 numbering) are located in the HA globular head domain. The mutations 
G186V and Q226L were identified to alter receptor-binding specificity from avian type to 
human type receptors (Watanabe et al., 2013). Further, two mutations (T712N and N1162D) 
are located in the HA2 stalk domain and may influence HA fusion and stability properties.   
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Figure 4.18: Amino acid differences between A/Shanghai/2/2013(H7N9) and a putative precursor 
in wild birds. a Mutations in HA1 (purple) and in HA2 (blue) are depicted in yellow. Amino acid 
positions are numbered according to H3 numbering and shown using H7 X-ray crystallisation data 
(4LN8; protein data bank). b H7 receptor-binding pocket binding sialic acid. Adjoined mutations are 
shown in yellow. c T712N (red) Interaction at the HA1-HA2 interface.  
To investigate this hypothesis, the A/Shanghai/2/2013 HA was synthesised (GeneScript™) and 
the substitutions T712N and N1162D were reverted to the avian consensus sequence 
independently or in combination with each other by site directed mutagenesis. The wild type 
and mutant A/Shanghai/2/2013 HAs been cloned into pCAGGS expression plasmids and were 
used to determine pH of syncytia formation as described previously (method section 3.3.11).  
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Figure 4.19: Syncytia formation of H7N9 HA-expressing HeLa cells. HeLa cells were transfected 
with plasmids coding for A/Shanghai/2/2013 or mutant HA. After transfection, cells were incubated in 
low pH buffers and cells were stained using Giemsa dye. Micro-photographs were taken at 300x 
magnification. 
The HA of the human isolate A/Shanghai/2/2013 induced cell-to-cell fusion starting at pH 5.2 
(figure 4.19). Introduction of the avian type threonine (T) into position 712 led to an increase 
in the pH of fusion induction by 0.2 pH units. No alteration in the pH fusion was observed after 
introduction of the avian type asparagine (N) at position 1162. Surprisingly, the combination 
of both mutations negates the effect of 712T, and HA initiates fusion at pH 5.2. This result 
suggests that 712N stabilized the HA of A/Shanghai/2/2013 by decreasing the pH-optimum of 
fusion and may have contributed to effective replication in humans.
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5 Discussion 
 
Over the past 100 years four influenza pandemics have cost millions of lives and have caused 
a high economic damage worldwide. These latest pandemics arose from viruses circulating in 
wild aquatic birds. Intermediate hosts, most likely domestic animals such as pigs and different 
poultry species, were thought to have participated in avian-to-human transmission. Thus, 
intermediate hosts may play a crucial role in influenza A virus transmission to humans as they 
act as a link between natural wild life and urban environments (Neumann and Kawaoka, 2015; 
Shelton et al., 2013).  
However, host range restriction is not yet fully defined. A variety of adaptive mutations in the 
viral polymerase and glycoproteins, HA and NA, are described to be essential to overcome 
species barriers. Amongst them, mutations in HA that define receptor specificity are studied 
the best. Domestic pigs and some poultry species express human-like sialic acid receptors on 
the respiratory epithelia. This makes HA adaptation of avian viruses to human-type receptor-
binding more likely, promoting effective transmission to humans (Skehel and Wiley, 2000). 
Recently, HA-mediated fusion and viral stability were identified to restrict inter- and 
intraspecies transmission under laboratory conditions (Herfst et al., 2012; Imai et al., 2012). 
As effective transmission is essential for virus circulation in humans, a certain viral stability 
evolves during pandemic emergence. Thus, characterising the stability of viruses from different 
hosts and subtypes may contribute to predict viral pandemic potential. 
 
This work investigates the role of membrane fusion activity and HA-stability as potential host 
restriction factors during interspecies transmission using several approaches and models. First, 
fusion activity of H1N1 avian-like swine viruses and closely related avian viruses was studied. 
In the second part alterations in HA during adaptation of an avian virus to pigs during 
laboratory experiments were characterised. The third part concentrates on potential differences 
in the pH optimum of fusion activity between closely related poultry and aquatic bird viruses 
of the same subtype. Finally, membrane fusion activity and HA stability of pandemic and 
zoonotic viruses were studied using cell-based fusion assays. 
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5.1 Avian-like swine H1N1 viruses have a higher pH of membrane fusion 
activity than their avian precursors 
 
Comparison of pH optima of HA-mediated fusion and HA stability of closely related avian and 
avian-like swine viruses was performed. The results demonstrated that avian-like swine viruses 
differ from their avian precursors in terms of a decreased susceptibility to the lysosomotropic 
agent ammonium chloride (figure 4.2a). In agreement with this finding, the HA of swine 
viruses possesses a higher pH of hemolytic activity when compared to avian viruses (figure 
4.2b), reflecting a higher pH optimum of HA-mediated membrane fusion activity (figure 4.2c). 
These results confirm similar observation previously made comparing fusion properties of a 
limited collection of avian and swine viruses (Scholtissek, 1985).   
Sequence analysis highlighted eight amino acids that are different between the tested avian and 
avian-like swine viruses (figure 4.4). These residues differ distinctly between HAs from both 
species and substitutions may emerge during avian-to-swine transmission. Among them, the 
swine-like amino acid (1132F) was identified to raise the pH of fusion induction by 0.2 pH 
units when introduced into an avian HA (figures 4.6 and 4.7).  
In order to reproduce the evolution of avian viruses during adaptation to pigs, a typical avian 
virus (A/duck/Bavaria/1/1977) was passaged in pigs by colleagues at the FLI (Riems, 
Germany) and NVRI (Pulawy, Poland). This work demonstrates that the resulting viruses 
obtained after passage 15 and 19, respectively, had acquired human-type receptor specificity 
but maintained binding to avian-type receptors (figure 4.9). Furthermore, a decrease in HA 
stability after treatment at low pH conditions for both pig-passaged viruses could be detected 
as observed for natural avian and swine isolates (figure 4.10). Thus, both pig-passaged viruses 
display an intermediate receptor-binding phenotype between avian and swine viruses. 
Nevertheless, the acquired mutations do not lead to increased replication efficiency in HTBE 
cultures for these viruses (figure 4.11). It is possible that the composition of internal genes or 
imbalance in HA/NA activity restrict replication in human bronchial epithelium. Taken 
together, the pig-passaged viruses show a switch in the receptor specificity and alteration of 
HA stability. The observed genetic and phenotypic changes agree nicely with the analysis of 
natural avian-to-swine transmission (section 4.1). Nevertheless, this does not seem sufficient 
to increase replication efficiency in HTBE cultures and does not confer consistent transmission 
in pigs.  
The pH optimum of HA-mediated fusion, as well, influences the timing and intracellular 
location of viral cell invasion after internalization. During lysosome maturation, endosomes 
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undergo continued acidification by H+-ATPases (Jefferies et al., 2008). Thereby, early 
endosomes possess a mildly acidic environment (pH 6.5 to 6), being further acidified during 
maturation to late endosomes (pH 5.5 to 5.0) and finally to lysosomes (pH 5.0 to 4.6). Influenza 
A viruses are believed to fuse at the stage of the late endosome where the endosomal pH drops 
to pH 5.0 (Grove and Marsh, 2011; Maxfield and Yamashiro, 1987; Sun and Whittaker, 2013). 
The presented results show that porcine viruses can fuse with the endosomal membrane and 
may enter the cytoplasm already at earlier stages during endosome maturation. Early 
endosomes are mostly located in the peripheral regions of the cell (Reviewed in Huotari and 
Helenius, 2011). Consequently, released RNPs reside longer in the cytoplasm until nuclear 
import. This may lead to a more efficient recognition by compounds of the innate immune 
response such as RIG-I. In fact, RIG-I is able to recognize incoming RNPs and binding is 
sufficient to establish an antiviral state within the cell (Ehrhardt et al., 2010; Weber et al., 
2015). On the contrary, the early escape from the maturing endosome may prevent viral 
recognition by endosome-associated innate immune response proteins, like Toll-like receptors 
(TLRs), and minimize the effect of antiviral proteins such as IFITMs (Gerlach et al. in 
preparation). At the time, little is known about the presence and distribution of antiviral 
proteins in endosomes. In addition, information on how fast endosomal acidification takes 
place among avian, swine and human cells is limited. Therefore, further studies on differences 
in cellular physiology and innate immune responses among different host species are needed 
to clarify the importance of this potential immune evasion mechanism. 
There is evidence that cell lines from different species differ in the degree of endosomal 
acidification. For example, Vero cells were found to possess less acidified endosomes 
compared to MDCK cells. As a consequence, avian and human influenza viruses display a 
decreased replication efficiency and evolve a higher pH optimum of fusion after several 
passages in Vero cells (Murakami et al., 2012). It is possible that porcine endosomes harbour 
a smaller number of H+-ATPases resulting in a lower endosomal acidification. This would 
cause a higher endosomal pH and would make a higher pH of fusion induction necessary, as 
was observed for viruses after natural and experimental swine adaptation. To further analyse 
this hypothesis, the expression and activity of H+-ATPases in different species has to be 
investigated in more detail. 
The pH of HA-mediated fusion is strongly related to viral stability in the environment. In fact, 
receptor-binding mediated by HA is abolished when fusion is induced. Consequently, the HA 
conformational change in the absence of a target membrane leads to virus inactivation (Skehel 
and Wiley, 2000). Indeed, infectivity of swine viruses is inhibited when treated at low pH prior 
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to cell culture infection compared to avian viruses (figure 4.2c). The high pH optimum of 
fusion therefore results in decreased environmental stability of swine viruses. This can affect 
both, viral stability in target tissue prior to infection, and efficiency of viral transmission 
between individuals. As the site of infection varies among hosts, changes in HA stability may 
be a result of adaptation to the new environmental conditions. Influenza A viruses infect the 
epithelium of the gastro-intestinal tract in wild birds, whereas they target the respiratory 
epithelium in mammals. Limited analyses of the pH conditions within the respiratory tract of 
humans and swine describe the human epithelium as slightly acidic (pH 5.5 – 6.5) whereas the 
swine respiratory tissue has a more neutral pH (pH 6.93) (Fischer and Widdicombe, 2006; 
Washington et al., 2000). To date, the pH conditions in the avian gastro-intestinal tract are 
poorly investigated. Adaptation to tissues that are acidified to a different degree may have 
contributed to differences in the pH optimum of membrane fusion between avian and swine 
viruses. One can speculate that the relatively neutral pH within the porcine respiratory tract 
allows a higher pH optimum for swine viruses to promote infectivity.  
 
Efficient transmission among individuals is a crucial step in the viral life cycle and with this a 
prerequisite for pandemic emergence. Therefore, viruses have to acquire a certain stability to 
facilitate transmission in a given medium (e.g. water, air or body fluids). Avian viruses require 
a sufficient stability for transmission as they spread via the fecal-oral route including short-
time persistence in water, which is slightly acidic and may lead to an reduced viral stability 
(Brown et al., 2009; Reed et al., 2010). The introduction into mammals results in a different 
viral transmission route as a consequence of different sites of infection. Mammalian viruses, 
in contrast to wild bird viruses, replicate in the respiratory tract. Consequently, either direct 
contact or airborne transmission via respiratory droplets is preferred for mammalian influenza 
A viruses (Sorrell et al., 2011). As a prerequisite for airborne transmission in humans and 
ferrets a switch of avian to human type receptor specificity is needed, as human type α2,6-
linked sialic acids are predominant in the upper human respiratory tract (reviewed in de Graaf 
and Fouchier, 2014). Nevertheless, two groups demonstrated for H5N1 viruses that a switch in 
receptor-binding preference alone is not sufficient to facilitate transmission via respiratory 
droplets in ferrets. Both identified additional mutations that increase receptor-binding avidity 
and create a new glycosylation site in the HA head domain. In addition the ferret-transmissible 
viruses acquired mutations stabilizing HA, indicating a role of HA stability in transmission 
(Imai et al., 2012; Linster et al., 2014). Compared to viruses of other subtypes, H5 virus belong 
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to the least stable influenza viruses (Galloway et al., 2013). As HA stability varies between 
different virus isolates and subtypes it remains unclear whether adaptation of HA stability and 
fusion activity is a general feature of interspecies transmission (DuBois et al., 2011). 
In contrast, low stability H5N1 viruses are able to transmit between ferrets via direct contact 
without mutations increasing their stability (Lowen et al., 2006; Maines et al., 2006; Schrauwen 
and Fouchier, 2014) suggesting less strict stability requirements for direct transmission. H5N1 
viruses studied by others (DuBois et al., 2011; Galloway et al., 2013) and swine viruses tested 
in this work show a comparable low stability. Even though limited studies on transmission of 
these viruses in pigs were performed, the low HA stability of swine viruses makes airborne 
transmission unlikely. It is possible that a high population density in pig farming houses with 
close contact among animals contributes to direct contact transmission. Consequently, HA does 
not necessarily need to possess a high stability to allow transmission. The fast reduction of HA 
stability during emergence of the EAsw lineage suggests an evolutionary advantage during 
avian-to-swine transmission. It is possible that a decreased stability confers a higher replication 
efficiency in the porcine lung.  
In summary, swine viruses differ from their avian precursors by a higher pH optimum of fusion 
and a lower HA stability. Additionally, during laboratory avian-to-swine transmission a 
decrease in HA stability, in addition to the switch in receptor specificity, was identified to 
rapidly occur in the course of pig adaptation. The combination of different pH requirements 
for replication, immune evasion, and transmissibility in different host species may represent a 
host range barrier.  
 
5.2 HA membrane fusion activity of H7 viruses differs between host 
species 
 
To investigate differences in the HA-mediated fusion and stability properties between different 
avian species, wild bird and poultry H7 viruses were compared. Among poultry viruses, H7 
viruses represent the most abundant subtype within poultry populations (Alexander, 2007; Lam 
et al., 2013). The presented results show that Eurasian poultry H7 viruses are less dependent 
on endosomal acidification during cell entry (figure 4.13a), possess a higher pH optimum of 
hemolytic activity (figure 4.13b) and are less stable than viruses from wild birds (figure 
4.13c). Eurasian H7 viruses displayed the highest pH of fusion and the lowest HA stability 
among viruses from all subtypes including North American H7 viruses. This difference does 
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not depend on the viral origin from wild birds or poultry species. One hypothesis is that this is 
the result of a continued exchange of viruses between wild birds and poultry species in Eurasia 
(Lebarbenchon and Stallknecht, 2011).  
North American H7 viruses possess a higher stability (figure 4.13) and display reduced 
virulence in mammals when compared to Eurasian H7 viruses (Belser et al., 2009). In mice, 
influenza viruses displaying a high pH of fusion show a higher virulence and pathogenicity 
than stable viruses with lower pH of fusion. H7 viruses of the Eurasian lineage are able to 
replicate efficiently in the respiratory tract without preceding adaptation (Belser et al., 2007; 
de Wit et al., 2005). This finding and the wide circulation of H7 viruses in domestic animals 
raise public health concerns. Nevertheless there is no evidence that humans are more 
susceptible to infection with H7 viruses than to viruses of other subtypes (Dybing et al., 2000), 
even though some North American H7 viruses are more adapted to humans based on their 
receptor-binding profile (Belser et al., 2009). 
Despite the fact that viruses with H5 HA were not investigated in this study, other studies 
indicate that H5 viruses show a similar stability to the tested H7 viruses (Russell, 2014). Both 
H5 and H7 viruses have caused human infections in the past. However, human infection with 
neither of them was accompanied by airborne human-to-human transmission, as most of the 
human infections can be traced back to direct contact to poultry (Gao et al., 2013). It is possible  
that airborne transmission requires a certain viral stability in order to be effective. Accordingly, 
the low stability of H7 and H5 viruses may obstruct airborne transmission and potentially 
favours direct contact transmission. 
The availability of early human H7N9 isolates from the recent outbreak in 2013 in Southeast 
Asia provides an opportunity to study potential changes in H7 virus stability during zoonotic 
infection. Early characterisation of these isolates revealed a dual receptor specificity (Watanabe 
et al., 2013). However, these viruses bind human-type receptors with low affinity. It is not clear 
whether the virus acquired human type receptor-binding before or shortly after human infection 
(Zhou et al., 2013). The human H7N9 can replicate efficiently in human trachea and lung 
cultures (Zhou et al., 2013). In the presented work, two mutations (T712N and N1162D) in the 
HA stalk were identified to separate the human isolate from the closest known avian virus. The 
avian-like amino acids were introduced into the HA of the human isolate and HA fusion activity 
was characterised. The exchange of threonine by asparagine in residue 712 results in an increase 
in the pH of fusion induction (figure 4.19). This indicates that A/Shanghai/2/2013 acquired a 
more stable HA than the closest avian virus prior to or following human infection. However, 
the zoonotic H7N9 is still less stable than known human-transmissible viruses. This fact could 
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be responsible at least in part for the inefficient human-to-human transmission during the recent 
H7N9 outbreak (Gao et al., 2013). The limited airborne transmission suggests that this virus is 
not yet fully adapted to humans and virus stability may increase with continued evolution in 
humans. A similar observation was made for currently circulating descendants of the swine-
origin 2009 pandemic virus. Directly after transmission to humans, the 2009 pandemic virus 
HA exhibits a lower stability than virus isolates of earlier pandemics (figure 4.14). Even 
though the virus readily transmitted among humans, continued circulation in the population 
resulted in increased stability (Cotter et al., 2014).  
Since a higher viral stability may be accompanied by a higher transmission efficiency, further 
studies involving recent human H7N9 are needed to elucidate the H7N9 virus evolution.  
 
The results presented in this thesis show that Eurasian H7 viruses from domestic birds possess 
a low environmental stability. As all known pandemic viruses show a high stability, which is 
believed to contribute to airborne transmission, the low stability of EA H7 viruses may hamper 
establishment in humans. Furthermore, the fusion modulating mutation in the human H7N9 in 
in addition to human type receptor-binding may have increased viral fitness in humans 
compared to typical poultry viruses. Nevertheless, the H7N9 virus is still not as stable as human 
adapted viruses and, in combination with other factors, this seems to limit transmissibility. The 
H7N9 outbreak in 2013, the circulation of several H7 viruses ready to infect humans, and the 
wide genetic compatibility of H7 HA with several NA subtypes illustrate the potential of H7 
viruses to cause a future pandemic.  
 
5.3 Membrane fusion activity and receptor-binding avidity of the HA of 
A/Hong Kong/1/1968  
 
The HA of the early pandemic isolate A/Hong Kong/1/1968 differs by seven amino acid 
substitutions from its predicted avian H3 precursor. Two of these mutations (Q222L and 
G226S) are known to facilitate the switch in receptor-binding specificity from avian to human 
type binding (Rogers and Paulson, 1983; Viswanathan et al., 2010). Results of the present work 
indicate that the five remaining mutations (R61I, D81N, N92K, A144G and N193S) when 
reverted to the avian sequence (rHK/R5), increase receptor-binding avidity to both human and 
avian type sialic acid receptors (figure 4.17a). No effect on dependency on acidification during 
cell entry could be observed (figure 4.17b). This is in contrast to poultry H5 viruses that need 
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to change HA-stability for adaptation to humans (Herfst et al., 2012; Imai et al., 2012). Whereas 
most avian H5 viruses possess a low stability, the avian precursor of the 1968 pandemic virus 
was sufficiently stable to replicate in, and transmit between humans. Thus, avian viruses may 
or may not require changes in fusion pH and stability depending on their origin and properties. 
Both, rHK and rHK/R5 are able to replicate in pigs (figure 4.16), but unlike the human wild 
type, rHK/R5 is not able to transmit efficiently between pigs (Van Poucke et al., 2015). As 
discussed in section 1.7, changes in the receptor specificity, binding avidity, and stability were 
required for airborne transmission of two different H5N1 avian viruses in ferrets (Imai et al., 
2012; Linster et al., 2014). Alteration of receptor-binding avidity but no difference in HA 
stability have occurred during the emergence of the 1968 pandemic virus. In this work, the HA 
glycosylation status was not studied, but sequence analysis identified the mutation D81N to 
remove a potential glycosylation site within the HA. It is likely that the removal of this 
glycosylation site contributes to changes in binding avidity. Further studies using single point 
mutants are needed to understand the role of this position during the emergence of the 1968 
pandemic virus.  
After several rounds of replication in pigs an additional mutation in the HA occurred, D60G. 
This position is structurally in close proximity to the reverted amino acid 62 and may 
complement its function. A phenotypic characterisation of the virus harbouring D60G revealed 
a lower pH of fusion during cell entry but displayed no altered receptor-binding avidity when 
compared to rHK/R5. It is likely that the lower pH of membrane fusion results in a higher HA 
stability. This finding disagrees with the increase of fusion pH observed during natural avian-
to-swine transmission shown in section 4.1. It is possible that this discrepancy is a result of 
different environmental settings. Differences in housing conditions (e.g. space per pig) in 
piggeries and laboratories may favour either direct or airborne transmission, which may 
influence stability necessities for transmission. However, the specific reason for this 
disagreement is not clear and further studies are needed for elucidation. Nevertheless, selection 
of the D60G mutation during transmission suggests that it compensates at least partially for 
avian-like amino acids in rHK/R5.  
As human viruses transmit via respiratory droplets (Belser et al., 2013; Tellier, 2006) and infect 
cells in the acidic environment of the human airway cavity (England et al., 1999; Washington 
et al., 2000), they may require a more stable HA. Our results indicate that five non-226/228 
mutations in the HA served to optimize viral receptor-binding avidity but have no influence on 
fusion and stability properties. Taking into account that the five mutations arose during 
adaptation to humans, HA stabilization seems to be important for the emergence of this 
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pandemic virus and may facilitate human-to-human transmission. To investigate the role of 
individual substitutions, single point mutants should be studied in the future. 
In summary, this work identifies swine viruses and Eurasian poultry H7 viruses to have a higher 
pH optimum of HA-mediated fusion and a lower HA stability than both wild bird and human 
viruses. These differences seem to influence interspecies transmission but most likely do not 
prevent general infection by contact transmission. Considering these findings, HA stability 
seems to be less important for individual infections, but required for viral spread within a 
population. Analysis of mutations acquired during transmission of the pandemic A/Hong 
Kong/1/1968 virus and the human H7N9 virus shows similar adaptation processes, indicating 
modification of HA fusion and stability properties. Therefore, viral replication and 
transmission may depend on optimal stability and fusion properties which represent potential 
host range restriction factors. However, many other factors, which have yet to be determined, 
characterise these optimal fusion properties. The findings presented in this work prompt further 
studies on membrane fusion characteristics in different host species and their potential effect 
on the zoonotic and pandemic potential of influenza A viruses.   
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8 Appendices 
8.1 Abbreviations 
 
A Absorption 
ATP  
 
Adenosine triphosphate 
 
BHK Baby hamster kidney 
BSA 
 
Bovine serum albumin 
 
c Concentration 
CI Confidence interval 
cm2 Square centimetre 
Crm1 Chromosomal maintenance 1 
cRNA complementary RNA 
CT Cytoplasmic tail 
CMV 
 
Cytomegalovirus 
 
DMEM  Dulbecco´s modified Eagle´s medium 
DNA Deoxyribonucleic acid 
dNTP 
 
Deoxynucleoside triphosphate 
 
EA Eurasian 
EAsw Eurasian avian-like swine 
EDTA Ethylenediaminetetraacetic acid 
e.g. exempli gratia (for example) 
ELISA Enzyme-linked immunosorbent assay 
ESWI European Scientific Working group on Influenza 
et al. 
 
et alii (and others) 
 
FAO Food and Agriculture Organization 
FCS Fetal calf serum 
FFU  Focus forming units 
FITC Fluorescein isothiocanate 
FLI 
 
Friedrich Loeffler Institute 
 
Gal Galactose 
GP 
 
Glycoprotein 
 
h Hour 
HA  Hemagglutinin 
HAD Hemadsorption site 
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HAT Human airway trypsine-like protease 
HAU Hemagglutination units 
HEF Hemagglutinin-esterase-fusion protein 
HEK human embryonic kidney 
HeLa Henrietta Lacks 
HPAI High pathogenic avian influenza  
hRBC  human red blood cells 
HRP Horse radish peroxidase 
HTBE 
 
Human tracheobronchial epithelial cells 
 
IC Inhibition concentration 
IFITM Interferon induced transmembrane protein 
IFN  Interferon 
IgG 
 
Immunoglobulin G 
 
Kb 
 
Kilo-base pair 
 
LB Lysogeny broth 
LPAIV 
 
Low pathogenic avian influenza virus 
 
M Mole 
M1/2 Matrixprotein 1/2 
mA Milliampere 
MCM Minichromosome maintenance compex 
MDCK Madin-Darby canine kidney 
MEM Minimum essential medium  
min Minute 
ml Millilitre 
mM Millimole 
MOI Multiplicity of infection 
mRNA 
 
messenger RNA 
 
NA Neuraminidase 
NAm North American 
NCBI National Centre for Biotechnology Information 
NEP Nuclear export protein 
NES Nuclear export sequence 
Neu5Ac N-acetylneuraminic acid 
Neu5Gc N-glycolylneuraminic acid 
ng Nanogramme 
NLS  Nuclear localization sequence 
nm Nanometre 
NP Nucleoprotein 
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NS1/2 Non structural protein 1/2 
NVRI National veterinary research institute  
NXF1 
 
Nuclear RNA export factor 1 
 
OIE 
 
World Organisation for Animal Health 
 
PA Polymerase acidic 
PB1 Polymerase basic 1 
PB2 Polymerase basic 2 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
PFU Plaque forming units 
Pfu Pyrococcus furiosus 
pH 
 
Potentia hydrogenii 
 
RBP Receptor-binding pocket 
rER Rough endoplasmic reticulum 
RIG-I Retinoic acid-inducible gene 1 
RNA Ribonucleic acid 
RNP Ribonucleoprotein 
rpm Revolutions per minute 
RT-PCR 
 
Reverse transcription polymerase chain reaction 
 
SAP Shrimp alkaline phosphatase 
sec Second 
SGP Sialylglycopolymers 
SP 
 
Signal peptide 
 
TBE Tris-Borate-EDTA 
TCID50 50% Tissue culture infective dose 
TM Transmembrane domain 
TMB 3,3′,5,5′-Tetramethylbenzidine  
TMPRSS2/4 Transmembrane protease serine S2/4 
TPCK Tosyl phenylalanyl chloromethyl ketone  
TREX Transcription export complex 
TSS Transformation and storage solution 
µg Microgramme 
µl Microlitre 
USA 
 
United States of America 
 
V Volts 
vRNA 
 
viral RNA 
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WHO World Health Organisation 
wt wild type 
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8.2 Amino acid abbreviations 
 
 
 
 
Amino acid 3-letter code 1-letter code 
Alanine  Ala A 
Arginine Arg R 
Asparagine Asn N 
Aspartic acid Asp D 
Cysteine Cys C 
Glutamic acid Glu E 
Glutamine Gln Q 
Glycine Gly G 
Histidine His H 
Isoleucine Ile I 
Leucine Leu L 
Lysine Lys K 
Methionine Met M 
Phenylalanine Phe F 
Proline Pro P 
Serine Ser S 
Threonine Thr T 
Tryptophan Try W 
Tyrosine Tyr Y 
Valine Val V 
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